data_1tle_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tle _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.472 ' ND2' ' OD1' ' A' ' 37' ' ' ASP . 2.8 m120 -54.09 170.41 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.489 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.72 67.36 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.2 -0.937 . . . . 0.0 110.912 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -142.82 62.72 1.4 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.93 -1.106 . . . . 0.0 109.17 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.547 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -154.14 152.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -107.77 129.23 24.47 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.26 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.91 -6.65 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.625 2.217 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.47 -69.33 0.57 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 169.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.596 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.01 152.78 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.256 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.62 65.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -15.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.091 -1.241 . . . . 0.0 111.019 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 150.0 43.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.723 -1.235 . . . . 0.0 109.476 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' ND2' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -84.29 122.06 28.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -6.91 57.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.844 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' N ' ' A' ' 21' ' ' THR . 2.5 pt? -108.22 -45.08 4.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 111.147 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.582 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -91.71 -15.5 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.65 -1.281 . . . . 0.0 110.199 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.96 61.01 5.87 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' CG ' ' ND2' ' A' ' 18' ' ' ASN . 9.2 pt-20 -156.56 152.46 27.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -1.164 . . . . 0.0 108.404 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 35.6 m -51.94 118.97 3.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.359 -1.463 . . . . 0.0 109.858 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CB ' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -84.61 -31.37 24.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.917 -1.115 . . . . 0.0 109.335 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -143.89 84.66 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' THR . 9.7 m -53.42 155.69 2.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.518 -1.364 . . . . 0.0 108.655 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -86.44 -66.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.04 -1.038 . . . . 0.0 112.452 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.547 ' O ' ' CG2' ' A' ' 31' ' ' THR . 19.0 m-85 -64.58 77.73 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.558 -0.714 . . . . 0.0 112.63 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m120 26.0 48.87 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.159 0.504 . . . . 0.0 111.504 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 44.6 p -121.92 150.94 41.28 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 109.635 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -139.32 171.46 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.68 158.63 10.67 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.27 -29.59 47.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -1.1 . . . . 0.0 110.095 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.99 32.0 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.812 -1.18 . . . . 0.0 109.77 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' CB ' ' A' ' 24' ' ' CYS . 90.0 m 49.74 27.23 2.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.211 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.472 ' OD1' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -94.82 20.44 8.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.342 -0.848 . . . . 0.0 109.624 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -130.7 -174.6 3.41 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.074 -1.017 . . . . 0.0 109.577 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 98.8 m -120.15 135.43 54.96 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' CE ' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -55.77 147.14 19.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.552 -1.343 . . . . 0.0 110.09 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.15 123.59 17.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.701 . . . . 0.0 109.69 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.43 -33.38 4.17 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.51 ' CE2' ' CE ' ' A' ' 40' ' ' LYS . 7.9 m-85 -122.47 129.83 52.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.219 1.009 . . . . 0.0 108.726 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.6 m-85 -118.46 178.85 4.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.16 -143.8 14.59 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 80.8 m-20 -115.98 110.11 44.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.482 -1.01 . . . . 0.0 109.061 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.492 ' CB ' HG23 ' A' ' 31' ' ' THR . 36.4 Cg_endo -78.42 -9.78 16.16 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.169 1.913 . . . . 0.0 110.586 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.79 37.89 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.23 153.16 41.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.232 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HG2' ' ND2' ' A' ' 51' ' ' ASN . 33.9 Cg_endo -75.01 -29.67 7.97 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.117 1.878 . . . . 0.0 108.949 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.49 ' ND2' ' HG2' ' A' ' 50' ' ' PRO . 4.4 m-80 -101.27 138.56 19.97 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.75 -19.4 16.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.104 1.869 . . . . 0.0 110.142 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.14 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 109.194 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -113.38 17.84 18.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 109.288 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -71.85 -130.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 9.7 m -101.07 102.89 13.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.8 mmtt -109.2 168.28 9.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.387 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 14.4 m120 -159.83 -160.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER 81.88 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 0.0 110.338 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.5 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 4.6 m120 -132.93 73.0 1.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.522 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.8 pp -146.48 150.85 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 108.921 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 3.6 m-20 -109.29 142.28 25.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.208 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.27 -8.94 17.62 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.507 2.138 . . . . 0.0 110.406 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -76.75 -48.66 18.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.466 -0.771 . . . . 0.0 110.804 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.36 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.564 -1.335 . . . . 0.0 108.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.96 83.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.859 -1.15 . . . . 0.0 110.916 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.64 -38.21 3.42 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.51 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 4.7 m-80 52.22 16.43 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -1.225 . . . . 0.0 110.251 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.2 p -129.75 169.72 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.665 -1.272 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.53 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.31 122.47 20.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.768 -1.208 . . . . 0.0 108.247 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -18.12 55.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.028 -1.045 . . . . 0.0 110.422 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -39.25 6.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 111.898 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -90.59 -42.26 10.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.342 -1.474 . . . . 0.0 110.411 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.11 76.07 1.32 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.8 tp10 -176.61 163.1 2.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.941 -1.329 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.465 ' SG ' ' CG2' ' A' ' 9' ' ' ILE . 3.5 m -48.34 114.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.0 109.218 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 12.5 tp -122.43 12.69 10.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.223 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HG3' ' C ' ' A' ' 25' ' ' LEU . 10.4 mttm -154.02 67.21 0.73 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 36.9 m -53.09 149.6 6.63 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.806 -1.184 . . . . 0.0 108.559 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.568 HD13 ' CE2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -104.13 -62.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.065 -1.022 . . . . 0.0 112.481 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' HD13 ' A' ' 28' ' ' ILE . 69.5 m-85 -69.7 73.07 0.38 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 29' ' ' TYR . 8.1 m-20 27.48 59.13 0.1 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.0 111.056 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 27' ' ' CYS . 30.8 p -121.74 152.38 39.5 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.43 -168.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.387 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.95 23.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.58 -30.5 63.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.913 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 64.5 m-85 -114.55 31.88 6.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.796 -1.19 . . . . 0.0 109.333 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.8 m 49.64 41.21 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 108.979 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -95.68 8.52 43.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -173.76 3.15 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.003 -1.061 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.64 137.57 53.79 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -55.82 146.73 20.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.65 -1.281 . . . . 0.0 109.791 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.31 129.0 38.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.249 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.85 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.221 -2.752 . . . . 0.0 106.221 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.66 129.96 46.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.102 0.953 . . . . 0.0 108.658 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -113.01 -173.95 2.35 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.65 -142.18 13.47 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.992 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 48.8 m-20 -129.08 103.72 18.42 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.536 -0.979 . . . . 0.0 109.173 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.436 ' CB ' HG23 ' A' ' 31' ' ' THR . 33.3 Cg_endo -73.4 -5.95 18.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.806 1.671 . . . . 0.0 110.283 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.86 38.65 2.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 108.867 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.4 158.11 37.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.828 . . . . 0.0 109.111 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 -15.76 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.288 1.992 . . . . 0.0 109.986 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.453 ' CB ' ' HB2' ' A' ' 54' ' ' ASP . 2.6 m-20 -100.45 135.24 20.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 108.958 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.29 -19.22 17.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 0.0 110.782 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.27 -1.0 25.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.884 -1.135 . . . . 0.0 109.623 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.453 ' HB2' ' CB ' ' A' ' 51' ' ' ASN . 1.8 m-20 -107.76 -3.42 19.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 12.8 mttp -59.27 -105.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 110.312 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 73.7 m -75.21 177.39 6.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.709 -1.244 . . . . 0.0 108.592 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER 163.63 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.202 -0.936 . . . . 0.0 109.79 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' HG22 ' A' ' 9' ' ' ILE . 1.5 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.356 0.598 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 55.2 m-80 -164.59 -165.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 56.9 m-20 66.4 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 110.608 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.568 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 2.3 m120 -115.73 63.45 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.123 . . . . 0.0 110.959 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.49 ' C ' HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -142.47 173.19 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.074 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.519 ' OD2' ' CG2' ' A' ' 28' ' ' ILE . 6.9 m-20 -107.8 128.56 25.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.845 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 -1.03 11.16 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.723 2.282 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.64 -68.82 0.59 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.369 -0.832 . . . . 0.0 109.381 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.43 161.7 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.894 -1.129 . . . . 0.0 108.694 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.7 116.51 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 0.0 109.971 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 108.55 -40.35 2.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 15' ' ' GLY . 2.7 m-80 38.85 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.997 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 15' ' ' GLY . 15.5 p -124.98 172.5 9.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.772 -1.205 . . . . 0.0 110.691 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 126.36 29.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -20.48 54.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.803 -1.186 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.08 -42.68 4.36 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.812 -1.18 . . . . 0.0 111.924 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -82.81 -32.94 27.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.436 -1.415 . . . . 0.0 110.228 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 76.22 67.31 1.71 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -160.69 158.95 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.243 . . . . 0.0 108.978 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 72.4 m -48.45 111.54 0.47 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.074 -1.016 . . . . 0.0 108.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.567 ' HB2' ' ND2' ' A' ' 18' ' ' ASN . 37.7 tp -126.8 9.47 6.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.248 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -126.1 60.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 111.561 -179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 67.2 m -56.34 146.37 24.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.549 -1.344 . . . . 0.0 107.741 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -110.02 -62.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.629 -1.294 . . . . 0.0 112.813 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 28' ' ' ILE . 60.2 m-85 -72.59 69.54 0.88 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.27 -0.894 . . . . 0.0 112.69 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 33.63 63.79 0.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.431 177.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 47' ' ' PRO . 3.3 p -122.1 158.82 28.44 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.219 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -118.32 -173.4 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.975 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.61 147.9 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.03 -33.93 58.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -1.066 . . . . 0.0 109.816 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' SG ' ' A' ' 24' ' ' CYS . 3.7 m-85 -116.28 36.91 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.91 -1.119 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 5.3 m 52.99 50.54 17.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.991 . . . . 0.0 108.804 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -92.99 -6.32 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.013 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.28 -167.64 1.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 6.2 m -121.6 137.36 54.77 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -55.4 149.28 13.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.556 -1.34 . . . . 0.0 109.661 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 126.67 28.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.647 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.22 4.22 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.544 ' HB3' ' CA ' ' A' ' 57' ' ' LYS . 25.4 m-85 -127.92 129.86 47.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.159 0.98 . . . . 0.0 109.076 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.14 178.62 4.25 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.61 -144.52 14.89 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.336 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.4 m120 -132.66 105.28 12.97 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.897 . . . . 0.0 108.947 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' HG23 ' A' ' 31' ' ' THR . 31.5 Cg_endo -71.72 0.78 6.5 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.305 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.38 41.51 2.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.03 -1.044 . . . . 0.0 109.18 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.2 157.36 38.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.247 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.93 -13.72 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.335 2.023 . . . . 0.0 110.422 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 3.3 m120 -100.55 132.5 22.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.7 -20.18 13.83 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.145 1.896 . . . . 0.0 110.638 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.36 -8.43 45.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.998 -1.064 . . . . 0.0 109.623 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 51' ' ' ASN . 46.2 m-20 -105.69 -15.35 14.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.708 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.4 mtmm -59.3 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.094 -1.004 . . . . 0.0 109.933 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 85.6 m -93.93 144.89 25.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 108.79 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.544 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 170.36 172.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.34 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.2 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 m120 -52.09 -176.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.0 70.62 5.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.003 -1.061 . . . . 0.0 110.65 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 77.2 m-20 -144.88 63.66 1.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.887 -1.133 . . . . 0.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pt -149.96 150.32 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.171 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 1.4 m-20 -108.39 120.08 47.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 109.242 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.54 -3.79 14.41 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.551 2.167 . . . . 0.0 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.29 -67.75 0.71 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 109.488 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.76 179.22 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.402 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.09 149.27 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 109.54 -12.8 33.01 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -38.22 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -1.161 . . . . 0.0 110.474 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' GLY . 6.3 t -123.88 156.12 36.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -81.08 119.21 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -18.27 63.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.824 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.92 -40.6 5.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.818 -1.176 . . . . 0.0 111.817 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 1.9 p -91.34 -33.54 15.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.424 -1.423 . . . . 0.0 110.667 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 82.69 70.24 1.36 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 4.3 tp10 -163.41 167.98 20.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.27 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 62.2 m -64.44 107.13 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.487 -1.383 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.515 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.75 14.8 25.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 70.81 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.703 -1.248 . . . . 0.0 111.422 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 75.2 m -54.78 148.61 12.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.303 -1.498 . . . . 0.0 108.293 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.47 -63.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.794 -1.191 . . . . 0.0 112.82 -178.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.519 ' O ' ' CG2' ' A' ' 31' ' ' THR . 99.4 m-85 -57.17 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 0.0 112.159 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 29' ' ' TYR . 62.2 m-80 21.2 49.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.356 0.598 . . . . 0.0 111.341 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 26.6 p -122.86 155.21 37.09 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.364 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -125.01 -162.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.564 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.19 146.39 6.58 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.99 -30.02 13.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.478 -1.013 . . . . 0.0 109.828 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.98 41.32 3.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.75 -1.219 . . . . 0.0 109.838 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.6 m 50.6 29.74 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.005 . . . . 0.0 109.573 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -90.23 10.73 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 -167.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.256 -0.903 . . . . 0.0 109.167 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.483 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 23.0 m -121.84 128.8 52.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -57.0 143.45 38.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.61 126.26 26.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.88 -31.65 4.68 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -134.23 128.39 33.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.195 0.998 . . . . 0.0 109.428 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 4.8 m-85 -108.2 -179.38 3.87 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.76 -142.21 13.63 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.373 -1.394 . . . . 0.0 109.997 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 58.8 m-80 -128.56 105.07 19.17 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.933 . . . . 0.0 109.121 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.7 Cg_endo -80.34 -4.81 13.27 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.406 2.071 . . . . 0.0 110.357 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.2 mt -110.08 38.48 2.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.21 36.3 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.133 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.67 -24.07 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.201 1.934 . . . . 0.0 109.277 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.2 135.56 19.88 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 -18.99 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.193 1.928 . . . . 0.0 110.29 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.93 -17.66 60.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 109.419 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 55' ' ' LYS . 96.9 m-20 -105.03 11.91 32.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.5 OUTLIER -63.41 -139.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.324 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 14.1 m -99.69 104.33 16.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.866 -1.146 . . . . 0.0 108.913 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mtmt -109.1 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.484 179.927 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.275 0.559 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -78.24 81.32 4.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.086 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -152.59 -134.92 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.496 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 15.6 m120 -89.42 76.14 7.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 110.066 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.585 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -141.73 167.01 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 108.877 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.551 ' OD2' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -105.12 135.35 19.32 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.365 -0.834 . . . . 0.0 109.156 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.43 -25.22 9.92 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.362 2.042 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -77.32 -10.58 59.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 111.086 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.83 -165.8 0.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.286 -1.509 . . . . 0.0 109.017 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.3 t -111.63 83.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 110.288 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 81.92 -19.69 9.34 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.798 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-80 45.12 25.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.424 . . . . 0.0 109.214 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 34.1 m -123.0 175.94 6.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.91 123.38 31.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -61.84 -10.92 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 110.963 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 21' ' ' THR . 1.9 pt? -110.33 -41.05 4.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.7 -1.25 . . . . 0.0 111.986 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.567 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -90.12 -33.01 16.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.292 -1.505 . . . . 0.0 110.132 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.99 1.33 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -166.35 145.87 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.32 . . . . 0.0 109.384 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.25 107.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.589 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.36 44.28 2.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.0 110.534 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -148.72 60.07 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 108.895 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 92.1 m -54.15 150.03 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.87 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.585 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.82 -62.05 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.279 -0.888 . . . . 0.0 111.92 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE1' HD11 ' A' ' 28' ' ' ILE . 8.8 m-30 -75.24 65.62 1.61 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.647 -0.658 . . . . 0.0 112.378 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 29' ' ' TYR . 17.3 m120 38.47 62.07 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 110.924 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.406 HG23 ' OD1' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -125.74 156.79 38.85 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.284 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -122.98 -164.99 1.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.38 22.28 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -32.96 43.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -1.069 . . . . 0.0 109.712 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.473 ' OH ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 m-85 -121.47 38.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 109.557 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.4 m 55.72 33.3 21.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.547 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.81 13.77 13.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -131.31 -178.08 4.69 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 64.1 m -125.49 129.79 50.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -56.99 143.43 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.696 -1.252 . . . . 0.0 109.729 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.11 136.3 57.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.274 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.27 -39.85 2.2 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 106.25 -2.74 . . . . 0.0 106.25 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 56' ' ' CYS . 8.9 m-85 -120.55 130.98 54.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -109.61 175.57 5.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 130.69 -140.79 12.06 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 6.8 m-80 -134.01 123.23 16.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.672 -0.899 . . . . 0.0 109.091 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.3 Cg_endo -77.28 -8.31 17.38 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.742 1.628 . . . . 0.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.08 38.59 2.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.41 151.0 37.28 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.48 -25.23 13.2 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.272 1.981 . . . . 0.0 109.56 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.92 134.44 20.44 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.47 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 33.7 Cg_endo -75.75 -17.16 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.996 1.797 . . . . 0.0 110.169 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.51 -13.44 54.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.012 -1.055 . . . . 0.0 109.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.64 11.03 16.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 6.5 ttmm -77.57 -129.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.189 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 3.9 m -91.61 81.81 5.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.663 -1.273 . . . . 0.0 108.308 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -114.74 167.29 10.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.76 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.433 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -56.96 -174.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.581 -1.324 . . . . 0.0 108.344 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.68 67.61 9.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.864 -1.148 . . . . 0.0 110.608 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 5.6 m-20 -138.22 57.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.78 -1.2 . . . . 0.0 110.145 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.563 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pp -150.32 154.88 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.162 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.436 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -108.39 129.14 24.42 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.01 -4.48 14.93 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.517 2.144 . . . . 0.0 110.906 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.57 -72.15 0.39 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.813 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -57.08 161.23 3.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 t -106.15 141.75 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 107.56 -11.2 39.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 34.1 m-80 -40.75 -32.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -1.177 . . . . 0.0 110.047 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 15.8 p -122.57 125.87 46.58 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.0 -1.062 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -100.82 118.75 37.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.438 -0.789 . . . . 0.0 112.101 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -80.9 -24.38 38.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' N ' ' HG3' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -92.35 -38.37 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.026 . . . . 0.0 110.486 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 18' ' ' ASN . 15.7 p -85.54 7.25 23.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 108.622 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . 123.6 -79.93 0.35 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER 177.62 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.29 -1.712 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.22 119.49 35.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.127 -1.608 . . . . 0.0 107.243 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.589 ' HG ' ' CG ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -119.57 -13.07 9.22 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.88 -177.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 23.2 mtpt -156.82 77.48 0.89 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.491 -1.381 . . . . 0.0 111.03 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.8 m -53.74 145.94 14.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.468 -1.395 . . . . 0.0 108.17 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.563 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -96.97 -63.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.882 -1.136 . . . . 0.0 112.397 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.543 ' O ' ' CG2' ' A' ' 31' ' ' THR . 22.9 m-85 -57.85 81.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.287 0.565 . . . . 0.0 112.386 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' TYR . 11.4 m-20 20.62 50.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.477 0.656 . . . . 0.0 111.796 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 34.5 p -120.37 149.64 42.02 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.41 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.48 -175.47 2.95 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.247 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.4 150.43 22.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CZ ' ' O ' ' A' ' 21' ' ' THR . 22.1 t80 -57.0 -28.58 62.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.114 -1.227 . . . . 0.0 110.177 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -116.42 26.83 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.682 -1.261 . . . . 0.0 109.967 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.3 m 52.52 54.27 10.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 108.914 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -8.71 31.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 0.0 110.262 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.51 -172.61 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.919 -1.113 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 22.3 m -117.8 134.99 54.36 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 152.01 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.384 -1.447 . . . . 0.0 109.147 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.58 124.28 19.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.406 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.22 -34.57 3.79 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.12 128.76 47.84 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.197 0.998 . . . . 0.0 108.984 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -123.43 -179.35 4.3 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.37 -142.47 12.47 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.8 m120 -130.85 103.24 15.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.554 -0.968 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HB3' HG23 ' A' ' 31' ' ' THR . 36.6 Cg_endo -79.18 -1.56 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.278 1.985 . . . . 0.0 110.311 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 37.99 2.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.84 156.38 42.69 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.129 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.06 -20.75 12.71 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.272 1.981 . . . . 0.0 109.522 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.45 131.18 24.26 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.31 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.3 -18.62 15.88 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.268 1.979 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 -21.63 59.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.075 . . . . 0.0 109.498 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.16 13.81 30.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.968 . . . . 0.0 109.401 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -67.58 -137.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 56.8 m -99.36 105.34 17.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.766 -1.209 . . . . 0.0 109.479 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -115.95 -156.46 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.482 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.407 ' O ' HD12 ' A' ' 9' ' ' ILE . 49.8 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 68.6 m-80 -144.58 -154.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.239 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 3.8 m-20 82.51 -134.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.77 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.532 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 9.1 m-80 -89.35 72.32 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.494 ' HA ' HG12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -142.89 148.76 19.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 19.9 m-20 -114.88 154.9 46.95 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 110.575 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.76 -19.67 12.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.5 2.133 . . . . 0.0 110.095 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . 30.1 m120 -77.66 -32.99 53.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 112.021 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.56 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.164 -1.585 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.76 79.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.987 -1.071 . . . . 0.0 110.155 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 88.05 -32.51 4.32 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 7.4 m-80 64.4 1.85 1.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -1.086 . . . . 0.0 110.916 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HA ' HD11 ' A' ' 25' ' ' LEU . 5.6 m -123.68 179.48 4.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.541 -1.349 . . . . 0.0 109.862 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -92.34 131.09 37.81 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -68.89 -24.94 64.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.669 -1.269 . . . . 0.0 110.426 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.63 -36.53 10.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.921 -1.112 . . . . 0.0 111.23 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 -39.1 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.748 -1.22 . . . . 0.0 110.098 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.72 70.73 1.34 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.537 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.5 tp10 -171.54 157.26 4.73 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.305 . . . . 0.0 109.332 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' ' CG2' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -63.04 111.53 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.744 -0.598 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.555 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -128.89 39.42 3.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.107 -0.996 . . . . 0.0 110.791 178.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -149.8 67.83 1.0 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.494 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 75.4 m -53.92 146.93 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.879 -1.138 . . . . 0.0 109.839 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -103.54 -61.82 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.89 . . . . 0.0 111.88 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.571 ' CD2' ' HD3' ' A' ' 55' ' ' LYS . 42.1 m-85 -77.54 63.62 2.7 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 112.292 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 29' ' ' TYR . 69.5 m-80 39.06 60.84 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.839 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 8' ' ' ASN . 35.8 p -123.17 148.1 46.13 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 108.956 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -112.66 -165.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.92 18.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' PHE . 1.2 t80 -53.55 -29.9 39.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.779 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.537 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 85.4 m-85 -120.62 37.53 4.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 46.2 m 49.42 52.94 13.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.161 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.52 0.79 31.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 110.463 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -131.27 -173.7 3.18 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.802 -1.186 . . . . 0.0 109.143 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 64.8 m -111.94 126.62 55.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -57.42 151.89 15.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.807 -1.183 . . . . 0.0 109.763 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.85 125.37 23.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.14 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.8 -32.52 4.4 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -129.51 129.0 43.97 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.325 1.06 . . . . 0.0 109.178 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -114.58 174.34 6.01 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 133.53 -144.05 15.9 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.382 -1.389 . . . . 0.0 109.962 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 45.7 m-20 -130.06 112.47 17.17 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.573 -0.957 . . . . 0.0 109.353 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 35.0 Cg_endo -75.88 -3.07 13.37 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.128 1.885 . . . . 0.0 110.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.49 40.68 2.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.0 153.43 38.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.005 . . . . 0.0 109.197 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.51 -27.66 9.03 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.083 1.855 . . . . 0.0 109.285 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.22 137.6 19.73 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.69 -17.17 18.28 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.142 1.895 . . . . 0.0 110.326 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.9 -24.74 58.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 109.16 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.23 27.28 9.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.571 ' HD3' ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -83.38 -143.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 95.2 m -91.95 83.33 5.18 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.2 mtpt -115.37 170.56 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.008 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.65 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.516 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 68.7 m-80 -35.88 -97.88 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.585 -0.697 . . . . 0.0 110.704 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' ASN . 12.5 m-20 42.27 -94.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.139 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m120 -144.23 68.22 1.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.016 -1.052 . . . . 0.0 110.184 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.561 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.7 pp -142.5 163.93 17.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.44 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 90.3 m-20 -105.96 109.83 63.52 Favored Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.4 -5.74 15.83 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.851 2.367 . . . . 0.0 111.18 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.26 -70.77 0.47 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 109.079 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 160.62 13.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.147 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 15' ' ' GLY . 83.2 t -104.13 151.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.35 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' HG11 ' A' ' 14' ' ' VAL . . . 108.53 -2.69 32.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 11.2 m-80 -60.34 -5.92 1.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.366 . . . . 0.0 111.189 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HA ' HD13 ' A' ' 25' ' ' LEU . 79.8 m -121.66 177.39 5.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.584 -1.323 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -93.01 133.17 36.42 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -11.24 60.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.916 -1.115 . . . . 0.0 111.677 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 21' ' ' THR . 1.7 pp -102.09 -47.99 4.37 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.539 -1.351 . . . . 0.0 110.985 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.5 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.0 -23.84 20.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.636 -1.29 . . . . 0.0 109.872 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.54 61.48 3.85 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -147.25 156.52 43.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.108 -1.23 . . . . 0.0 109.273 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.1 m -64.43 112.52 3.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.88 41.74 3.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.977 -1.077 . . . . 0.0 110.339 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 68.72 0.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.449 -0.782 . . . . 0.0 108.979 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 79.7 m -53.72 151.4 6.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.92 -1.113 . . . . 0.0 109.953 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.561 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.35 -58.74 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.49 -0.757 . . . . 0.0 111.327 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -77.86 47.59 0.64 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.589 -0.695 . . . . 0.0 111.695 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.07 63.47 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.722 -1.236 . . . . 0.0 110.532 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -123.33 158.53 30.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 108.701 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -116.35 -163.8 0.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.38 147.83 12.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.41 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 3.8 t80 -53.95 -32.06 52.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -1.092 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -119.82 38.59 3.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.786 -1.196 . . . . 0.0 109.293 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 68.6 m 52.88 53.43 12.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -107.8 7.31 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.845 . . . . 0.0 109.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -130.79 -167.36 1.82 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.207 -0.933 . . . . 0.0 109.745 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 1.6 m -121.26 135.87 55.06 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -56.5 145.62 27.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.662 -1.274 . . . . 0.0 109.692 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.46 124.77 21.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 109.585 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.99 -31.89 4.58 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.471 ' HB3' ' N ' ' A' ' 57' ' ' LYS . 4.3 m-85 -127.28 129.75 48.27 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.302 1.049 . . . . 0.0 109.114 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.07 175.5 5.44 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.155 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 140.85 -147.21 18.84 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.441 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 53.7 m-20 -135.67 102.11 10.53 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.984 . . . . 0.0 109.844 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 34.3 Cg_endo -75.1 1.4 7.82 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.13 1.887 . . . . 0.0 110.448 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.95 39.29 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 108.915 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.75 156.67 44.61 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.58 -16.34 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.386 2.057 . . . . 0.0 110.121 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.23 128.44 33.42 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.074 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.92 -19.64 15.81 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.192 1.928 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.49 5.78 46.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.412 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -119.68 1.3 11.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 86.8 mttt -69.72 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.987 -1.07 . . . . 0.0 110.358 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 13.8 m -99.14 147.52 25.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 0.0 109.375 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -160.22 167.38 27.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 109.171 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.519 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -80.06 85.71 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 0.0 109.209 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.44 ' OD1' HG22 ' A' ' 9' ' ' ILE . 41.5 p30 -170.93 -140.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.837 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.564 ' ND2' ' CG2' ' A' ' 31' ' ' THR . 12.9 m-20 -96.69 83.01 3.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.056 -1.028 . . . . 0.0 110.137 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.5 pp -149.26 150.36 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.532 -0.73 . . . . 0.0 109.157 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.4 m-20 -107.94 126.9 28.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.302 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.84 -15.47 18.94 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.365 2.044 . . . . 0.0 110.924 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.84 -71.48 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 109.605 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.09 176.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 15' ' ' GLY . 39.3 t -115.32 163.68 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.488 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . 107.38 -17.57 36.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.7 m120 -64.69 -2.56 2.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.275 . . . . 0.0 111.125 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.08 142.3 44.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.629 -1.294 . . . . 0.0 108.923 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.562 ' ND2' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 125.18 28.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.951 -1.093 . . . . 0.0 108.23 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -20.61 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.967 . . . . 0.0 110.29 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.41 -42.0 5.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.011 -1.056 . . . . 0.0 111.499 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -86.31 -39.3 16.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.609 -1.307 . . . . 0.0 110.274 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 71.11 1.32 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 1.3 tp10 -174.84 161.97 3.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.988 -1.301 . . . . 0.0 108.734 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.3 m -48.76 124.46 8.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.879 -1.138 . . . . 0.0 109.888 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -123.6 -28.43 3.88 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.09 -1.006 . . . . 0.0 111.613 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -114.1 84.31 2.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.52 -1.363 . . . . 0.0 110.952 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 60.9 m -55.37 153.33 7.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.637 -1.29 . . . . 0.0 110.039 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -106.66 -66.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.035 -1.041 . . . . 0.0 112.421 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 6.3 m-30 -68.87 75.97 0.31 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.55 -0.719 . . . . 0.0 112.895 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.49 ' C ' ' O ' ' A' ' 29' ' ' TYR . 4.3 m-20 29.42 52.24 0.09 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.435 0.636 . . . . 0.0 111.224 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.564 ' CG2' ' ND2' ' A' ' 8' ' ' ASN . 70.0 p -120.9 151.8 39.24 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 108.816 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . . . -119.88 -153.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.46 148.45 6.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.09 -24.09 62.64 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.36 -1.082 . . . . 0.0 110.256 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 55.3 m-85 -114.58 20.87 15.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.63 -1.294 . . . . 0.0 110.24 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 82.6 m 62.26 29.5 17.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 109.655 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -103.2 23.95 11.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.181 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.39 -176.67 4.04 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.215 -0.928 . . . . 0.0 109.208 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.66 139.8 53.09 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.03 141.45 34.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.469 -1.394 . . . . 0.0 109.47 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.53 128.58 37.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.642 -0.661 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.24 2.95 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -128.63 129.57 46.06 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.162 0.982 . . . . 0.0 108.756 177.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.9 m-85 -111.07 -179.61 3.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.17 -139.35 9.76 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.454 -1.355 . . . . 0.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -124.67 100.43 34.51 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.733 -0.863 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.519 ' CB ' HG23 ' A' ' 31' ' ' THR . 36.3 Cg_endo -79.68 -8.41 14.68 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 37.88 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 109.952 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.47 152.66 42.17 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.118 -0.989 . . . . 0.0 109.136 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.78 -27.44 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -101.12 134.15 20.54 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.33 -1.04 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.105 1.87 . . . . 0.0 110.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.01 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 108.661 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.6 31.74 4.52 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 6.6 ttmt -73.01 -145.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.691 -0.631 . . . . 0.0 109.919 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 6.9 m -100.13 94.07 6.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.083 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.33 -167.03 1.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.483 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 16.1 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 72.2 m-20 -106.04 -144.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.1 t0 83.21 -72.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.575 ' ND2' ' CG2' ' A' ' 31' ' ' THR . 4.0 m120 -137.69 70.83 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.832 -1.167 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CA ' HG12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -141.92 149.54 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.072 -1.018 . . . . 0.0 109.646 179.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 28' ' ' ILE . 31.5 m-20 -109.39 126.3 29.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.262 -0.899 . . . . 0.0 109.909 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.02 -9.16 16.72 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.376 2.05 . . . . 0.0 110.636 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.0 -74.2 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.0 109.811 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 170.15 3.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.077 -1.015 . . . . 0.0 109.548 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 15' ' ' GLY . 25.7 t -106.71 157.41 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 25' ' ' LEU . . . 106.48 -31.87 7.86 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' GLY . 11.7 m-80 -44.38 -24.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -1.211 . . . . 0.0 109.897 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 3.6 m -127.7 161.77 28.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 109.293 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.569 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -95.86 130.04 42.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.751 -1.218 . . . . 0.0 108.217 179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -62.73 -34.39 77.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 0.0 110.632 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 -37.48 8.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.847 -1.158 . . . . 0.0 111.617 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.77 -13.02 49.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.618 -1.301 . . . . 0.0 110.168 -179.155 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.59 47.82 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -129.9 170.27 14.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -1.139 . . . . 0.0 108.637 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 9' ' ' ILE . 60.1 m -70.06 102.52 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.665 -1.272 . . . . 0.0 109.411 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -79.11 -11.31 59.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.127 . . . . 0.0 110.118 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -160.16 95.63 1.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.727 -1.233 . . . . 0.0 111.25 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 71.3 m -54.43 153.64 5.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.336 -1.477 . . . . 0.0 108.77 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.541 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -102.53 -59.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.723 -1.236 . . . . 0.0 112.871 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -75.12 40.1 0.15 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.742 . . . . 0.0 112.169 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 58.29 68.6 0.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.476 -1.39 . . . . 0.0 110.571 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.575 ' CG2' ' ND2' ' A' ' 8' ' ' ASN . 36.9 p -133.68 147.48 51.4 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -110.3 -159.02 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.36 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 147.32 10.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 t80 -50.67 -30.35 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -1.002 . . . . 0.0 109.764 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -124.12 43.4 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.892 -1.13 . . . . 0.0 109.375 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.1 m 51.88 48.27 23.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 108.633 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.46 3.52 45.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.289 -0.882 . . . . 0.0 110.48 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 -172.26 2.79 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.918 -1.114 . . . . 0.0 109.659 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 77.6 m -117.32 130.52 56.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -57.14 146.75 26.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.787 -1.196 . . . . 0.0 109.667 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.21 129.04 38.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.483 -0.761 . . . . 0.0 109.697 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.47 -35.85 3.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.398 -2.681 . . . . 0.0 106.398 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 7.9 m-85 -126.11 132.14 51.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.189 0.995 . . . . 0.0 108.661 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' LYS . 4.4 m-85 -111.69 -178.11 3.35 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 127.98 -144.96 15.63 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 22.8 m120 -129.06 120.22 20.14 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.597 -0.943 . . . . 0.0 109.066 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.6 Cg_endo -77.41 -18.02 14.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.979 1.786 . . . . 0.0 111.204 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.9 tp -109.55 37.11 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.943 -1.098 . . . . 0.0 110.019 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.16 151.43 41.7 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 108.762 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.44 -29.61 9.09 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.155 1.903 . . . . 0.0 109.022 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -101.26 128.63 28.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.76 -12.02 24.13 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.053 1.835 . . . . 0.0 110.469 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.96 59.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.98 -1.075 . . . . 0.0 108.792 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.63 15.0 22.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -65.96 -146.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 71.0 m -90.95 82.44 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.018 -1.051 . . . . 0.0 108.417 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 43' ' ' PHE . 1.7 mttm -124.83 -174.61 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.576 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.294 179.801 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -51.52 159.35 0.75 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 75.34 5.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.502 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.577 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 50.2 m-20 -145.02 67.03 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 0.0 110.24 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.487 ' C ' HG12 ' A' ' 28' ' ' ILE . 2.7 pt -149.52 176.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -106.56 147.36 34.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.206 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 -40.24 0.49 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.439 2.093 . . . . 0.0 111.201 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.511 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -78.34 -5.17 51.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -178.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.963 -1.71 . . . . 0.0 109.011 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.7 80.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.074 . . . . 0.0 110.329 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 -22.91 6.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 22.9 m-80 54.88 15.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.883 -1.363 . . . . 0.0 110.63 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.21 159.77 32.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.883 -1.136 . . . . 0.0 109.503 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.7 120.18 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -64.62 -19.65 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.869 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -97.77 -41.26 8.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.771 -1.205 . . . . 0.0 110.893 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -91.94 -64.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.698 -1.251 . . . . 0.0 109.922 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 116.92 79.16 0.72 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -178.15 159.3 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.984 -1.303 . . . . 0.0 108.259 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' A' ' 9' ' ' ILE . 1.2 m -47.86 119.23 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.604 -1.31 . . . . 0.0 108.648 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 1.1 tm? -125.77 27.86 6.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 110.294 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.4 mttt -160.2 63.1 0.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.965 -1.084 . . . . 0.0 109.927 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 46.6 m -55.39 150.66 11.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.956 -1.09 . . . . 0.0 109.709 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.577 ' CD1' ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.8 -64.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.0 111.816 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CG2' ' A' ' 31' ' ' THR . 24.5 m-85 -59.5 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' C ' ' O ' ' A' ' 29' ' ' TYR . 10.1 m-20 24.32 52.65 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.233 0.539 . . . . 0.0 111.257 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 38.2 p -121.45 144.67 48.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.075 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -115.56 -169.82 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.594 -0.691 . . . . 0.0 109.567 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.93 148.1 21.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 3.1 t80 -52.66 -27.31 16.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -126.55 37.91 4.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.814 -1.178 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.6 m 52.18 53.5 12.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.931 -1.105 . . . . 0.0 108.605 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -97.75 -7.42 30.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.782 . . . . 0.0 110.376 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -174.74 3.46 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.828 -1.17 . . . . 0.0 109.685 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 47' ' ' PRO . 3.2 m -122.15 136.21 54.88 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -56.21 149.82 15.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.655 -1.278 . . . . 0.0 108.944 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.54 132.6 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -36.5 3.13 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 106.769 -2.533 . . . . 0.0 106.769 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -124.24 129.58 51.03 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.21 1.005 . . . . 0.0 108.999 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.51 173.35 6.45 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.78 19.24 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.635 -1.269 . . . . 0.0 109.975 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 38.6 m-20 -115.27 107.35 49.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.435 -1.038 . . . . 0.0 109.53 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.521 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 37.7 Cg_endo -79.35 -13.35 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.246 1.964 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.1 39.07 2.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.8 . . . . 0.0 109.828 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.78 148.68 35.63 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.37 -23.32 13.32 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.358 2.039 . . . . 0.0 109.901 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -99.89 135.58 20.42 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.412 -0.805 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.91 -19.89 17.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.152 1.901 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.15 -27.22 59.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.26 38.16 2.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.171 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -89.84 -145.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.681 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 47' ' ' PRO . 74.9 m -101.47 106.16 17.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 109.719 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.11 173.14 8.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -0.968 . . . . 0.0 109.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.507 -179.876 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 27.2 p . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.391 0.615 . . . . 0.0 112.197 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 78.7 m-20 -78.03 -135.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 38.1 m-20 74.27 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.932 . . . . 0.0 110.693 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.492 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 1.8 m120 -115.62 74.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.799 -1.188 . . . . 0.0 110.492 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.554 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.8 pp -154.22 146.85 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 108.818 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -108.93 128.53 25.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.407 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.13 -14.38 18.78 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.427 2.084 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.32 -72.24 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.37 163.05 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 109.29 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.76 152.13 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.076 -1.015 . . . . 0.0 109.36 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 112.35 -28.48 9.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 13.6 m-80 -42.72 -26.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -1.183 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 15' ' ' GLY . 1.7 p -126.06 149.63 48.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 108.998 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -82.71 126.64 32.59 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -34.0 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.734 -1.229 . . . . 0.0 110.215 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -34.36 10.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.93 -1.106 . . . . 0.0 111.425 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -22.73 23.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.659 -1.276 . . . . 0.0 110.378 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.45 69.56 1.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -163.97 169.5 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 108.861 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 7.0 m -65.58 101.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.241 -1.537 . . . . 0.0 109.301 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.26 -26.04 26.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 79.52 1.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.787 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 76.3 m -53.62 152.85 4.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.432 -1.418 . . . . 0.0 108.518 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.554 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -92.13 -64.85 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.966 -1.084 . . . . 0.0 112.317 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 28' ' ' ILE . 57.0 m-85 -73.21 71.54 1.19 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.428 -0.795 . . . . 0.0 112.616 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 31.34 54.22 0.22 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.586 -0.697 . . . . 0.0 111.094 177.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.494 HG23 ' CB ' ' A' ' 47' ' ' PRO . 11.5 p -122.55 151.74 41.08 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.161 -0.962 . . . . 0.0 109.65 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -123.49 -163.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.04 152.86 27.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 1.1 t80 -51.61 -34.34 36.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 109.832 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -119.67 39.62 3.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.796 -1.19 . . . . 0.0 109.63 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 39.4 m 50.31 32.64 6.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.01 -1.056 . . . . 0.0 109.013 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.31 10.88 20.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.403 -0.811 . . . . 0.0 109.707 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.68 -173.72 3.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.107 -0.996 . . . . 0.0 109.529 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 56.4 m -119.97 131.7 55.26 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.722 -1.236 . . . . 0.0 109.355 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.62 130.27 46.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.561 -0.712 . . . . 0.0 109.614 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.53 -36.52 3.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -126.08 129.43 49.1 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.238 1.018 . . . . 0.0 109.001 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -110.58 171.93 7.17 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.9 -145.02 17.16 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.932 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 11.3 m120 -115.27 108.05 48.5 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.969 . . . . 0.0 108.793 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 34.8 Cg_endo -75.14 -7.73 19.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.87 1.714 . . . . 0.0 110.749 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -122.09 42.48 3.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 155.58 43.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 0.0 108.952 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.35 -22.02 14.63 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.203 1.935 . . . . 0.0 109.689 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m-80 -100.82 134.47 20.47 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.528 -0.733 . . . . 0.0 109.157 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.71 -19.19 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.243 1.962 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.35 12.44 29.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.061 -1.024 . . . . 0.0 109.724 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 m-20 -135.62 30.01 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.904 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 39.3 mttm -97.57 -116.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.957 -1.089 . . . . 0.0 110.544 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 2.8 m -100.67 105.69 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.648 -1.283 . . . . 0.0 109.59 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 1.5 mptt -105.54 170.51 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.487 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 22.7 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 35' ' ' TYR . 28.1 m120 -39.92 147.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.486 -0.759 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 8' ' ' ASN . 6.5 t70 -80.81 69.72 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.547 ' C ' HG13 ' A' ' 28' ' ' ILE . 2.2 m120 -139.26 64.62 1.46 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.116 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.581 ' HA ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -154.4 -177.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' N ' HG12 ' A' ' 9' ' ' ILE . 43.5 m-20 -107.35 112.47 62.68 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.773 -1.205 . . . . 0.0 109.304 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.15 -8.47 17.58 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.665 2.244 . . . . 0.0 110.954 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -78.63 -74.1 0.29 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.28 -167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.107 -0.996 . . . . 0.0 109.269 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.16 156.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.968 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.89 36.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 28.8 m-80 -52.41 -16.19 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 110.51 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t -121.95 149.08 43.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 108.902 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.19 126.62 31.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.877 -1.139 . . . . 0.0 108.302 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -69.16 -39.83 78.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.401 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -24.92 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.549 -1.345 . . . . 0.0 111.242 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -92.55 -32.65 14.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.358 -1.464 . . . . 0.0 109.881 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' CD ' ' A' ' 23' ' ' GLU . . . 71.25 63.24 3.18 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -159.89 159.41 32.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.104 -1.233 . . . . 0.0 109.258 -179.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 23.3 m -55.83 114.85 2.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.91 -34.49 10.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.884 -1.135 . . . . 0.0 109.862 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -123.21 83.05 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.197 -0.939 . . . . 0.0 110.376 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 65.1 m -53.91 155.71 3.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.488 -1.383 . . . . 0.0 109.278 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -107.13 -64.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 120.84 -1.163 . . . . 0.0 112.86 -178.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' A' ' 30' ' ' ASN . 55.4 m-85 -59.21 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.294 -0.879 . . . . 0.0 112.091 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.531 ' C ' ' O ' ' A' ' 29' ' ' TYR . 76.2 m-20 22.99 50.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.304 0.573 . . . . 0.0 111.254 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 29' ' ' TYR . 1.2 p -121.54 151.28 40.5 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -121.72 176.47 5.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.9 152.23 24.72 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.421 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 5.0 t80 -56.56 -32.0 64.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -1.123 . . . . 0.0 109.714 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 26.2 m-85 -117.33 22.38 12.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.917 -1.114 . . . . 0.0 109.245 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.8 m 61.17 61.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -90.28 -21.59 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.873 . . . . 0.0 111.286 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -131.9 -174.26 3.37 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.584 -1.322 . . . . 0.0 109.596 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.62 137.55 50.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -55.43 156.9 4.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.488 -1.382 . . . . 0.0 109.604 -178.32 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 123.94 18.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.24 -30.52 4.97 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 107.111 -2.395 . . . . 0.0 107.111 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 6.0 m-85 -127.04 128.46 46.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.272 1.034 . . . . 0.0 109.109 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -108.45 -156.85 0.59 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.53 -151.48 18.32 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.323 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 13.4 m120 -135.06 104.77 10.45 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HB3' HG23 ' A' ' 31' ' ' THR . 36.1 Cg_endo -78.01 1.48 8.88 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.028 1.819 . . . . 0.0 109.857 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.8 38.22 2.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 108.863 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.52 148.5 39.34 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.447 -0.783 . . . . 0.0 109.142 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.92 -28.52 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.23 1.954 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -101.19 140.99 21.73 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.123 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.95 -11.75 21.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.233 1.955 . . . . 0.0 110.39 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.84 60.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.942 -1.098 . . . . 0.0 109.099 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -117.21 30.13 7.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 109.018 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.2 ttmt -87.21 -139.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.795 . . . . 0.0 109.175 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 56.6 m -91.96 162.65 14.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.951 -1.093 . . . . 0.0 109.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 1.3 mmtp 174.39 -167.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.348 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.485 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 8.2 m-20 -54.63 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 49.7 m-20 102.89 -102.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.3 m120 -120.97 67.57 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.857 -1.152 . . . . 0.0 109.546 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.553 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.4 pt -139.18 162.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.476 ' OD1' HD12 ' A' ' 28' ' ' ILE . 58.5 m-20 -106.77 119.34 51.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.66 -4.14 14.63 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.684 2.256 . . . . 0.0 111.234 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.69 -68.76 0.62 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.358 -0.839 . . . . 0.0 109.85 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.27 171.04 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.989 -1.069 . . . . 0.0 110.039 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.44 164.64 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.302 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.05 4.61 57.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 8.4 m-80 -63.26 -0.92 0.9 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.837 -1.39 . . . . 0.0 111.669 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 p -128.41 158.23 38.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.334 -1.479 . . . . 0.0 109.747 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.58 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.59 130.14 40.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -58.84 -35.98 73.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.73 -1.231 . . . . 0.0 111.786 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.15 -34.24 10.12 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.545 -1.347 . . . . 0.0 112.158 -177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 2.6 p -83.86 -34.15 24.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.431 -1.418 . . . . 0.0 110.446 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.77 66.68 1.99 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 8.5 tp10 -162.32 160.9 27.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 108.832 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' CYS . . . . . 0.462 ' SG ' HG22 ' A' ' 9' ' ' ILE . 4.5 m -48.18 120.08 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.975 -1.078 . . . . 0.0 108.348 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.58 ' HB2' ' ND2' ' A' ' 18' ' ' ASN . 8.7 tp -125.65 15.62 8.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.294 -0.878 . . . . 0.0 110.724 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 12.2 mtpt -159.07 77.89 0.74 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.131 -0.98 . . . . 0.0 109.586 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 13.7 m -57.86 155.25 10.73 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.666 -1.271 . . . . 0.0 110.189 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.553 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.26 -63.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.535 ' O ' ' CG2' ' A' ' 31' ' ' THR . 25.5 m-85 -68.15 72.53 0.19 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER 33.09 52.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 111.476 177.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 20.3 p -122.07 145.15 48.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.955 -1.09 . . . . 0.0 109.091 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -124.56 166.21 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.39 155.38 9.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 35' ' ' TYR . 10.7 t80 -56.04 -30.35 61.79 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -1.121 . . . . 0.0 109.949 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CD1' ' HD1' ' A' ' 34' ' ' PHE . 14.2 m-85 -117.49 29.41 7.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.164 . . . . 0.0 109.628 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.3 m 49.84 43.25 24.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.705 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.38 21.29 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.33 -179.22 5.13 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.223 -0.923 . . . . 0.0 108.874 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 1.4 m -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -55.77 138.14 48.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.717 -1.24 . . . . 0.0 109.805 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 5.0 pt-20 -61.09 130.54 46.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.597 -0.689 . . . . 0.0 109.815 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.74 -34.96 3.57 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 13.9 m-85 -130.53 131.74 45.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.133 0.968 . . . . 0.0 108.479 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' LYS . 2.3 m-85 -105.53 -179.91 4.08 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.34 -145.22 17.09 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.886 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 30.6 m120 -118.73 111.93 37.27 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.972 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PRO . . . . . 0.481 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 36.3 Cg_endo -78.63 -29.1 3.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 110.731 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.435 ' O ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -112.16 44.93 1.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.989 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.67 154.06 50.4 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.002 -1.062 . . . . 0.0 108.859 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.73 -31.13 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.019 1.813 . . . . 0.0 108.83 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.94 139.33 20.22 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 33.5 Cg_endo -75.18 0.77 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.048 1.832 . . . . 0.0 109.869 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.95 -13.6 53.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.701 -1.249 . . . . 0.0 109.248 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 4.0 m-20 -111.03 40.37 2.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.293 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -70.43 -155.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 109.057 -179.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 5.9 m -101.37 90.57 4.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -114.84 177.04 4.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.571 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.61 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.1 -41.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.45 2.1 . . . . 0.0 110.364 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 p -106.11 133.91 50.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.469 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 19.6 mm-40 -64.97 136.02 56.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 109.742 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 18.0 t 178.9 157.19 0.5 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.472 ' ND2' ' OD1' ' A' ' 37' ' ' ASP . 2.8 m120 -54.09 170.41 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.489 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.72 67.36 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.2 -0.937 . . . . 0.0 110.912 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.444 ' OD1' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -142.82 62.72 1.4 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.93 -1.106 . . . . 0.0 109.17 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.547 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -154.14 152.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -107.77 129.23 24.47 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.26 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.91 -6.65 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.625 2.217 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.47 -69.33 0.57 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 169.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.596 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.01 152.78 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.256 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.62 65.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -15.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.091 -1.241 . . . . 0.0 111.019 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 150.0 43.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.723 -1.235 . . . . 0.0 109.476 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' ND2' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -84.29 122.06 28.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -6.91 57.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.844 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.582 ' HG ' ' N ' ' A' ' 21' ' ' THR . 2.5 pt? -108.22 -45.08 4.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 111.147 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.582 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -91.71 -15.5 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.65 -1.281 . . . . 0.0 110.199 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.96 61.01 5.87 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' CG ' ' ND2' ' A' ' 18' ' ' ASN . 9.2 pt-20 -156.56 152.46 27.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -1.164 . . . . 0.0 108.404 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 35.6 m -51.94 118.97 3.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.359 -1.463 . . . . 0.0 109.858 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CB ' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -84.61 -31.37 24.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.917 -1.115 . . . . 0.0 109.335 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -143.89 84.66 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 31' ' ' THR . 9.7 m -53.42 155.69 2.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.518 -1.364 . . . . 0.0 108.655 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -86.44 -66.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.04 -1.038 . . . . 0.0 112.452 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.547 ' O ' ' CG2' ' A' ' 31' ' ' THR . 19.0 m-85 -64.58 77.73 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.558 -0.714 . . . . 0.0 112.63 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m120 26.0 48.87 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.159 0.504 . . . . 0.0 111.504 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 44.6 p -121.92 150.94 41.28 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 109.635 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -139.32 171.46 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.68 158.63 10.67 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.27 -29.59 47.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -1.1 . . . . 0.0 110.095 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.99 32.0 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.812 -1.18 . . . . 0.0 109.77 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' CB ' ' A' ' 24' ' ' CYS . 90.0 m 49.74 27.23 2.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.211 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.472 ' OD1' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -94.82 20.44 8.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.342 -0.848 . . . . 0.0 109.624 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -130.7 -174.6 3.41 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.074 -1.017 . . . . 0.0 109.577 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.458 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 98.8 m -120.15 135.43 54.96 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' CE ' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -55.77 147.14 19.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.552 -1.343 . . . . 0.0 110.09 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.15 123.59 17.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.701 . . . . 0.0 109.69 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.43 -33.38 4.17 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.51 ' CE2' ' CE ' ' A' ' 40' ' ' LYS . 7.9 m-85 -122.47 129.83 52.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.219 1.009 . . . . 0.0 108.726 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.477 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.6 m-85 -118.46 178.85 4.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.16 -143.8 14.59 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 80.8 m-20 -115.98 110.11 44.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.482 -1.01 . . . . 0.0 109.061 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' CB ' HG23 ' A' ' 31' ' ' THR . 36.4 Cg_endo -78.42 -9.78 16.16 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.169 1.913 . . . . 0.0 110.586 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.79 37.89 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.23 153.16 41.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.232 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HG2' ' ND2' ' A' ' 51' ' ' ASN . 33.9 Cg_endo -75.01 -29.67 7.97 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.117 1.878 . . . . 0.0 108.949 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.49 ' ND2' ' HG2' ' A' ' 50' ' ' PRO . 4.4 m-80 -101.27 138.56 19.97 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.75 -19.4 16.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.104 1.869 . . . . 0.0 110.142 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.14 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 109.194 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -113.38 17.84 18.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 109.288 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -71.85 -130.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 9.7 m -101.07 102.89 13.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.8 mmtt -109.2 168.28 9.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.387 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.472 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 34.8 Cg_endo -78.23 -90.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.623 2.216 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 17' ' ' CYS . 57.1 m -103.7 151.71 22.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 109.325 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.97 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -166.29 160.99 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 14.4 m120 -159.83 -160.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER 81.88 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 0.0 110.338 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.5 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 4.6 m120 -132.93 73.0 1.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.522 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.8 pp -146.48 150.85 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 108.921 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.473 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 3.6 m-20 -109.29 142.28 25.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.208 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.27 -8.94 17.62 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.507 2.138 . . . . 0.0 110.406 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -76.75 -48.66 18.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.466 -0.771 . . . . 0.0 110.804 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.36 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.564 -1.335 . . . . 0.0 108.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.96 83.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.859 -1.15 . . . . 0.0 110.916 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.472 ' HA2' ' HB2' ' A' ' 2' ' ' PRO . . . 105.64 -38.21 3.42 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.51 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 4.7 m-80 52.22 16.43 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -1.225 . . . . 0.0 110.251 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.472 ' HB3' ' HB2' ' A' ' 3' ' ' CYS . 30.2 p -129.75 169.72 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.665 -1.272 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.53 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.31 122.47 20.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.768 -1.208 . . . . 0.0 108.247 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -18.12 55.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.028 -1.045 . . . . 0.0 110.422 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -39.25 6.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 111.898 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.485 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -90.59 -42.26 10.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.342 -1.474 . . . . 0.0 110.411 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.11 76.07 1.32 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.8 tp10 -176.61 163.1 2.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.941 -1.329 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.465 ' SG ' ' CG2' ' A' ' 9' ' ' ILE . 3.5 m -48.34 114.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.0 109.218 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.53 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 12.5 tp -122.43 12.69 10.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.223 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.419 ' HG3' ' C ' ' A' ' 25' ' ' LEU . 10.4 mttm -154.02 67.21 0.73 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 36.9 m -53.09 149.6 6.63 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.806 -1.184 . . . . 0.0 108.559 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.568 HD13 ' CE2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -104.13 -62.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.065 -1.022 . . . . 0.0 112.481 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' HD13 ' A' ' 28' ' ' ILE . 69.5 m-85 -69.7 73.07 0.38 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 29' ' ' TYR . 8.1 m-20 27.48 59.13 0.1 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.0 111.056 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.47 ' OG1' ' HB3' ' A' ' 27' ' ' CYS . 30.8 p -121.74 152.38 39.5 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.43 -168.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.387 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.95 23.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.58 -30.5 63.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.913 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 64.5 m-85 -114.55 31.88 6.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.796 -1.19 . . . . 0.0 109.333 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.8 m 49.64 41.21 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 108.979 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -95.68 8.52 43.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -173.76 3.15 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.003 -1.061 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.64 137.57 53.79 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -55.82 146.73 20.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.65 -1.281 . . . . 0.0 109.791 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.31 129.0 38.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.249 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.85 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.221 -2.752 . . . . 0.0 106.221 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.66 129.96 46.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.102 0.953 . . . . 0.0 108.658 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -113.01 -173.95 2.35 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.65 -142.18 13.47 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.992 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.575 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 48.8 m-20 -129.08 103.72 18.42 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.536 -0.979 . . . . 0.0 109.173 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.436 ' CB ' HG23 ' A' ' 31' ' ' THR . 33.3 Cg_endo -73.4 -5.95 18.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.806 1.671 . . . . 0.0 110.283 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.86 38.65 2.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 108.867 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -93.4 158.11 37.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.828 . . . . 0.0 109.111 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.37 -15.76 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.288 1.992 . . . . 0.0 109.986 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.453 ' CB ' ' HB2' ' A' ' 54' ' ' ASP . 2.6 m-20 -100.45 135.24 20.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 108.958 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.29 -19.22 17.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 0.0 110.782 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.27 -1.0 25.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.884 -1.135 . . . . 0.0 109.623 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.453 ' HB2' ' CB ' ' A' ' 51' ' ' ASN . 1.8 m-20 -107.76 -3.42 19.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.575 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 12.8 mttp -59.27 -105.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 110.312 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 73.7 m -75.21 177.39 6.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.709 -1.244 . . . . 0.0 108.592 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER 163.63 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.202 -0.936 . . . . 0.0 109.79 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.479 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.3 Cg_endo -77.23 135.06 14.81 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.452 2.102 . . . . 0.0 110.692 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 5.6 m 61.78 -178.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.099 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.413 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 7.5 tt0 179.76 127.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.524 -0.735 . . . . 0.0 109.09 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.455 ' SG ' HG22 ' A' ' 9' ' ' ILE . 1.5 t -145.09 174.59 10.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 109.86 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 55.2 m-80 -164.59 -165.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 56.9 m-20 66.4 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 110.608 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.568 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 2.3 m120 -115.73 63.45 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.123 . . . . 0.0 110.959 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.49 ' C ' HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -142.47 173.19 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.074 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.519 ' OD2' ' CG2' ' A' ' 28' ' ' ILE . 6.9 m-20 -107.8 128.56 25.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.845 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 -1.03 11.16 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.723 2.282 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.64 -68.82 0.59 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.369 -0.832 . . . . 0.0 109.381 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.43 161.7 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.894 -1.129 . . . . 0.0 108.694 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.7 116.51 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 0.0 109.971 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 108.55 -40.35 2.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 15' ' ' GLY . 2.7 m-80 38.85 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.997 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 15' ' ' GLY . 15.5 p -124.98 172.5 9.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.772 -1.205 . . . . 0.0 110.691 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.567 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 126.36 29.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -20.48 54.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.803 -1.186 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -109.08 -42.68 4.36 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.812 -1.18 . . . . 0.0 111.924 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -82.81 -32.94 27.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.436 -1.415 . . . . 0.0 110.228 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 76.22 67.31 1.71 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.583 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -160.69 158.95 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.243 . . . . 0.0 108.978 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 72.4 m -48.45 111.54 0.47 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.074 -1.016 . . . . 0.0 108.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.567 ' HB2' ' ND2' ' A' ' 18' ' ' ASN . 37.7 tp -126.8 9.47 6.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.248 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -126.1 60.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 111.561 -179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.475 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 67.2 m -56.34 146.37 24.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.549 -1.344 . . . . 0.0 107.741 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.569 HD11 ' CD2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -110.02 -62.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.629 -1.294 . . . . 0.0 112.813 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.569 ' CD2' HD11 ' A' ' 28' ' ' ILE . 60.2 m-85 -72.59 69.54 0.88 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.27 -0.894 . . . . 0.0 112.69 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 33.63 63.79 0.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.431 177.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.482 HG23 ' HB3' ' A' ' 47' ' ' PRO . 3.3 p -122.1 158.82 28.44 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.219 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -118.32 -173.4 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.975 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.61 147.9 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.583 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.03 -33.93 58.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -1.066 . . . . 0.0 109.816 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' SG ' ' A' ' 24' ' ' CYS . 3.7 m-85 -116.28 36.91 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.91 -1.119 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 5.3 m 52.99 50.54 17.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.991 . . . . 0.0 108.804 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -92.99 -6.32 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.013 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.28 -167.64 1.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 6.2 m -121.6 137.36 54.77 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -55.4 149.28 13.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.556 -1.34 . . . . 0.0 109.661 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 126.67 28.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.647 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.22 4.22 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.544 ' HB3' ' CA ' ' A' ' 57' ' ' LYS . 25.4 m-85 -127.92 129.86 47.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.159 0.98 . . . . 0.0 109.076 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.14 178.62 4.25 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.61 -144.52 14.89 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.336 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.601 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.4 m120 -132.66 105.28 12.97 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.897 . . . . 0.0 108.947 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.482 ' HB3' HG23 ' A' ' 31' ' ' THR . 31.5 Cg_endo -71.72 0.78 6.5 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.305 -178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.38 41.51 2.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.03 -1.044 . . . . 0.0 109.18 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.2 157.36 38.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.247 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.93 -13.72 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.335 2.023 . . . . 0.0 110.422 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.428 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 3.3 m120 -100.55 132.5 22.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.7 -20.18 13.83 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.145 1.896 . . . . 0.0 110.638 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.36 -8.43 45.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.998 -1.064 . . . . 0.0 109.623 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.428 ' HB2' ' HB2' ' A' ' 51' ' ' ASN . 46.2 m-20 -105.69 -15.35 14.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.708 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.4 mtmm -59.3 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.094 -1.004 . . . . 0.0 109.933 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 85.6 m -93.93 144.89 25.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 108.79 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.544 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 170.36 172.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.34 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 4' ' ' GLN . 36.2 Cg_endo -75.41 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.274 1.983 . . . . 0.0 110.003 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 2' ' ' PRO . 24.5 t 35.46 -91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 0.0 110.536 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' N ' ' O ' ' A' ' 2' ' ' PRO . 5.8 tt0 -40.03 116.35 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.82 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.2 p -110.59 -143.87 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 0.0 108.956 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 m120 -52.09 -176.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.0 70.62 5.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.003 -1.061 . . . . 0.0 110.65 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 77.2 m-20 -144.88 63.66 1.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.887 -1.133 . . . . 0.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.562 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pt -149.96 150.32 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.171 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 1.4 m-20 -108.39 120.08 47.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 109.242 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.54 -3.79 14.41 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.551 2.167 . . . . 0.0 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.29 -67.75 0.71 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 109.488 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.76 179.22 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.402 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.09 149.27 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 109.54 -12.8 33.01 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -38.22 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -1.161 . . . . 0.0 110.474 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' GLY . 6.3 t -123.88 156.12 36.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -81.08 119.21 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -18.27 63.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.824 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.92 -40.6 5.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.818 -1.176 . . . . 0.0 111.817 -178.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 1.9 p -91.34 -33.54 15.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.424 -1.423 . . . . 0.0 110.667 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 82.69 70.24 1.36 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 4.3 tp10 -163.41 167.98 20.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.27 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 62.2 m -64.44 107.13 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.487 -1.383 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.515 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.75 14.8 25.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 70.81 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.703 -1.248 . . . . 0.0 111.422 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 75.2 m -54.78 148.61 12.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.303 -1.498 . . . . 0.0 108.293 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.562 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.47 -63.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.794 -1.191 . . . . 0.0 112.82 -178.628 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.519 ' O ' ' CG2' ' A' ' 31' ' ' THR . 99.4 m-85 -57.17 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 0.0 112.159 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 29' ' ' TYR . 62.2 m-80 21.2 49.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.356 0.598 . . . . 0.0 111.341 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 26.6 p -122.86 155.21 37.09 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.364 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -125.01 -162.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.564 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.19 146.39 6.58 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.99 -30.02 13.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.478 -1.013 . . . . 0.0 109.828 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.98 41.32 3.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.75 -1.219 . . . . 0.0 109.838 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.6 m 50.6 29.74 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.005 . . . . 0.0 109.573 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 9.7 p30 -90.23 10.73 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.48 -167.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.256 -0.903 . . . . 0.0 109.167 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.483 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 23.0 m -121.84 128.8 52.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -57.0 143.45 38.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.61 126.26 26.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.88 -31.65 4.68 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -134.23 128.39 33.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.195 0.998 . . . . 0.0 109.428 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 4.8 m-85 -108.2 -179.38 3.87 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.76 -142.21 13.63 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.373 -1.394 . . . . 0.0 109.997 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 58.8 m-80 -128.56 105.07 19.17 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.933 . . . . 0.0 109.121 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.483 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.7 Cg_endo -80.34 -4.81 13.27 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.406 2.071 . . . . 0.0 110.357 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 70.2 mt -110.08 38.48 2.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.21 36.3 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.133 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.67 -24.07 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.201 1.934 . . . . 0.0 109.277 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.2 135.56 19.88 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 -18.99 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.193 1.928 . . . . 0.0 110.29 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.93 -17.66 60.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 109.419 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 55' ' ' LYS . 96.9 m-20 -105.03 11.91 32.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.5 OUTLIER -63.41 -139.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.324 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 14.1 m -99.69 104.33 16.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.866 -1.146 . . . . 0.0 108.913 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mtmt -109.1 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.484 179.927 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.37 2.7 7.83 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.655 2.236 . . . . 0.0 110.567 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.9 t -148.86 141.29 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.03 140.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.026 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.7 129.27 22.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.865 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -78.24 81.32 4.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.086 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -152.59 -134.92 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.496 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 15.6 m120 -89.42 76.14 7.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 110.066 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.585 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -141.73 167.01 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 108.877 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.551 ' OD2' ' CG2' ' A' ' 28' ' ' ILE . 0.0 OUTLIER -105.12 135.35 19.32 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.365 -0.834 . . . . 0.0 109.156 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.43 -25.22 9.92 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.362 2.042 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -77.32 -10.58 59.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 111.086 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.83 -165.8 0.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.286 -1.509 . . . . 0.0 109.017 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.3 t -111.63 83.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 110.288 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 81.92 -19.69 9.34 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.798 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-80 45.12 25.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.424 . . . . 0.0 109.214 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 34.1 m -123.0 175.94 6.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.91 123.38 31.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -61.84 -10.92 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 110.963 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.567 ' HG ' ' N ' ' A' ' 21' ' ' THR . 1.9 pt? -110.33 -41.05 4.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.7 -1.25 . . . . 0.0 111.986 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.567 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -90.12 -33.01 16.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.292 -1.505 . . . . 0.0 110.132 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.99 1.33 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -166.35 145.87 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.32 . . . . 0.0 109.384 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.25 107.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.589 ' C ' ' CD1' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.36 44.28 2.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.0 110.534 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -148.72 60.07 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 108.895 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 92.1 m -54.15 150.03 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.87 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.585 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.82 -62.05 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.279 -0.888 . . . . 0.0 111.92 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' CE1' HD11 ' A' ' 28' ' ' ILE . 8.8 m-30 -75.24 65.62 1.61 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.647 -0.658 . . . . 0.0 112.378 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 29' ' ' TYR . 17.3 m120 38.47 62.07 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 110.924 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.406 HG23 ' OD1' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -125.74 156.79 38.85 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.284 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -122.98 -164.99 1.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.38 22.28 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -32.96 43.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -1.069 . . . . 0.0 109.712 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.473 ' OH ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 m-85 -121.47 38.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 109.557 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.4 m 55.72 33.3 21.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.547 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.81 13.77 13.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.9 ttt180 -131.31 -178.08 4.69 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.468 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 64.1 m -125.49 129.79 50.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -56.99 143.43 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.696 -1.252 . . . . 0.0 109.729 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.11 136.3 57.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.274 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.27 -39.85 2.2 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 106.25 -2.74 . . . . 0.0 106.25 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.411 ' HB3' ' O ' ' A' ' 56' ' ' CYS . 8.9 m-85 -120.55 130.98 54.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -109.61 175.57 5.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 130.69 -140.79 12.06 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 6.8 m-80 -134.01 123.23 16.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.672 -0.899 . . . . 0.0 109.091 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.468 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.3 Cg_endo -77.28 -8.31 17.38 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.742 1.628 . . . . 0.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.08 38.59 2.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.41 151.0 37.28 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.48 -25.23 13.2 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.272 1.981 . . . . 0.0 109.56 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.92 134.44 20.44 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.47 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 33.7 Cg_endo -75.75 -17.16 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.996 1.797 . . . . 0.0 110.169 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.51 -13.44 54.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.012 -1.055 . . . . 0.0 109.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.64 11.03 16.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 6.5 ttmm -77.57 -129.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.189 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 3.9 m -91.61 81.81 5.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.663 -1.273 . . . . 0.0 108.308 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -114.74 167.29 10.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.76 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.433 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 176.25 10.11 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.689 2.259 . . . . 0.0 111.034 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.442 ' HA ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 p -115.42 90.74 3.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.459 ' HG2' HD12 ' A' ' 9' ' ' ILE . 86.0 mt-30 -155.08 117.07 4.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.35 -135.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -56.96 -174.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.581 -1.324 . . . . 0.0 108.344 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.68 67.61 9.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.864 -1.148 . . . . 0.0 110.608 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 5.6 m-20 -138.22 57.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.78 -1.2 . . . . 0.0 110.145 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.563 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pp -150.32 154.88 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.162 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.436 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -108.39 129.14 24.42 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.01 -4.48 14.93 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.517 2.144 . . . . 0.0 110.906 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.57 -72.15 0.39 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.813 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -57.08 161.23 3.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 t -106.15 141.75 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 107.56 -11.2 39.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 34.1 m-80 -40.75 -32.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -1.177 . . . . 0.0 110.047 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 15.8 p -122.57 125.87 46.58 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.0 -1.062 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.589 ' CG ' ' HG ' ' A' ' 25' ' ' LEU . 0.5 OUTLIER -100.82 118.75 37.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.438 -0.789 . . . . 0.0 112.101 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.491 ' HG3' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -80.9 -24.38 38.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' N ' ' HG3' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -92.35 -38.37 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.026 . . . . 0.0 110.486 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.525 ' OG1' ' HB3' ' A' ' 18' ' ' ASN . 15.7 p -85.54 7.25 23.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 108.622 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . 123.6 -79.93 0.35 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER 177.62 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.29 -1.712 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.22 119.49 35.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.127 -1.608 . . . . 0.0 107.243 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.589 ' HG ' ' CG ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -119.57 -13.07 9.22 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.88 -177.064 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.484 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 23.2 mtpt -156.82 77.48 0.89 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.491 -1.381 . . . . 0.0 111.03 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.453 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.8 m -53.74 145.94 14.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.468 -1.395 . . . . 0.0 108.17 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.563 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -96.97 -63.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.882 -1.136 . . . . 0.0 112.397 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.543 ' O ' ' CG2' ' A' ' 31' ' ' THR . 22.9 m-85 -57.85 81.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.287 0.565 . . . . 0.0 112.386 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' TYR . 11.4 m-20 20.62 50.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.477 0.656 . . . . 0.0 111.796 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.543 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 34.5 p -120.37 149.64 42.02 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.41 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.48 -175.47 2.95 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.247 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.4 150.43 22.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CZ ' ' O ' ' A' ' 21' ' ' THR . 22.1 t80 -57.0 -28.58 62.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.114 -1.227 . . . . 0.0 110.177 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -116.42 26.83 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.682 -1.261 . . . . 0.0 109.967 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.3 m 52.52 54.27 10.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 108.914 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -8.71 31.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 0.0 110.262 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.51 -172.61 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.919 -1.113 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 22.3 m -117.8 134.99 54.36 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 152.01 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.384 -1.447 . . . . 0.0 109.147 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.58 124.28 19.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.406 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.22 -34.57 3.79 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.12 128.76 47.84 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.197 0.998 . . . . 0.0 108.984 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -123.43 -179.35 4.3 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.37 -142.47 12.47 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.8 m120 -130.85 103.24 15.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.554 -0.968 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.487 ' HB3' HG23 ' A' ' 31' ' ' THR . 36.6 Cg_endo -79.18 -1.56 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.278 1.985 . . . . 0.0 110.311 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 37.99 2.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.84 156.38 42.69 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.129 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.06 -20.75 12.71 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.272 1.981 . . . . 0.0 109.522 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.45 131.18 24.26 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.31 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.3 -18.62 15.88 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.268 1.979 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 -21.63 59.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.075 . . . . 0.0 109.498 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.16 13.81 30.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.968 . . . . 0.0 109.401 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.1 OUTLIER -67.58 -137.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 56.8 m -99.36 105.34 17.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.766 -1.209 . . . . 0.0 109.479 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -115.95 -156.46 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.482 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.66 104.69 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.545 2.163 . . . . 0.0 110.296 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.1 100.41 8.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.619 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.12 114.33 1.72 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.407 ' O ' HD12 ' A' ' 9' ' ' ILE . 49.8 t -178.07 154.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 68.6 m-80 -144.58 -154.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.239 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 3.8 m-20 82.51 -134.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.77 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.532 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 9.1 m-80 -89.35 72.32 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.494 ' HA ' HG12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -142.89 148.76 19.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.489 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 19.9 m-20 -114.88 154.9 46.95 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 110.575 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.76 -19.67 12.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.5 2.133 . . . . 0.0 110.095 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . 30.1 m120 -77.66 -32.99 53.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 112.021 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.56 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.164 -1.585 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.76 79.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.987 -1.071 . . . . 0.0 110.155 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 88.05 -32.51 4.32 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 7.4 m-80 64.4 1.85 1.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -1.086 . . . . 0.0 110.916 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HA ' HD11 ' A' ' 25' ' ' LEU . 5.6 m -123.68 179.48 4.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.541 -1.349 . . . . 0.0 109.862 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.52 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -92.34 131.09 37.81 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -68.89 -24.94 64.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.669 -1.269 . . . . 0.0 110.426 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -96.63 -36.53 10.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.921 -1.112 . . . . 0.0 111.23 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.48 -39.1 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.748 -1.22 . . . . 0.0 110.098 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.72 70.73 1.34 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.537 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.5 tp10 -171.54 157.26 4.73 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.305 . . . . 0.0 109.332 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.407 ' SG ' ' CG2' ' A' ' 9' ' ' ILE . 0.9 OUTLIER -63.04 111.53 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.744 -0.598 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.555 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -128.89 39.42 3.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.107 -0.996 . . . . 0.0 110.791 178.971 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -149.8 67.83 1.0 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.494 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 75.4 m -53.92 146.93 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.879 -1.138 . . . . 0.0 109.839 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.564 HD13 ' CE2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -103.54 -61.82 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.89 . . . . 0.0 111.88 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' CD2' ' HD3' ' A' ' 55' ' ' LYS . 42.1 m-85 -77.54 63.62 2.7 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 112.292 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 29' ' ' TYR . 69.5 m-80 39.06 60.84 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.839 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.525 ' CG2' ' OD1' ' A' ' 8' ' ' ASN . 35.8 p -123.17 148.1 46.13 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 108.956 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -112.66 -165.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.92 18.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' PHE . 1.2 t80 -53.55 -29.9 39.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.779 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.537 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 85.4 m-85 -120.62 37.53 4.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.523 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 46.2 m 49.42 52.94 13.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.161 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.52 0.79 31.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 110.463 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -131.27 -173.7 3.18 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.802 -1.186 . . . . 0.0 109.143 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 64.8 m -111.94 126.62 55.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -57.42 151.89 15.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.807 -1.183 . . . . 0.0 109.763 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.85 125.37 23.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.14 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.8 -32.52 4.4 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -129.51 129.0 43.97 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.325 1.06 . . . . 0.0 109.178 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -114.58 174.34 6.01 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.438 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 133.53 -144.05 15.9 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.382 -1.389 . . . . 0.0 109.962 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 45.7 m-20 -130.06 112.47 17.17 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.573 -0.957 . . . . 0.0 109.353 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.451 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 35.0 Cg_endo -75.88 -3.07 13.37 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.128 1.885 . . . . 0.0 110.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.49 40.68 2.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.0 153.43 38.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.005 . . . . 0.0 109.197 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.51 -27.66 9.03 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.083 1.855 . . . . 0.0 109.285 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.22 137.6 19.73 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.69 -17.17 18.28 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.142 1.895 . . . . 0.0 110.326 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.9 -24.74 58.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 109.16 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.23 27.28 9.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.571 ' HD3' ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -83.38 -143.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.458 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 95.2 m -91.95 83.33 5.18 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.2 mtpt -115.37 170.56 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.008 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.65 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.454 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.4 Cg_endo -76.29 175.31 11.51 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.496 2.131 . . . . 0.0 110.285 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.6 t -64.01 91.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.69 94.03 3.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.516 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -113.02 85.78 2.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.06 -1.025 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 68.7 m-80 -35.88 -97.88 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.585 -0.697 . . . . 0.0 110.704 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' ASN . 12.5 m-20 42.27 -94.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.139 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 4.2 m120 -144.23 68.22 1.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.016 -1.052 . . . . 0.0 110.184 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.561 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.7 pp -142.5 163.93 17.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.44 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 90.3 m-20 -105.96 109.83 63.52 Favored Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.4 -5.74 15.83 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.851 2.367 . . . . 0.0 111.18 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.26 -70.77 0.47 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 109.079 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 160.62 13.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.147 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG11 ' N ' ' A' ' 15' ' ' GLY . 83.2 t -104.13 151.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.35 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.401 ' N ' HG11 ' A' ' 14' ' ' VAL . . . 108.53 -2.69 32.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 11.2 m-80 -60.34 -5.92 1.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.366 . . . . 0.0 111.189 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' HA ' HD13 ' A' ' 25' ' ' LEU . 79.8 m -121.66 177.39 5.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.584 -1.323 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -93.01 133.17 36.42 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -11.24 60.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.916 -1.115 . . . . 0.0 111.677 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.5 HD13 ' N ' ' A' ' 21' ' ' THR . 1.7 pp -102.09 -47.99 4.37 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.539 -1.351 . . . . 0.0 110.985 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.5 ' N ' HD13 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.0 -23.84 20.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.636 -1.29 . . . . 0.0 109.872 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.54 61.48 3.85 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.486 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -147.25 156.52 43.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.108 -1.23 . . . . 0.0 109.273 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 2.1 m -64.43 112.52 3.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.557 ' O ' ' CD2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.88 41.74 3.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.977 -1.077 . . . . 0.0 110.339 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 68.72 0.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.449 -0.782 . . . . 0.0 108.979 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 79.7 m -53.72 151.4 6.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.92 -1.113 . . . . 0.0 109.953 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.561 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -105.35 -58.74 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.49 -0.757 . . . . 0.0 111.327 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -77.86 47.59 0.64 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.589 -0.695 . . . . 0.0 111.695 -178.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.07 63.47 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.722 -1.236 . . . . 0.0 110.532 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.471 ' OG1' ' HB3' ' A' ' 36' ' ' CYS . 0.7 OUTLIER -123.33 158.53 30.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 108.701 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -116.35 -163.8 0.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.38 147.83 12.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.41 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 3.8 t80 -53.95 -32.06 52.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -1.092 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.41 ' CE1' ' HD2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -119.82 38.59 3.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.786 -1.196 . . . . 0.0 109.293 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 68.6 m 52.88 53.43 12.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -107.8 7.31 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.845 . . . . 0.0 109.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.428 ' O ' ' HG3' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -130.79 -167.36 1.82 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.207 -0.933 . . . . 0.0 109.745 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 1.6 m -121.26 135.87 55.06 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -56.5 145.62 27.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.662 -1.274 . . . . 0.0 109.692 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.46 124.77 21.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 109.585 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.99 -31.89 4.58 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' HB3' ' N ' ' A' ' 57' ' ' LYS . 4.3 m-85 -127.28 129.75 48.27 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.302 1.049 . . . . 0.0 109.114 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.07 175.5 5.44 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.155 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 140.85 -147.21 18.84 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.441 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 53.7 m-20 -135.67 102.11 10.53 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.984 . . . . 0.0 109.844 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.428 ' HG3' ' O ' ' A' ' 38' ' ' ARG . 34.3 Cg_endo -75.1 1.4 7.82 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.13 1.887 . . . . 0.0 110.448 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.95 39.29 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 108.915 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.75 156.67 44.61 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.58 -16.34 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.386 2.057 . . . . 0.0 110.121 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.23 128.44 33.42 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.074 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.92 -19.64 15.81 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.192 1.928 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.49 5.78 46.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.412 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -119.68 1.3 11.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 86.8 mttt -69.72 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.987 -1.07 . . . . 0.0 110.358 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 13.8 m -99.14 147.52 25.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 0.0 109.375 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -160.22 167.38 27.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 109.171 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.519 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.41 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 3' ' ' CYS . 36.2 Cg_endo -77.69 -157.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.524 2.149 . . . . 0.0 110.561 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -36.36 148.55 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.599 -0.688 . . . . 0.0 110.409 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.0 tt0 -177.97 118.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.868 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.72 159.5 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -80.06 85.71 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 0.0 109.209 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' OD1' HG22 ' A' ' 9' ' ' ILE . 41.5 p30 -170.93 -140.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.837 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.564 ' ND2' ' CG2' ' A' ' 31' ' ' THR . 12.9 m-20 -96.69 83.01 3.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.056 -1.028 . . . . 0.0 110.137 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.5 pp -149.26 150.36 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.532 -0.73 . . . . 0.0 109.157 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.4 m-20 -107.94 126.9 28.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.302 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.84 -15.47 18.94 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.365 2.044 . . . . 0.0 110.924 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.84 -71.48 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 109.605 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.09 176.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 15' ' ' GLY . 39.3 t -115.32 163.68 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.488 ' N ' ' CG1' ' A' ' 14' ' ' VAL . . . 107.38 -17.57 36.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.56 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.7 m120 -64.69 -2.56 2.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.275 . . . . 0.0 111.125 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t -136.08 142.3 44.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.629 -1.294 . . . . 0.0 108.923 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.562 ' ND2' ' N ' ' A' ' 23' ' ' GLU . 0.1 OUTLIER -77.43 125.18 28.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.951 -1.093 . . . . 0.0 108.23 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -20.61 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.967 . . . . 0.0 110.29 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.41 -42.0 5.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.011 -1.056 . . . . 0.0 111.499 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.453 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -86.31 -39.3 16.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.609 -1.307 . . . . 0.0 110.274 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 71.11 1.32 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 1.3 tp10 -174.84 161.97 3.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.988 -1.301 . . . . 0.0 108.734 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 1.3 m -48.76 124.46 8.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.879 -1.138 . . . . 0.0 109.888 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.552 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -123.6 -28.43 3.88 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.09 -1.006 . . . . 0.0 111.613 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -114.1 84.31 2.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.52 -1.363 . . . . 0.0 110.952 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.479 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 60.9 m -55.37 153.33 7.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.637 -1.29 . . . . 0.0 110.039 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -106.66 -66.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.035 -1.041 . . . . 0.0 112.421 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.547 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 6.3 m-30 -68.87 75.97 0.31 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.55 -0.719 . . . . 0.0 112.895 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' C ' ' O ' ' A' ' 29' ' ' TYR . 4.3 m-20 29.42 52.24 0.09 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.435 0.636 . . . . 0.0 111.224 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.564 ' CG2' ' ND2' ' A' ' 8' ' ' ASN . 70.0 p -120.9 151.8 39.24 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 108.816 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . . . -119.88 -153.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.46 148.45 6.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.09 -24.09 62.64 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.36 -1.082 . . . . 0.0 110.256 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 55.3 m-85 -114.58 20.87 15.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.63 -1.294 . . . . 0.0 110.24 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 35' ' ' TYR . 82.6 m 62.26 29.5 17.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 109.655 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -103.2 23.95 11.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.181 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HB3' ' HB2' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.39 -176.67 4.04 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.215 -0.928 . . . . 0.0 109.208 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.66 139.8 53.09 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.03 141.45 34.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.469 -1.394 . . . . 0.0 109.47 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.53 128.58 37.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.642 -0.661 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.24 2.95 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -128.63 129.57 46.06 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.162 0.982 . . . . 0.0 108.756 177.569 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.9 m-85 -111.07 -179.61 3.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.17 -139.35 9.76 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.454 -1.355 . . . . 0.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -124.67 100.43 34.51 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.733 -0.863 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.519 ' CB ' HG23 ' A' ' 31' ' ' THR . 36.3 Cg_endo -79.68 -8.41 14.68 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 37.88 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 109.952 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.47 152.66 42.17 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.118 -0.989 . . . . 0.0 109.136 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.78 -27.44 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -101.12 134.15 20.54 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.33 -1.04 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.105 1.87 . . . . 0.0 110.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.01 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 108.661 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.6 31.74 4.52 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.441 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 6.6 ttmt -73.01 -145.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.691 -0.631 . . . . 0.0 109.919 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 6.9 m -100.13 94.07 6.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.083 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.33 -167.03 1.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.483 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.66 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 110.44 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.502 ' HB3' ' CD1' ' A' ' 9' ' ' ILE . 3.8 t -99.8 154.87 17.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' CYS . 1.8 mt-30 -39.32 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.725 -0.609 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 16.1 p -53.75 125.37 18.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 109.346 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 72.2 m-20 -106.04 -144.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.1 t0 83.21 -72.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.575 ' ND2' ' CG2' ' A' ' 31' ' ' THR . 4.0 m120 -137.69 70.83 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.832 -1.167 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.541 ' CA ' HG12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -141.92 149.54 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.072 -1.018 . . . . 0.0 109.646 179.172 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.452 ' OD2' HG23 ' A' ' 28' ' ' ILE . 31.5 m-20 -109.39 126.3 29.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.262 -0.899 . . . . 0.0 109.909 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.02 -9.16 16.72 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.376 2.05 . . . . 0.0 110.636 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.0 -74.2 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.0 109.811 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 170.15 3.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.077 -1.015 . . . . 0.0 109.548 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG11 ' N ' ' A' ' 15' ' ' GLY . 25.7 t -106.71 157.41 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 25' ' ' LEU . . . 106.48 -31.87 7.86 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.4 ' C ' ' O ' ' A' ' 15' ' ' GLY . 11.7 m-80 -44.38 -24.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -1.211 . . . . 0.0 109.897 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 3.6 m -127.7 161.77 28.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 109.293 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.569 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -95.86 130.04 42.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.751 -1.218 . . . . 0.0 108.217 179.176 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -62.73 -34.39 77.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 0.0 110.632 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 -37.48 8.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.847 -1.158 . . . . 0.0 111.617 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.77 -13.02 49.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.618 -1.301 . . . . 0.0 110.168 -179.155 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.59 47.82 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -129.9 170.27 14.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -1.139 . . . . 0.0 108.637 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.526 ' SG ' ' CG2' ' A' ' 9' ' ' ILE . 60.1 m -70.06 102.52 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.665 -1.272 . . . . 0.0 109.411 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 15' ' ' GLY . 0.2 OUTLIER -79.11 -11.31 59.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.127 . . . . 0.0 110.118 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -160.16 95.63 1.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.727 -1.233 . . . . 0.0 111.25 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 71.3 m -54.43 153.64 5.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.336 -1.477 . . . . 0.0 108.77 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -102.53 -59.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.723 -1.236 . . . . 0.0 112.871 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -75.12 40.1 0.15 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.742 . . . . 0.0 112.169 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 58.29 68.6 0.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.476 -1.39 . . . . 0.0 110.571 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.575 ' CG2' ' ND2' ' A' ' 8' ' ' ASN . 36.9 p -133.68 147.48 51.4 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -110.3 -159.02 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.36 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 147.32 10.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 t80 -50.67 -30.35 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -1.002 . . . . 0.0 109.764 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -124.12 43.4 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.892 -1.13 . . . . 0.0 109.375 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.1 m 51.88 48.27 23.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 108.633 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.46 3.52 45.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.289 -0.882 . . . . 0.0 110.48 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.17 -172.26 2.79 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.918 -1.114 . . . . 0.0 109.659 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.478 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 77.6 m -117.32 130.52 56.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -57.14 146.75 26.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.787 -1.196 . . . . 0.0 109.667 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.21 129.04 38.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.483 -0.761 . . . . 0.0 109.697 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.47 -35.85 3.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.398 -2.681 . . . . 0.0 106.398 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.475 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 7.9 m-85 -126.11 132.14 51.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.189 0.995 . . . . 0.0 108.661 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' LYS . 4.4 m-85 -111.69 -178.11 3.35 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 127.98 -144.96 15.63 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 22.8 m120 -129.06 120.22 20.14 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.597 -0.943 . . . . 0.0 109.066 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.478 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.6 Cg_endo -77.41 -18.02 14.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.979 1.786 . . . . 0.0 111.204 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 12.9 tp -109.55 37.11 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.943 -1.098 . . . . 0.0 110.019 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.16 151.43 41.7 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 108.762 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.44 -29.61 9.09 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.155 1.903 . . . . 0.0 109.022 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -101.26 128.63 28.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.76 -12.02 24.13 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.053 1.835 . . . . 0.0 110.469 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.96 59.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.98 -1.075 . . . . 0.0 108.792 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.63 15.0 22.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -65.96 -146.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 71.0 m -90.95 82.44 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.018 -1.051 . . . . 0.0 108.417 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.475 ' HA ' ' HB3' ' A' ' 43' ' ' PHE . 1.7 mttm -124.83 -174.61 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.576 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.294 179.801 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.44 156.41 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.395 2.063 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 160.62 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 108.832 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.86 116.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 110.072 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 p -157.88 176.43 12.57 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -51.52 159.35 0.75 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 75.34 5.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.502 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.577 ' HA ' ' CD1' ' A' ' 28' ' ' ILE . 50.2 m-20 -145.02 67.03 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 0.0 110.24 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.487 ' C ' HG12 ' A' ' 28' ' ' ILE . 2.7 pt -149.52 176.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -106.56 147.36 34.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.206 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 -40.24 0.49 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.439 2.093 . . . . 0.0 111.201 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.511 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -78.34 -5.17 51.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -178.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.963 -1.71 . . . . 0.0 109.011 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.7 80.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.074 . . . . 0.0 110.329 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 -22.91 6.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 22.9 m-80 54.88 15.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.883 -1.363 . . . . 0.0 110.63 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.21 159.77 32.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.883 -1.136 . . . . 0.0 109.503 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.7 120.18 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -64.62 -19.65 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.869 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' HG ' ' N ' ' A' ' 21' ' ' THR . 0.5 OUTLIER -97.77 -41.26 8.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.771 -1.205 . . . . 0.0 110.893 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.471 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -91.94 -64.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.698 -1.251 . . . . 0.0 109.922 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 116.92 79.16 0.72 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -178.15 159.3 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.984 -1.303 . . . . 0.0 108.259 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.429 ' SG ' HG23 ' A' ' 9' ' ' ILE . 1.2 m -47.86 119.23 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.604 -1.31 . . . . 0.0 108.648 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.539 ' O ' ' CD1' ' A' ' 25' ' ' LEU . 1.1 tm? -125.77 27.86 6.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 110.294 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.4 mttt -160.2 63.1 0.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.965 -1.084 . . . . 0.0 109.927 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.488 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 46.6 m -55.39 150.66 11.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.956 -1.09 . . . . 0.0 109.709 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.577 ' CD1' ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.8 -64.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.0 111.816 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.54 ' O ' ' CG2' ' A' ' 31' ' ' THR . 24.5 m-85 -59.5 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' C ' ' O ' ' A' ' 29' ' ' TYR . 10.1 m-20 24.32 52.65 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.233 0.539 . . . . 0.0 111.257 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.54 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 38.2 p -121.45 144.67 48.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.075 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -115.56 -169.82 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.594 -0.691 . . . . 0.0 109.567 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.93 148.1 21.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.417 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 3.1 t80 -52.66 -27.31 16.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CZ ' ' HD2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -126.55 37.91 4.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.814 -1.178 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.6 m 52.18 53.5 12.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.931 -1.105 . . . . 0.0 108.605 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -97.75 -7.42 30.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.782 . . . . 0.0 110.376 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -174.74 3.46 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.828 -1.17 . . . . 0.0 109.685 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' SG ' ' HG3' ' A' ' 47' ' ' PRO . 3.2 m -122.15 136.21 54.88 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -56.21 149.82 15.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.655 -1.278 . . . . 0.0 108.944 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.54 132.6 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -36.5 3.13 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 106.769 -2.533 . . . . 0.0 106.769 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -124.24 129.58 51.03 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.21 1.005 . . . . 0.0 108.999 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.51 173.35 6.45 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.78 19.24 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.635 -1.269 . . . . 0.0 109.975 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 38.6 m-20 -115.27 107.35 49.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.435 -1.038 . . . . 0.0 109.53 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.521 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 37.7 Cg_endo -79.35 -13.35 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.246 1.964 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.1 39.07 2.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.8 . . . . 0.0 109.828 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.78 148.68 35.63 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.37 -23.32 13.32 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.358 2.039 . . . . 0.0 109.901 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -99.89 135.58 20.42 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.412 -0.805 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.91 -19.89 17.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.152 1.901 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.15 -27.22 59.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.26 38.16 2.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.171 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -89.84 -145.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.681 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 47' ' ' PRO . 74.9 m -101.47 106.16 17.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 109.719 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.11 173.14 8.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -0.968 . . . . 0.0 109.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.507 -179.876 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . 0.47 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.8 Cg_endo -78.07 -59.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.647 2.231 . . . . 0.0 110.772 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 29.7 m -80.1 174.71 11.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.494 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' O ' ' C ' ' A' ' 5' ' ' CYS . 15.8 tp60 179.85 -115.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' C ' ' O ' ' A' ' 4' ' ' GLN . 27.2 p -0.15 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.391 0.615 . . . . 0.0 112.197 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.519 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 78.7 m-20 -78.03 -135.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 38.1 m-20 74.27 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.932 . . . . 0.0 110.693 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.492 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 1.8 m120 -115.62 74.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.799 -1.188 . . . . 0.0 110.492 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.554 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.8 pp -154.22 146.85 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 108.818 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.497 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.7 OUTLIER -108.93 128.53 25.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.407 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.13 -14.38 18.78 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.427 2.084 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.32 -72.24 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.37 163.05 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 109.29 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.76 152.13 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.076 -1.015 . . . . 0.0 109.36 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 112.35 -28.48 9.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 13.6 m-80 -42.72 -26.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -1.183 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 15' ' ' GLY . 1.7 p -126.06 149.63 48.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 108.998 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -82.71 126.64 32.59 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -34.0 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.734 -1.229 . . . . 0.0 110.215 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -34.36 10.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.93 -1.106 . . . . 0.0 111.425 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -22.73 23.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.659 -1.276 . . . . 0.0 110.378 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.45 69.56 1.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -163.97 169.5 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 108.861 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 7.0 m -65.58 101.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.241 -1.537 . . . . 0.0 109.301 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.26 -26.04 26.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 79.52 1.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.787 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.476 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 76.3 m -53.62 152.85 4.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.432 -1.418 . . . . 0.0 108.518 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.554 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -92.13 -64.85 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.966 -1.084 . . . . 0.0 112.317 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.494 ' CE2' HD11 ' A' ' 28' ' ' ILE . 57.0 m-85 -73.21 71.54 1.19 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.428 -0.795 . . . . 0.0 112.616 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 31.34 54.22 0.22 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.586 -0.697 . . . . 0.0 111.094 177.812 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.494 HG23 ' CB ' ' A' ' 47' ' ' PRO . 11.5 p -122.55 151.74 41.08 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.161 -0.962 . . . . 0.0 109.65 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -123.49 -163.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.04 152.86 27.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.565 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 1.1 t80 -51.61 -34.34 36.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 109.832 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.427 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -119.67 39.62 3.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.796 -1.19 . . . . 0.0 109.63 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 39.4 m 50.31 32.64 6.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.01 -1.056 . . . . 0.0 109.013 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.31 10.88 20.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.403 -0.811 . . . . 0.0 109.707 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.68 -173.72 3.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.107 -0.996 . . . . 0.0 109.529 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.459 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 56.4 m -119.97 131.7 55.26 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.722 -1.236 . . . . 0.0 109.355 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.62 130.27 46.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.561 -0.712 . . . . 0.0 109.614 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.53 -36.52 3.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -126.08 129.43 49.1 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.238 1.018 . . . . 0.0 109.001 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -110.58 171.93 7.17 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.9 -145.02 17.16 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.932 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.604 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 11.3 m120 -115.27 108.05 48.5 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.969 . . . . 0.0 108.793 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 34.8 Cg_endo -75.14 -7.73 19.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.87 1.714 . . . . 0.0 110.749 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.447 HD12 ' HB3' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -122.09 42.48 3.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 155.58 43.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 0.0 108.952 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.35 -22.02 14.63 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.203 1.935 . . . . 0.0 109.689 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m-80 -100.82 134.47 20.47 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.528 -0.733 . . . . 0.0 109.157 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.71 -19.19 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.243 1.962 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.35 12.44 29.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.061 -1.024 . . . . 0.0 109.724 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.464 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 m-20 -135.62 30.01 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.904 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 39.3 mttm -97.57 -116.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.957 -1.089 . . . . 0.0 110.544 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 2.8 m -100.67 105.69 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.648 -1.283 . . . . 0.0 109.59 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 1.5 mptt -105.54 170.51 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.487 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.37 -76.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.564 2.176 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.4 t -73.71 151.18 40.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -158.13 110.69 2.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 110.42 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 22.7 p -164.95 169.75 16.08 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 35' ' ' TYR . 28.1 m120 -39.92 147.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.486 -0.759 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 8' ' ' ASN . 6.5 t70 -80.81 69.72 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.547 ' C ' HG13 ' A' ' 28' ' ' ILE . 2.2 m120 -139.26 64.62 1.46 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.116 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.581 ' HA ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -154.4 -177.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' N ' HG12 ' A' ' 9' ' ' ILE . 43.5 m-20 -107.35 112.47 62.68 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.773 -1.205 . . . . 0.0 109.304 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.15 -8.47 17.58 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.665 2.244 . . . . 0.0 110.954 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -78.63 -74.1 0.29 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.28 -167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.107 -0.996 . . . . 0.0 109.269 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.16 156.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.968 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.89 36.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 28.8 m-80 -52.41 -16.19 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 110.51 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t -121.95 149.08 43.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 108.902 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.574 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.19 126.62 31.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.877 -1.139 . . . . 0.0 108.302 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -69.16 -39.83 78.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.401 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -24.92 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.549 -1.345 . . . . 0.0 111.242 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -92.55 -32.65 14.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.358 -1.464 . . . . 0.0 109.881 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' CD ' ' A' ' 23' ' ' GLU . . . 71.25 63.24 3.18 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.571 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -159.89 159.41 32.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.104 -1.233 . . . . 0.0 109.258 -179.369 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 23.3 m -55.83 114.85 2.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.574 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.91 -34.49 10.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.884 -1.135 . . . . 0.0 109.862 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -123.21 83.05 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.197 -0.939 . . . . 0.0 110.376 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.54 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 65.1 m -53.91 155.71 3.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.488 -1.383 . . . . 0.0 109.278 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.581 HG13 ' HA ' ' A' ' 9' ' ' ILE . 0.5 OUTLIER -107.13 -64.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 120.84 -1.163 . . . . 0.0 112.86 -178.89 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.531 ' O ' ' C ' ' A' ' 30' ' ' ASN . 55.4 m-85 -59.21 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.294 -0.879 . . . . 0.0 112.091 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' C ' ' O ' ' A' ' 29' ' ' TYR . 76.2 m-20 22.99 50.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.304 0.573 . . . . 0.0 111.254 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.484 HG21 ' O ' ' A' ' 29' ' ' TYR . 1.2 p -121.54 151.28 40.5 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.406 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -121.72 176.47 5.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.9 152.23 24.72 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.421 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 5.0 t80 -56.56 -32.0 64.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -1.123 . . . . 0.0 109.714 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 26.2 m-85 -117.33 22.38 12.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.917 -1.114 . . . . 0.0 109.245 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.8 m 61.17 61.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -90.28 -21.59 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.873 . . . . 0.0 111.286 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -131.9 -174.26 3.37 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.584 -1.322 . . . . 0.0 109.596 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.62 137.55 50.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -55.43 156.9 4.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.488 -1.382 . . . . 0.0 109.604 -178.32 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 123.94 18.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.24 -30.52 4.97 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 107.111 -2.395 . . . . 0.0 107.111 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 57' ' ' LYS . 6.0 m-85 -127.04 128.46 46.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.272 1.034 . . . . 0.0 109.109 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -108.45 -156.85 0.59 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.53 -151.48 18.32 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.323 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 13.4 m120 -135.06 104.77 10.45 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' HB3' HG23 ' A' ' 31' ' ' THR . 36.1 Cg_endo -78.01 1.48 8.88 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.028 1.819 . . . . 0.0 109.857 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -108.8 38.22 2.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 108.863 179.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.52 148.5 39.34 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.447 -0.783 . . . . 0.0 109.142 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.92 -28.52 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.23 1.954 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -101.19 140.99 21.73 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.123 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.95 -11.75 21.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.233 1.955 . . . . 0.0 110.39 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.84 60.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.942 -1.098 . . . . 0.0 109.099 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -117.21 30.13 7.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 109.018 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.2 ttmt -87.21 -139.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.795 . . . . 0.0 109.175 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 56.6 m -91.96 162.65 14.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.951 -1.093 . . . . 0.0 109.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 1.3 mmtp 174.39 -167.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.348 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.485 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 4' ' ' GLN . 35.2 Cg_endo -75.6 -94.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.203 1.935 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' O ' ' C ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER 48.47 -87.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -37.81 130.63 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.49 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.481 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.4 p -151.02 108.33 3.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.433 -0.792 . . . . 0.0 109.203 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 8.2 m-20 -54.63 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 49.7 m-20 102.89 -102.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.541 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.3 m120 -120.97 67.57 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.857 -1.152 . . . . 0.0 109.546 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.553 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.4 pt -139.18 162.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.476 ' OD1' HD12 ' A' ' 28' ' ' ILE . 58.5 m-20 -106.77 119.34 51.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.66 -4.14 14.63 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.684 2.256 . . . . 0.0 111.234 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.69 -68.76 0.62 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.358 -0.839 . . . . 0.0 109.85 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.27 171.04 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.989 -1.069 . . . . 0.0 110.039 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.9 t -111.44 164.64 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.302 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.05 4.61 57.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 8.4 m-80 -63.26 -0.92 0.9 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.837 -1.39 . . . . 0.0 111.669 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 p -128.41 158.23 38.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.334 -1.479 . . . . 0.0 109.747 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.58 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.59 130.14 40.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -58.84 -35.98 73.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.73 -1.231 . . . . 0.0 111.786 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.15 -34.24 10.12 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.545 -1.347 . . . . 0.0 112.158 -177.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 2.6 p -83.86 -34.15 24.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.431 -1.418 . . . . 0.0 110.446 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.77 66.68 1.99 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 8.5 tp10 -162.32 160.9 27.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 108.832 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' CYS . . . . . 0.462 ' SG ' HG22 ' A' ' 9' ' ' ILE . 4.5 m -48.18 120.08 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.975 -1.078 . . . . 0.0 108.348 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.58 ' HB2' ' ND2' ' A' ' 18' ' ' ASN . 8.7 tp -125.65 15.62 8.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.294 -0.878 . . . . 0.0 110.724 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.501 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 12.2 mtpt -159.07 77.89 0.74 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.131 -0.98 . . . . 0.0 109.586 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 13.7 m -57.86 155.25 10.73 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.666 -1.271 . . . . 0.0 110.189 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.553 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -111.26 -63.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.535 ' O ' ' CG2' ' A' ' 31' ' ' THR . 25.5 m-85 -68.15 72.53 0.19 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER 33.09 52.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 111.476 177.621 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.535 ' CG2' ' O ' ' A' ' 29' ' ' TYR . 20.3 p -122.07 145.15 48.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.955 -1.09 . . . . 0.0 109.091 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -124.56 166.21 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.39 155.38 9.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.4 ' HD1' ' CD1' ' A' ' 35' ' ' TYR . 10.7 t80 -56.04 -30.35 61.79 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -1.121 . . . . 0.0 109.949 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CD1' ' HD1' ' A' ' 34' ' ' PHE . 14.2 m-85 -117.49 29.41 7.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.164 . . . . 0.0 109.628 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.3 m 49.84 43.25 24.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.705 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.38 21.29 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.33 -179.22 5.13 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.223 -0.923 . . . . 0.0 108.874 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . 0.453 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 1.4 m -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.9 ttmt -55.77 138.14 48.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.717 -1.24 . . . . 0.0 109.805 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 5.0 pt-20 -61.09 130.54 46.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.597 -0.689 . . . . 0.0 109.815 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.74 -34.96 3.57 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 13.9 m-85 -130.53 131.74 45.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.133 0.968 . . . . 0.0 108.479 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' LYS . 2.3 m-85 -105.53 -179.91 4.08 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.34 -145.22 17.09 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.886 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 30.6 m120 -118.73 111.93 37.27 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.972 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.481 ' CB ' ' O ' ' A' ' 38' ' ' ARG . 36.3 Cg_endo -78.63 -29.1 3.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 110.731 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' O ' HD21 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -112.16 44.93 1.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.989 -179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.67 154.06 50.4 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.002 -1.062 . . . . 0.0 108.859 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.73 -31.13 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.019 1.813 . . . . 0.0 108.83 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.94 139.33 20.22 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 33.5 Cg_endo -75.18 0.77 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.048 1.832 . . . . 0.0 109.869 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.95 -13.6 53.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.701 -1.249 . . . . 0.0 109.248 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 4.0 m-20 -111.03 40.37 2.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.293 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -70.43 -155.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 109.057 -179.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 5.9 m -101.37 90.57 4.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -114.84 177.04 4.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.571 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.61 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.472 ' ND2' ' OD1' ' A' ' 37' ' ' ASP . 2.8 m120 -54.09 170.41 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.489 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.72 67.36 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.2 -0.937 . . . . 0.0 110.912 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -142.82 62.72 1.4 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.93 -1.106 . . . . 0.0 109.17 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.558 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -154.14 152.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -107.77 129.23 24.47 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.26 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.91 -6.65 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.625 2.217 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.47 -69.33 0.57 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 169.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.596 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.01 152.78 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.256 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.62 65.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -15.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.091 -1.241 . . . . 0.0 111.019 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 150.0 43.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.723 -1.235 . . . . 0.0 109.476 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' ND2' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -84.29 122.06 28.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -6.91 57.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.844 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.896 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -108.22 -45.08 4.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 111.147 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -91.71 -15.5 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.65 -1.281 . . . . 0.0 110.199 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.96 61.01 5.87 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' CG ' ' ND2' ' A' ' 18' ' ' ASN . 9.2 pt-20 -156.56 152.46 27.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -1.164 . . . . 0.0 108.404 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 35.6 m -51.94 118.97 3.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.359 -1.463 . . . . 0.0 109.858 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CB ' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -84.61 -31.37 24.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.917 -1.115 . . . . 0.0 109.335 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -143.89 84.66 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' THR . 9.7 m -53.42 155.69 2.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.518 -1.364 . . . . 0.0 108.655 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -86.44 -66.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.04 -1.038 . . . . 0.0 112.452 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.093 ' O ' HG23 ' A' ' 31' ' ' THR . 19.0 m-85 -64.58 77.73 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.558 -0.714 . . . . 0.0 112.63 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 29' ' ' TYR . 7.5 m-20 26.0 48.87 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.159 0.504 . . . . 0.0 111.504 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.093 HG23 ' O ' ' A' ' 29' ' ' TYR . 44.6 p -121.92 150.94 41.28 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 109.635 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -139.32 171.46 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.68 158.63 10.67 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.27 -29.59 47.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -1.1 . . . . 0.0 110.095 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.99 32.0 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.812 -1.18 . . . . 0.0 109.77 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' CB ' ' A' ' 24' ' ' CYS . 90.0 m 49.74 27.23 2.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.211 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.472 ' OD1' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -94.82 20.44 8.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.342 -0.848 . . . . 0.0 109.624 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -130.7 -174.6 3.41 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.074 -1.017 . . . . 0.0 109.577 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.433 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 98.8 m -120.15 135.43 54.96 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' CE ' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -55.77 147.14 19.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.552 -1.343 . . . . 0.0 110.09 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.15 123.59 17.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.701 . . . . 0.0 109.69 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.43 -33.38 4.17 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.51 ' CE2' ' CE ' ' A' ' 40' ' ' LYS . 7.9 m-85 -122.47 129.83 52.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.219 1.009 . . . . 0.0 108.726 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.6 m-85 -118.46 178.85 4.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.16 -143.8 14.59 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 80.8 m-20 -115.98 110.11 44.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.482 -1.01 . . . . 0.0 109.061 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.4 Cg_endo -78.42 -9.78 16.16 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.169 1.913 . . . . 0.0 110.586 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.79 37.89 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HE2' ' A' ' 55' ' ' LYS . . . -93.23 153.16 41.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.232 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.01 -29.67 7.97 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.117 1.878 . . . . 0.0 108.949 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -101.27 138.56 19.97 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.75 -19.4 16.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.104 1.869 . . . . 0.0 110.142 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.14 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 109.194 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -113.38 17.84 18.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 109.288 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -71.85 -130.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 9.7 m -101.07 102.89 13.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.8 mmtt -109.2 168.28 9.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.387 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 14.4 m120 -159.83 -160.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER 81.88 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 0.0 110.338 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 4.6 m120 -132.93 73.0 1.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.623 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.8 pp -146.48 150.85 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 108.921 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.779 ' OD2' HG21 ' A' ' 28' ' ' ILE . 3.6 m-20 -109.29 142.28 25.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.208 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.27 -8.94 17.62 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.507 2.138 . . . . 0.0 110.406 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -76.75 -48.66 18.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.466 -0.771 . . . . 0.0 110.804 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.36 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.564 -1.335 . . . . 0.0 108.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.96 83.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.859 -1.15 . . . . 0.0 110.916 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.64 -38.21 3.42 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.51 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 4.7 m-80 52.22 16.43 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -1.225 . . . . 0.0 110.251 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.2 p -129.75 169.72 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.665 -1.272 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.633 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.31 122.47 20.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.768 -1.208 . . . . 0.0 108.247 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -18.12 55.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.028 -1.045 . . . . 0.0 110.422 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -39.25 6.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 111.898 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -90.59 -42.26 10.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.342 -1.474 . . . . 0.0 110.411 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.11 76.07 1.32 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.8 tp10 -176.61 163.1 2.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.941 -1.329 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' SG ' HG21 ' A' ' 9' ' ' ILE . 3.5 m -48.34 114.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.0 109.218 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 18' ' ' ASN . 12.5 tp -122.43 12.69 10.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.223 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HG3' ' C ' ' A' ' 25' ' ' LEU . 10.4 mttm -154.02 67.21 0.73 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 36.9 m -53.09 149.6 6.63 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.806 -1.184 . . . . 0.0 108.559 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.779 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -104.13 -62.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.065 -1.022 . . . . 0.0 112.481 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.933 ' O ' HG23 ' A' ' 31' ' ' THR . 69.5 m-85 -69.7 73.07 0.38 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 29' ' ' TYR . 8.1 m-20 27.48 59.13 0.1 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.0 111.056 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 29' ' ' TYR . 30.8 p -121.74 152.38 39.5 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.43 -168.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.387 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.95 23.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.58 -30.5 63.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.913 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 64.5 m-85 -114.55 31.88 6.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.796 -1.19 . . . . 0.0 109.333 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.8 m 49.64 41.21 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 108.979 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -95.68 8.52 43.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -173.76 3.15 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.003 -1.061 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.64 137.57 53.79 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -55.82 146.73 20.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.65 -1.281 . . . . 0.0 109.791 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.31 129.0 38.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.249 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.85 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.221 -2.752 . . . . 0.0 106.221 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.66 129.96 46.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.102 0.953 . . . . 0.0 108.658 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -113.01 -173.95 2.35 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.65 -142.18 13.47 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.992 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 48.8 m-20 -129.08 103.72 18.42 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.536 -0.979 . . . . 0.0 109.173 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 31' ' ' THR . 33.3 Cg_endo -73.4 -5.95 18.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.806 1.671 . . . . 0.0 110.283 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -109.86 38.65 2.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 108.867 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -93.4 158.11 37.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.828 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 33.7 Cg_endo -75.37 -15.76 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.288 1.992 . . . . 0.0 109.986 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 54' ' ' ASP . 2.6 m-20 -100.45 135.24 20.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 108.958 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.29 -19.22 17.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 0.0 110.782 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.27 -1.0 25.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.884 -1.135 . . . . 0.0 109.623 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 51' ' ' ASN . 1.8 m-20 -107.76 -3.42 19.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 12.8 mttp -59.27 -105.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 110.312 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 73.7 m -75.21 177.39 6.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.709 -1.244 . . . . 0.0 108.592 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER 163.63 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.202 -0.936 . . . . 0.0 109.79 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 1.5 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.356 0.598 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 55.2 m-80 -164.59 -165.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 56.9 m-20 66.4 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 110.608 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.947 ' HA ' HD11 ' A' ' 28' ' ' ILE . 6.2 m-20 -115.73 63.45 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.123 . . . . 0.0 110.959 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.528 ' C ' HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -142.47 173.19 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.074 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.665 ' CG ' HG21 ' A' ' 28' ' ' ILE . 6.9 m-20 -107.8 128.56 25.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.845 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 -1.03 11.16 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.723 2.282 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.64 -68.82 0.59 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.369 -0.832 . . . . 0.0 109.381 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.43 161.7 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.894 -1.129 . . . . 0.0 108.694 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.7 116.51 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 0.0 109.971 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 108.55 -40.35 2.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 5.6 m120 38.85 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.997 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 15' ' ' GLY . 15.5 p -124.98 172.5 9.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.772 -1.205 . . . . 0.0 110.691 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.65 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 126.36 29.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -20.48 54.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.803 -1.186 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -109.08 -42.68 4.36 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.812 -1.18 . . . . 0.0 111.924 -178.769 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -82.81 -32.94 27.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.436 -1.415 . . . . 0.0 110.228 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 76.22 67.31 1.71 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -160.69 158.95 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.243 . . . . 0.0 108.978 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 72.4 m -48.45 111.54 0.47 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.074 -1.016 . . . . 0.0 108.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 18' ' ' ASN . 37.7 tp -126.8 9.47 6.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.248 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -126.1 60.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 111.561 -179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 67.2 m -56.34 146.37 24.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.549 -1.344 . . . . 0.0 107.741 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.947 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -110.02 -62.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.629 -1.294 . . . . 0.0 112.813 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.805 ' H ' HD12 ' A' ' 28' ' ' ILE . 60.2 m-85 -72.59 69.54 0.88 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.27 -0.894 . . . . 0.0 112.69 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 33.63 63.79 0.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.431 177.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' SG ' ' A' ' 56' ' ' CYS . 3.3 p -122.1 158.82 28.44 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.219 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -118.32 -173.4 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.975 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.61 147.9 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.03 -33.93 58.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -1.066 . . . . 0.0 109.816 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' SG ' ' A' ' 24' ' ' CYS . 3.7 m-85 -116.28 36.91 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.91 -1.119 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 5.3 m 52.99 50.54 17.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.991 . . . . 0.0 108.804 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -92.99 -6.32 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.013 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.28 -167.64 1.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 6.2 m -121.6 137.36 54.77 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -55.4 149.28 13.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.556 -1.34 . . . . 0.0 109.661 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 126.67 28.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.647 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.22 4.22 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.553 ' HB3' ' CA ' ' A' ' 57' ' ' LYS . 25.4 m-85 -127.92 129.86 47.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.159 0.98 . . . . 0.0 109.076 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.14 178.62 4.25 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.61 -144.52 14.89 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.336 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.4 m120 -132.66 105.28 12.97 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.897 . . . . 0.0 108.947 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.72 0.78 6.5 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.305 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -116.38 41.51 2.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.03 -1.044 . . . . 0.0 109.18 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.2 157.36 38.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.247 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.93 -13.72 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.335 2.023 . . . . 0.0 110.422 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 57.7 m-20 -100.55 132.5 22.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.7 -20.18 13.83 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.145 1.896 . . . . 0.0 110.638 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.36 -8.43 45.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.998 -1.064 . . . . 0.0 109.623 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 51' ' ' ASN . 46.2 m-20 -105.69 -15.35 14.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.708 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.4 mtmm -59.3 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.094 -1.004 . . . . 0.0 109.933 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 85.6 m -93.93 144.89 25.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 108.79 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 170.36 172.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.34 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.2 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 m120 -52.09 -176.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.0 70.62 5.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.003 -1.061 . . . . 0.0 110.65 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 77.2 m-20 -144.88 63.66 1.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.887 -1.133 . . . . 0.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pt -149.96 150.32 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.171 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 1.4 m-20 -108.39 120.08 47.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 109.242 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.54 -3.79 14.41 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.551 2.167 . . . . 0.0 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.29 -67.75 0.71 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 109.488 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.76 179.22 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.402 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.09 149.27 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 109.54 -12.8 33.01 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -38.22 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -1.161 . . . . 0.0 110.474 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' GLY . 6.3 t -123.88 156.12 36.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -81.08 119.21 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -18.27 63.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.824 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -105.92 -40.6 5.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.818 -1.176 . . . . 0.0 111.817 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 1.9 p -91.34 -33.54 15.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.424 -1.423 . . . . 0.0 110.667 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 82.69 70.24 1.36 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 4.3 tp10 -163.41 167.98 20.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.27 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 62.2 m -64.44 107.13 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.487 -1.383 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.75 14.8 25.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 70.81 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.703 -1.248 . . . . 0.0 111.422 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 75.2 m -54.78 148.61 12.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.303 -1.498 . . . . 0.0 108.293 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.578 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.47 -63.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.794 -1.191 . . . . 0.0 112.82 -178.628 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.038 ' O ' HG23 ' A' ' 31' ' ' THR . 99.4 m-85 -57.17 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 0.0 112.159 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 29' ' ' TYR . 62.2 m-80 21.2 49.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.356 0.598 . . . . 0.0 111.341 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.038 HG23 ' O ' ' A' ' 29' ' ' TYR . 26.6 p -122.86 155.21 37.09 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.364 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -125.01 -162.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.564 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.19 146.39 6.58 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.99 -30.02 13.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.478 -1.013 . . . . 0.0 109.828 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.98 41.32 3.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.75 -1.219 . . . . 0.0 109.838 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.6 m 50.6 29.74 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.005 . . . . 0.0 109.573 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.625 ' HA ' HD21 ' A' ' 48' ' ' LEU . 9.7 p30 -90.23 10.73 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.48 -167.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.256 -0.903 . . . . 0.0 109.167 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 23.0 m -121.84 128.8 52.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -57.0 143.45 38.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.61 126.26 26.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.88 -31.65 4.68 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -134.23 128.39 33.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.195 0.998 . . . . 0.0 109.428 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 4.8 m-85 -108.2 -179.38 3.87 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.76 -142.21 13.63 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.373 -1.394 . . . . 0.0 109.997 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 58.8 m-80 -128.56 105.07 19.17 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.933 . . . . 0.0 109.121 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.7 Cg_endo -80.34 -4.81 13.27 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.406 2.071 . . . . 0.0 110.357 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 37' ' ' ASP . 70.2 mt -110.08 38.48 2.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.21 36.3 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.133 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.67 -24.07 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.201 1.934 . . . . 0.0 109.277 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.2 135.56 19.88 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 -18.99 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.193 1.928 . . . . 0.0 110.29 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.93 -17.66 60.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 109.419 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 55' ' ' LYS . 96.9 m-20 -105.03 11.91 32.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -63.41 -139.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.324 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 14.1 m -99.69 104.33 16.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.866 -1.146 . . . . 0.0 108.913 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mtmt -109.1 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.484 179.927 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.275 0.559 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -78.24 81.32 4.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.086 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -152.59 -134.92 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.756 ' OD1' HG21 ' A' ' 31' ' ' THR . 15.6 m120 -89.42 76.14 7.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 110.066 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -141.73 167.01 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 108.877 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.62 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -105.12 135.35 19.32 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.365 -0.834 . . . . 0.0 109.156 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.43 -25.22 9.92 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.362 2.042 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -77.32 -10.58 59.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 111.086 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.422 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . . . -78.83 -165.8 0.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.286 -1.509 . . . . 0.0 109.017 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.3 t -111.63 83.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 110.288 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 81.92 -19.69 9.34 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.798 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 5.9 m120 45.12 25.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.424 . . . . 0.0 109.214 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 34.1 m -123.0 175.94 6.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.91 123.38 31.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -61.84 -10.92 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 110.963 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -110.33 -41.05 4.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.7 -1.25 . . . . 0.0 111.986 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -90.12 -33.01 16.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.292 -1.505 . . . . 0.0 110.132 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.99 1.33 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -166.35 145.87 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.32 . . . . 0.0 109.384 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.25 107.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.868 HD13 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.36 44.28 2.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.0 110.534 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -148.72 60.07 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 108.895 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 92.1 m -54.15 150.03 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.87 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.82 -62.05 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.279 -0.888 . . . . 0.0 111.92 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 8.8 m-30 -75.24 65.62 1.61 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.647 -0.658 . . . . 0.0 112.378 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 29' ' ' TYR . 17.3 m120 38.47 62.07 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 110.924 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.756 HG21 ' OD1' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -125.74 156.79 38.85 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.284 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -122.98 -164.99 1.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.38 22.28 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -32.96 43.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -1.069 . . . . 0.0 109.712 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' OH ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 m-85 -121.47 38.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 109.557 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.4 m 55.72 33.3 21.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.547 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.81 13.77 13.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.714 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.9 ttt180 -131.31 -178.08 4.69 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 64.1 m -125.49 129.79 50.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -56.99 143.43 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.696 -1.252 . . . . 0.0 109.729 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.11 136.3 57.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.274 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.27 -39.85 2.2 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 106.25 -2.74 . . . . 0.0 106.25 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 56' ' ' CYS . 8.9 m-85 -120.55 130.98 54.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -109.61 175.57 5.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 130.69 -140.79 12.06 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 6.8 m-80 -134.01 123.23 16.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.672 -0.899 . . . . 0.0 109.091 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.582 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -77.28 -8.31 17.38 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.742 1.628 . . . . 0.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.08 38.59 2.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.41 151.0 37.28 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.48 -25.23 13.2 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.272 1.981 . . . . 0.0 109.56 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.92 134.44 20.44 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.452 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 33.7 Cg_endo -75.75 -17.16 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.996 1.797 . . . . 0.0 110.169 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.51 -13.44 54.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.012 -1.055 . . . . 0.0 109.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.64 11.03 16.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 6.5 ttmm -77.57 -129.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.189 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 3.9 m -91.61 81.81 5.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.663 -1.273 . . . . 0.0 108.308 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -114.74 167.29 10.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.76 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.433 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -56.96 -174.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.581 -1.324 . . . . 0.0 108.344 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.68 67.61 9.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.864 -1.148 . . . . 0.0 110.608 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 5.6 m-20 -138.22 57.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.78 -1.2 . . . . 0.0 110.145 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.58 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pp -150.32 154.88 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.162 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.745 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -108.39 129.14 24.42 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.01 -4.48 14.93 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.517 2.144 . . . . 0.0 110.906 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.57 -72.15 0.39 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.813 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -57.08 161.23 3.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 t -106.15 141.75 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 107.56 -11.2 39.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 34.1 m-80 -40.75 -32.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -1.177 . . . . 0.0 110.047 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 15.8 p -122.57 125.87 46.58 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.0 -1.062 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.884 ' ND2' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -100.82 118.75 37.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.438 -0.789 . . . . 0.0 112.101 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.589 ' HG3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -80.9 -24.38 38.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -92.35 -38.37 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.026 . . . . 0.0 110.486 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 18' ' ' ASN . 15.7 p -85.54 7.25 23.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 108.622 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . 123.6 -79.93 0.35 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER 177.62 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.29 -1.712 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.22 119.49 35.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.127 -1.608 . . . . 0.0 107.243 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.884 HD12 ' ND2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -119.57 -13.07 9.22 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.88 -177.064 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 23.2 mtpt -156.82 77.48 0.89 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.491 -1.381 . . . . 0.0 111.03 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.8 m -53.74 145.94 14.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.468 -1.395 . . . . 0.0 108.17 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -96.97 -63.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.882 -1.136 . . . . 0.0 112.397 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.048 ' O ' HG23 ' A' ' 31' ' ' THR . 22.9 m-85 -57.85 81.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.287 0.565 . . . . 0.0 112.386 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' TYR . 11.4 m-20 20.62 50.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.477 0.656 . . . . 0.0 111.796 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.048 HG23 ' O ' ' A' ' 29' ' ' TYR . 34.5 p -120.37 149.64 42.02 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.41 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.48 -175.47 2.95 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.247 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.4 150.43 22.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CZ ' ' O ' ' A' ' 21' ' ' THR . 22.1 t80 -57.0 -28.58 62.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.114 -1.227 . . . . 0.0 110.177 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -116.42 26.83 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.682 -1.261 . . . . 0.0 109.967 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.3 m 52.52 54.27 10.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 108.914 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -8.71 31.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 0.0 110.262 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.51 -172.61 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.919 -1.113 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 22.3 m -117.8 134.99 54.36 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 152.01 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.384 -1.447 . . . . 0.0 109.147 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.58 124.28 19.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.406 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.22 -34.57 3.79 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.12 128.76 47.84 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.197 0.998 . . . . 0.0 108.984 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -123.43 -179.35 4.3 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.37 -142.47 12.47 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.8 m120 -130.85 103.24 15.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.554 -0.968 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -79.18 -1.56 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.278 1.985 . . . . 0.0 110.311 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 37.99 2.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.84 156.38 42.69 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.129 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.06 -20.75 12.71 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.272 1.981 . . . . 0.0 109.522 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.45 131.18 24.26 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.31 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.3 -18.62 15.88 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.268 1.979 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 -21.63 59.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.075 . . . . 0.0 109.498 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.16 13.81 30.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.968 . . . . 0.0 109.401 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -67.58 -137.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 56.8 m -99.36 105.34 17.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.766 -1.209 . . . . 0.0 109.479 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -115.95 -156.46 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.482 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 9' ' ' ILE . 68.6 m-80 -144.58 -154.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.239 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 3.8 m-20 82.51 -134.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.77 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.901 ' OD1' HG21 ' A' ' 31' ' ' THR . 9.1 m-80 -89.35 72.32 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.98 HG21 ' SG ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -142.89 148.76 19.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.642 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 19.9 m-20 -114.88 154.9 46.95 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 110.575 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.76 -19.67 12.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.5 2.133 . . . . 0.0 110.095 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . 30.1 m120 -77.66 -32.99 53.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 112.021 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.475 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . . . -54.56 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.164 -1.585 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.76 79.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.987 -1.071 . . . . 0.0 110.155 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 88.05 -32.51 4.32 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 10.6 m120 64.4 1.85 1.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -1.086 . . . . 0.0 110.916 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.6 m -123.68 179.48 4.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.541 -1.349 . . . . 0.0 109.862 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -92.34 131.09 37.81 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -68.89 -24.94 64.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.669 -1.269 . . . . 0.0 110.426 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -96.63 -36.53 10.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.921 -1.112 . . . . 0.0 111.23 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -90.48 -39.1 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.748 -1.22 . . . . 0.0 110.098 -179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.72 70.73 1.34 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 2.5 tp10 -171.54 157.26 4.73 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.305 . . . . 0.0 109.332 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.98 ' SG ' HG21 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -63.04 111.53 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.744 -0.598 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.961 HD22 ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -128.89 39.42 3.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.107 -0.996 . . . . 0.0 110.791 178.971 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -149.8 67.83 1.0 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 75.4 m -53.92 146.93 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.879 -1.138 . . . . 0.0 109.839 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -103.54 -61.82 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.89 . . . . 0.0 111.88 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD2' ' HD3' ' A' ' 55' ' ' LYS . 42.1 m-85 -77.54 63.62 2.7 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 112.292 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 29' ' ' TYR . 69.5 m-80 39.06 60.84 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.839 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.901 HG21 ' OD1' ' A' ' 8' ' ' ASN . 35.8 p -123.17 148.1 46.13 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 108.956 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -112.66 -165.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.92 18.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' PHE . 1.2 t80 -53.55 -29.9 39.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.779 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 85.4 m-85 -120.62 37.53 4.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 46.2 m 49.42 52.94 13.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.161 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.52 0.79 31.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 110.463 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -131.27 -173.7 3.18 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.802 -1.186 . . . . 0.0 109.143 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 64.8 m -111.94 126.62 55.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -57.42 151.89 15.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.807 -1.183 . . . . 0.0 109.763 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.85 125.37 23.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.14 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.8 -32.52 4.4 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -129.51 129.0 43.97 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.325 1.06 . . . . 0.0 109.178 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -114.58 174.34 6.01 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 133.53 -144.05 15.9 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.382 -1.389 . . . . 0.0 109.962 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 45.7 m-20 -130.06 112.47 17.17 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.573 -0.957 . . . . 0.0 109.353 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 35.0 Cg_endo -75.88 -3.07 13.37 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.128 1.885 . . . . 0.0 110.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.49 40.68 2.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.0 153.43 38.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.005 . . . . 0.0 109.197 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.51 -27.66 9.03 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.083 1.855 . . . . 0.0 109.285 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.22 137.6 19.73 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.69 -17.17 18.28 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.142 1.895 . . . . 0.0 110.326 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.9 -24.74 58.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 109.16 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.23 27.28 9.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -83.38 -143.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 95.2 m -91.95 83.33 5.18 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.2 mtpt -115.37 170.56 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.008 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.65 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 68.7 m-80 -35.88 -97.88 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.585 -0.697 . . . . 0.0 110.704 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' ASN . 12.5 m-20 42.27 -94.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.139 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.757 ' CG ' HG21 ' A' ' 31' ' ' THR . 4.2 m120 -144.23 68.22 1.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.016 -1.052 . . . . 0.0 110.184 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.745 HG21 ' SG ' ' A' ' 24' ' ' CYS . 2.7 pp -142.5 163.93 17.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.756 ' OD1' HG21 ' A' ' 28' ' ' ILE . 90.3 m-20 -105.96 109.83 63.52 Favored Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.4 -5.74 15.83 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.851 2.367 . . . . 0.0 111.18 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.26 -70.77 0.47 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 109.079 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 160.62 13.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.147 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.2 t -104.13 151.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.53 -2.69 32.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 11.2 m-80 -60.34 -5.92 1.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.366 . . . . 0.0 111.189 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 25' ' ' LEU . 79.8 m -121.66 177.39 5.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.584 -1.323 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -93.01 133.17 36.42 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -11.24 60.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.916 -1.115 . . . . 0.0 111.677 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 21' ' ' THR . 1.7 pp -102.09 -47.99 4.37 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.539 -1.351 . . . . 0.0 110.985 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.478 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.0 -23.84 20.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.636 -1.29 . . . . 0.0 109.872 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.54 61.48 3.85 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -147.25 156.52 43.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.108 -1.23 . . . . 0.0 109.273 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.745 ' SG ' HG21 ' A' ' 9' ' ' ILE . 2.1 m -64.43 112.52 3.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.949 HD22 ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.88 41.74 3.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.977 -1.077 . . . . 0.0 110.339 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 68.72 0.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.449 -0.782 . . . . 0.0 108.979 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 79.7 m -53.72 151.4 6.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.92 -1.113 . . . . 0.0 109.953 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -105.35 -58.74 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.49 -0.757 . . . . 0.0 111.327 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 28' ' ' ILE . 54.4 m-85 -77.86 47.59 0.64 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.589 -0.695 . . . . 0.0 111.695 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.07 63.47 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.722 -1.236 . . . . 0.0 110.532 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.757 HG21 ' CG ' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -123.33 158.53 30.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 108.701 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -116.35 -163.8 0.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.38 147.83 12.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 3.8 t80 -53.95 -32.06 52.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -1.092 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -119.82 38.59 3.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.786 -1.196 . . . . 0.0 109.293 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 68.6 m 52.88 53.43 12.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -107.8 7.31 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.845 . . . . 0.0 109.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.79 -167.36 1.82 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.207 -0.933 . . . . 0.0 109.745 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 1.6 m -121.26 135.87 55.06 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -56.5 145.62 27.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.662 -1.274 . . . . 0.0 109.692 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.46 124.77 21.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 109.585 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.99 -31.89 4.58 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.495 ' HB3' ' N ' ' A' ' 57' ' ' LYS . 4.3 m-85 -127.28 129.75 48.27 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.302 1.049 . . . . 0.0 109.114 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.07 175.5 5.44 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.155 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 140.85 -147.21 18.84 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.441 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 53.7 m-20 -135.67 102.11 10.53 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.984 . . . . 0.0 109.844 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HG3' ' C ' ' A' ' 38' ' ' ARG . 34.3 Cg_endo -75.1 1.4 7.82 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.13 1.887 . . . . 0.0 110.448 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -109.95 39.29 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 108.915 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.75 156.67 44.61 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.58 -16.34 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.386 2.057 . . . . 0.0 110.121 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.23 128.44 33.42 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.074 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.92 -19.64 15.81 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.192 1.928 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.49 5.78 46.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.412 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -119.68 1.3 11.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 86.8 mttt -69.72 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.987 -1.07 . . . . 0.0 110.358 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 13.8 m -99.14 147.52 25.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 0.0 109.375 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -160.22 167.38 27.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 109.171 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.519 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -80.06 85.71 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 0.0 109.209 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 41.5 p30 -170.93 -140.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.837 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 1.015 ' ND2' HG21 ' A' ' 31' ' ' THR . 12.9 m-20 -96.69 83.01 3.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.056 -1.028 . . . . 0.0 110.137 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 1.01 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.5 pp -149.26 150.36 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.532 -0.73 . . . . 0.0 109.157 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 5.4 m-20 -107.94 126.9 28.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.302 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.84 -15.47 18.94 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.365 2.044 . . . . 0.0 110.924 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.84 -71.48 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 109.605 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.09 176.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 15' ' ' GLY . 39.3 t -115.32 163.68 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 107.38 -17.57 36.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 39.3 m-80 -64.69 -2.56 2.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.275 . . . . 0.0 111.125 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.08 142.3 44.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.629 -1.294 . . . . 0.0 108.923 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.585 ' OD1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.43 125.18 28.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.951 -1.093 . . . . 0.0 108.23 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -20.61 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.967 . . . . 0.0 110.29 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.41 -42.0 5.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.011 -1.056 . . . . 0.0 111.499 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -86.31 -39.3 16.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.609 -1.307 . . . . 0.0 110.274 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 71.11 1.32 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 1.3 tp10 -174.84 161.97 3.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.988 -1.301 . . . . 0.0 108.734 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 1.01 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m -48.76 124.46 8.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.879 -1.138 . . . . 0.0 109.888 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -123.6 -28.43 3.88 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.09 -1.006 . . . . 0.0 111.613 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -114.1 84.31 2.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.52 -1.363 . . . . 0.0 110.952 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 60.9 m -55.37 153.33 7.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.637 -1.29 . . . . 0.0 110.039 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -106.66 -66.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.035 -1.041 . . . . 0.0 112.421 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.06 ' O ' HG23 ' A' ' 31' ' ' THR . 6.3 m-30 -68.87 75.97 0.31 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.55 -0.719 . . . . 0.0 112.895 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.49 ' C ' ' O ' ' A' ' 29' ' ' TYR . 4.3 m-20 29.42 52.24 0.09 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.435 0.636 . . . . 0.0 111.224 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 29' ' ' TYR . 70.0 p -120.9 151.8 39.24 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 108.816 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -119.88 -153.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.46 148.45 6.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.09 -24.09 62.64 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.36 -1.082 . . . . 0.0 110.256 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 55.3 m-85 -114.58 20.87 15.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.63 -1.294 . . . . 0.0 110.24 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 82.6 m 62.26 29.5 17.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 109.655 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -103.2 23.95 11.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.181 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.39 -176.67 4.04 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.215 -0.928 . . . . 0.0 109.208 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.66 139.8 53.09 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.03 141.45 34.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.469 -1.394 . . . . 0.0 109.47 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.53 128.58 37.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.642 -0.661 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.24 2.95 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -128.63 129.57 46.06 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.162 0.982 . . . . 0.0 108.756 177.569 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.9 m-85 -111.07 -179.61 3.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.17 -139.35 9.76 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.454 -1.355 . . . . 0.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -124.67 100.43 34.51 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.733 -0.863 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.614 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -79.68 -8.41 14.68 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 37.88 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 109.952 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.47 152.66 42.17 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.118 -0.989 . . . . 0.0 109.136 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.78 -27.44 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -101.12 134.15 20.54 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.33 -1.04 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.105 1.87 . . . . 0.0 110.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.01 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 108.661 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.6 31.74 4.52 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 6.6 ttmt -73.01 -145.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.691 -0.631 . . . . 0.0 109.919 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 6.9 m -100.13 94.07 6.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.083 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.33 -167.03 1.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.483 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 16.1 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 72.2 m-20 -106.04 -144.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.1 t0 83.21 -72.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 1.052 ' ND2' HG21 ' A' ' 31' ' ' THR . 4.0 m120 -137.69 70.83 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.832 -1.167 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.553 ' CA ' HG12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -141.92 149.54 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.072 -1.018 . . . . 0.0 109.646 179.172 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.818 ' CG ' HG21 ' A' ' 28' ' ' ILE . 31.5 m-20 -109.39 126.3 29.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.262 -0.899 . . . . 0.0 109.909 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.02 -9.16 16.72 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.376 2.05 . . . . 0.0 110.636 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.0 -74.2 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.0 109.811 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 170.15 3.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.077 -1.015 . . . . 0.0 109.548 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.71 157.41 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 25' ' ' LEU . . . 106.48 -31.87 7.86 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 11.7 m-80 -44.38 -24.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -1.211 . . . . 0.0 109.897 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 3.6 m -127.7 161.77 28.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 109.293 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.569 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -95.86 130.04 42.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.751 -1.218 . . . . 0.0 108.217 179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -62.73 -34.39 77.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 0.0 110.632 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 -37.48 8.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.847 -1.158 . . . . 0.0 111.617 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.77 -13.02 49.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.618 -1.301 . . . . 0.0 110.168 -179.155 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.59 47.82 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -129.9 170.27 14.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -1.139 . . . . 0.0 108.637 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 9' ' ' ILE . 60.1 m -70.06 102.52 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.665 -1.272 . . . . 0.0 109.411 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.11 -11.31 59.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.127 . . . . 0.0 110.118 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -160.16 95.63 1.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.727 -1.233 . . . . 0.0 111.25 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 71.3 m -54.43 153.64 5.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.336 -1.477 . . . . 0.0 108.77 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -102.53 -59.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.723 -1.236 . . . . 0.0 112.871 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -75.12 40.1 0.15 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.742 . . . . 0.0 112.169 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 58.29 68.6 0.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.476 -1.39 . . . . 0.0 110.571 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.052 HG21 ' ND2' ' A' ' 8' ' ' ASN . 36.9 p -133.68 147.48 51.4 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -110.3 -159.02 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.36 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 147.32 10.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 t80 -50.67 -30.35 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -1.002 . . . . 0.0 109.764 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -124.12 43.4 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.892 -1.13 . . . . 0.0 109.375 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HB3' ' OD1' ' A' ' 8' ' ' ASN . 60.1 m 51.88 48.27 23.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 108.633 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.46 3.52 45.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.289 -0.882 . . . . 0.0 110.48 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -131.17 -172.26 2.79 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.918 -1.114 . . . . 0.0 109.659 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 77.6 m -117.32 130.52 56.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -57.14 146.75 26.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.787 -1.196 . . . . 0.0 109.667 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.21 129.04 38.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.483 -0.761 . . . . 0.0 109.697 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.47 -35.85 3.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.398 -2.681 . . . . 0.0 106.398 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 7.9 m-85 -126.11 132.14 51.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.189 0.995 . . . . 0.0 108.661 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' LYS . 4.4 m-85 -111.69 -178.11 3.35 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 127.98 -144.96 15.63 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 87.6 m-20 -129.06 120.22 20.14 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.597 -0.943 . . . . 0.0 109.066 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.6 Cg_endo -77.41 -18.02 14.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.979 1.786 . . . . 0.0 111.204 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD13 ' OD2' ' A' ' 7' ' ' ASP . 12.9 tp -109.55 37.11 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.943 -1.098 . . . . 0.0 110.019 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.16 151.43 41.7 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 108.762 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.44 -29.61 9.09 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.155 1.903 . . . . 0.0 109.022 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -101.26 128.63 28.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.76 -12.02 24.13 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.053 1.835 . . . . 0.0 110.469 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.96 59.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.98 -1.075 . . . . 0.0 108.792 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.63 15.0 22.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -65.96 -146.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 71.0 m -90.95 82.44 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.018 -1.051 . . . . 0.0 108.417 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 43' ' ' PHE . 1.7 mttm -124.83 -174.61 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.576 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.294 179.801 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -51.52 159.35 0.75 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 75.34 5.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.502 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.898 ' HA ' HD11 ' A' ' 28' ' ' ILE . 50.2 m-20 -145.02 67.03 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 0.0 110.24 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.53 ' C ' HG12 ' A' ' 28' ' ' ILE . 2.7 pt -149.52 176.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -106.56 147.36 34.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.206 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 -40.24 0.49 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.439 2.093 . . . . 0.0 111.201 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -78.34 -5.17 51.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.963 -1.71 . . . . 0.0 109.011 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.7 80.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.074 . . . . 0.0 110.329 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 -22.91 6.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 22.9 m-80 54.88 15.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.883 -1.363 . . . . 0.0 110.63 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.21 159.77 32.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.883 -1.136 . . . . 0.0 109.503 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.7 120.18 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -64.62 -19.65 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.869 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -97.77 -41.26 8.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.771 -1.205 . . . . 0.0 110.893 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -91.94 -64.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.698 -1.251 . . . . 0.0 109.922 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 116.92 79.16 0.72 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -178.15 159.3 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.984 -1.303 . . . . 0.0 108.259 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.2 m -47.86 119.23 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.604 -1.31 . . . . 0.0 108.648 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.946 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.1 tm? -125.77 27.86 6.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 110.294 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.4 mttt -160.2 63.1 0.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.965 -1.084 . . . . 0.0 109.927 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 46.6 m -55.39 150.66 11.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.956 -1.09 . . . . 0.0 109.709 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.898 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.8 -64.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.0 111.816 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 1.084 ' O ' HG23 ' A' ' 31' ' ' THR . 24.5 m-85 -59.5 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' C ' ' O ' ' A' ' 29' ' ' TYR . 10.1 m-20 24.32 52.65 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.233 0.539 . . . . 0.0 111.257 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 29' ' ' TYR . 38.2 p -121.45 144.67 48.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.075 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -115.56 -169.82 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.594 -0.691 . . . . 0.0 109.567 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.93 148.1 21.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 3.1 t80 -52.66 -27.31 16.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CZ ' ' HD2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -126.55 37.91 4.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.814 -1.178 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.6 m 52.18 53.5 12.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.931 -1.105 . . . . 0.0 108.605 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -97.75 -7.42 30.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.782 . . . . 0.0 110.376 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -174.74 3.46 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.828 -1.17 . . . . 0.0 109.685 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 47' ' ' PRO . 3.2 m -122.15 136.21 54.88 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -56.21 149.82 15.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.655 -1.278 . . . . 0.0 108.944 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.54 132.6 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -36.5 3.13 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 106.769 -2.533 . . . . 0.0 106.769 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -124.24 129.58 51.03 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.21 1.005 . . . . 0.0 108.999 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.51 173.35 6.45 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.78 19.24 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.635 -1.269 . . . . 0.0 109.975 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 38.6 m-20 -115.27 107.35 49.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.435 -1.038 . . . . 0.0 109.53 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.521 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 37.7 Cg_endo -79.35 -13.35 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.246 1.964 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.1 39.07 2.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.8 . . . . 0.0 109.828 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.78 148.68 35.63 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.37 -23.32 13.32 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.358 2.039 . . . . 0.0 109.901 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.89 135.58 20.42 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.412 -0.805 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.91 -19.89 17.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.152 1.901 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.15 -27.22 59.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.26 38.16 2.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.171 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -89.84 -145.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.681 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 47' ' ' PRO . 74.9 m -101.47 106.16 17.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 109.719 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.11 173.14 8.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -0.968 . . . . 0.0 109.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.507 -179.876 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 27.2 p . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.391 0.615 . . . . 0.0 112.197 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.513 ' HA ' HG12 ' A' ' 9' ' ' ILE . 78.7 m-20 -78.03 -135.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 38.1 m-20 74.27 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.932 . . . . 0.0 110.693 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.492 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 1.8 m120 -115.62 74.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.799 -1.188 . . . . 0.0 110.492 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.568 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.8 pp -154.22 146.85 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 108.818 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.902 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.93 128.53 25.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.407 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.13 -14.38 18.78 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.427 2.084 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -79.32 -72.24 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.37 163.05 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 109.29 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.76 152.13 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.076 -1.015 . . . . 0.0 109.36 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 112.35 -28.48 9.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 13.6 m-80 -42.72 -26.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -1.183 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 15' ' ' GLY . 1.7 p -126.06 149.63 48.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 108.998 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -82.71 126.64 32.59 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -34.0 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.734 -1.229 . . . . 0.0 110.215 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -34.36 10.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.93 -1.106 . . . . 0.0 111.425 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -22.73 23.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.659 -1.276 . . . . 0.0 110.378 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.45 69.56 1.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -163.97 169.5 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 108.861 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 7.0 m -65.58 101.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.241 -1.537 . . . . 0.0 109.301 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.26 -26.04 26.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 79.52 1.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.787 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 76.3 m -53.62 152.85 4.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.432 -1.418 . . . . 0.0 108.518 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.902 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -92.13 -64.85 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.966 -1.084 . . . . 0.0 112.317 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' THR . 57.0 m-85 -73.21 71.54 1.19 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.428 -0.795 . . . . 0.0 112.616 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 31.34 54.22 0.22 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.586 -0.697 . . . . 0.0 111.094 177.812 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 29' ' ' TYR . 11.5 p -122.55 151.74 41.08 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.161 -0.962 . . . . 0.0 109.65 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -123.49 -163.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.04 152.86 27.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 1.1 t80 -51.61 -34.34 36.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 109.832 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -119.67 39.62 3.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.796 -1.19 . . . . 0.0 109.63 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 39.4 m 50.31 32.64 6.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.01 -1.056 . . . . 0.0 109.013 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.31 10.88 20.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.403 -0.811 . . . . 0.0 109.707 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.68 -173.72 3.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.107 -0.996 . . . . 0.0 109.529 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 56.4 m -119.97 131.7 55.26 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.722 -1.236 . . . . 0.0 109.355 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.62 130.27 46.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.561 -0.712 . . . . 0.0 109.614 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.53 -36.52 3.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 3.2 m-85 -126.08 129.43 49.1 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.238 1.018 . . . . 0.0 109.001 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -110.58 171.93 7.17 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.9 -145.02 17.16 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.932 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 11.3 m120 -115.27 108.05 48.5 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.969 . . . . 0.0 108.793 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.734 ' HB3' HG22 ' A' ' 31' ' ' THR . 34.8 Cg_endo -75.14 -7.73 19.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.87 1.714 . . . . 0.0 110.749 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.09 42.48 3.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 155.58 43.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 0.0 108.952 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.35 -22.02 14.63 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.203 1.935 . . . . 0.0 109.689 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m-80 -100.82 134.47 20.47 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.528 -0.733 . . . . 0.0 109.157 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.71 -19.19 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.243 1.962 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.35 12.44 29.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.061 -1.024 . . . . 0.0 109.724 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 m-20 -135.62 30.01 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.904 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 39.3 mttm -97.57 -116.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.957 -1.089 . . . . 0.0 110.544 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 2.8 m -100.67 105.69 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.648 -1.283 . . . . 0.0 109.59 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 1.5 mptt -105.54 170.51 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.487 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 22.7 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 35' ' ' TYR . 28.1 m120 -39.92 147.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.486 -0.759 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 8' ' ' ASN . 6.5 t70 -80.81 69.72 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.957 ' HA ' HD11 ' A' ' 28' ' ' ILE . 2.2 m120 -139.26 64.62 1.46 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.116 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -154.4 -177.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 43.5 m-20 -107.35 112.47 62.68 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.773 -1.205 . . . . 0.0 109.304 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.15 -8.47 17.58 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.665 2.244 . . . . 0.0 110.954 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -78.63 -74.1 0.29 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.28 -167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.107 -0.996 . . . . 0.0 109.269 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.16 156.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.968 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.89 36.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 28.8 m-80 -52.41 -16.19 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 110.51 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t -121.95 149.08 43.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 108.902 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.558 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.19 126.62 31.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.877 -1.139 . . . . 0.0 108.302 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -69.16 -39.83 78.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.401 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -24.92 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.549 -1.345 . . . . 0.0 111.242 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -92.55 -32.65 14.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.358 -1.464 . . . . 0.0 109.881 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' CD ' ' A' ' 23' ' ' GLU . . . 71.25 63.24 3.18 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -159.89 159.41 32.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.104 -1.233 . . . . 0.0 109.258 -179.369 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 23.3 m -55.83 114.85 2.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.91 -34.49 10.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.884 -1.135 . . . . 0.0 109.862 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -123.21 83.05 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.197 -0.939 . . . . 0.0 110.376 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 65.1 m -53.91 155.71 3.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.488 -1.383 . . . . 0.0 109.278 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -107.13 -64.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 120.84 -1.163 . . . . 0.0 112.86 -178.89 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.764 ' H ' HD12 ' A' ' 28' ' ' ILE . 55.4 m-85 -59.21 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.294 -0.879 . . . . 0.0 112.091 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.531 ' C ' ' O ' ' A' ' 29' ' ' TYR . 76.2 m-20 22.99 50.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.304 0.573 . . . . 0.0 111.254 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 29' ' ' TYR . 1.2 p -121.54 151.28 40.5 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.72 176.47 5.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.9 152.23 24.72 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 5.0 t80 -56.56 -32.0 64.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -1.123 . . . . 0.0 109.714 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 26.2 m-85 -117.33 22.38 12.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.917 -1.114 . . . . 0.0 109.245 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 m 61.17 61.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -90.28 -21.59 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.873 . . . . 0.0 111.286 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -131.9 -174.26 3.37 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.584 -1.322 . . . . 0.0 109.596 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 34.1 m -112.62 137.55 50.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -55.43 156.9 4.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.488 -1.382 . . . . 0.0 109.604 -178.32 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 123.94 18.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.24 -30.52 4.97 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 107.111 -2.395 . . . . 0.0 107.111 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 30' ' ' ASN . 6.0 m-85 -127.04 128.46 46.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.272 1.034 . . . . 0.0 109.109 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -108.45 -156.85 0.59 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.53 -151.48 18.32 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.323 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 13.4 m120 -135.06 104.77 10.45 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 36.1 Cg_endo -78.01 1.48 8.88 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.028 1.819 . . . . 0.0 109.857 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 48' ' ' LEU . 2.1 mm? -108.8 38.22 2.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 108.863 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.52 148.5 39.34 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.447 -0.783 . . . . 0.0 109.142 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.92 -28.52 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.23 1.954 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -101.19 140.99 21.73 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.123 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.95 -11.75 21.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.233 1.955 . . . . 0.0 110.39 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.84 60.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.942 -1.098 . . . . 0.0 109.099 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -117.21 30.13 7.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 109.018 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.2 ttmt -87.21 -139.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.795 . . . . 0.0 109.175 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 56.6 m -91.96 162.65 14.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.951 -1.093 . . . . 0.0 109.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 1.3 mmtp 174.39 -167.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.348 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.485 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 8.2 m-20 -54.63 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 49.7 m-20 102.89 -102.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.3 m120 -120.97 67.57 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.857 -1.152 . . . . 0.0 109.546 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.569 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.4 pt -139.18 162.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.699 ' CG ' HG21 ' A' ' 28' ' ' ILE . 58.5 m-20 -106.77 119.34 51.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.66 -4.14 14.63 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.684 2.256 . . . . 0.0 111.234 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.69 -68.76 0.62 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.358 -0.839 . . . . 0.0 109.85 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.27 171.04 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.989 -1.069 . . . . 0.0 110.039 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 15' ' ' GLY . 35.9 t -111.44 164.64 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.302 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 98.05 4.61 57.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 8.4 m-80 -63.26 -0.92 0.9 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.837 -1.39 . . . . 0.0 111.669 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 p -128.41 158.23 38.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.334 -1.479 . . . . 0.0 109.747 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.634 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.59 130.14 40.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -58.84 -35.98 73.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.73 -1.231 . . . . 0.0 111.786 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.15 -34.24 10.12 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.545 -1.347 . . . . 0.0 112.158 -177.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 2.6 p -83.86 -34.15 24.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.431 -1.418 . . . . 0.0 110.446 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.77 66.68 1.99 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 8.5 tp10 -162.32 160.9 27.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 108.832 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' CYS . . . . . 0.403 ' SG ' HG21 ' A' ' 9' ' ' ILE . 4.5 m -48.18 120.08 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.975 -1.078 . . . . 0.0 108.348 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 18' ' ' ASN . 8.7 tp -125.65 15.62 8.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.294 -0.878 . . . . 0.0 110.724 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 12.2 mtpt -159.07 77.89 0.74 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.131 -0.98 . . . . 0.0 109.586 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 13.7 m -57.86 155.25 10.73 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.666 -1.271 . . . . 0.0 110.189 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.699 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -111.26 -63.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.833 ' O ' HG23 ' A' ' 31' ' ' THR . 25.5 m-85 -68.15 72.53 0.19 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER 33.09 52.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 111.476 177.621 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 29' ' ' TYR . 20.3 p -122.07 145.15 48.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.955 -1.09 . . . . 0.0 109.091 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -124.56 166.21 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.39 155.38 9.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.04 -30.35 61.79 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -1.121 . . . . 0.0 109.949 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.49 29.41 7.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.164 . . . . 0.0 109.628 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.3 m 49.84 43.25 24.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.705 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.38 21.29 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.33 -179.22 5.13 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.223 -0.923 . . . . 0.0 108.874 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 1.4 m -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 4.9 ttmt -55.77 138.14 48.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.717 -1.24 . . . . 0.0 109.805 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 5.0 pt-20 -61.09 130.54 46.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.597 -0.689 . . . . 0.0 109.815 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.74 -34.96 3.57 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 13.9 m-85 -130.53 131.74 45.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.133 0.968 . . . . 0.0 108.479 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' LYS . 2.3 m-85 -105.53 -179.91 4.08 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.34 -145.22 17.09 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.886 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 30.6 m120 -118.73 111.93 37.27 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.972 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PRO . . . . . 0.491 ' CB ' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -78.63 -29.1 3.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 110.731 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.16 44.93 1.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.989 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.67 154.06 50.4 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.002 -1.062 . . . . 0.0 108.859 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.73 -31.13 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.019 1.813 . . . . 0.0 108.83 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.94 139.33 20.22 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 33.5 Cg_endo -75.18 0.77 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.048 1.832 . . . . 0.0 109.869 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.95 -13.6 53.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.701 -1.249 . . . . 0.0 109.248 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 4.0 m-20 -111.03 40.37 2.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.293 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -70.43 -155.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 109.057 -179.233 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 5.9 m -101.37 90.57 4.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -114.84 177.04 4.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.571 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.61 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.1 -41.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.45 2.1 . . . . 0.0 110.364 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 p -106.11 133.91 50.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 19.6 mm-40 -64.97 136.02 56.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 109.742 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 18.0 t 178.9 157.19 0.5 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.472 ' ND2' ' OD1' ' A' ' 37' ' ' ASP . 2.8 m120 -54.09 170.41 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.489 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.72 67.36 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.2 -0.937 . . . . 0.0 110.912 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -142.82 62.72 1.4 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.93 -1.106 . . . . 0.0 109.17 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.558 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -154.14 152.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -107.77 129.23 24.47 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.26 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.91 -6.65 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.625 2.217 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.47 -69.33 0.57 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 169.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.596 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.01 152.78 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.256 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.62 65.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -15.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.091 -1.241 . . . . 0.0 111.019 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 150.0 43.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.723 -1.235 . . . . 0.0 109.476 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' ND2' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -84.29 122.06 28.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -6.91 57.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.844 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.896 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -108.22 -45.08 4.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 111.147 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -91.71 -15.5 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.65 -1.281 . . . . 0.0 110.199 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.96 61.01 5.87 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' CG ' ' ND2' ' A' ' 18' ' ' ASN . 9.2 pt-20 -156.56 152.46 27.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -1.164 . . . . 0.0 108.404 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 35.6 m -51.94 118.97 3.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.359 -1.463 . . . . 0.0 109.858 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CB ' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -84.61 -31.37 24.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.917 -1.115 . . . . 0.0 109.335 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -143.89 84.66 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' THR . 9.7 m -53.42 155.69 2.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.518 -1.364 . . . . 0.0 108.655 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -86.44 -66.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.04 -1.038 . . . . 0.0 112.452 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.093 ' O ' HG23 ' A' ' 31' ' ' THR . 19.0 m-85 -64.58 77.73 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.558 -0.714 . . . . 0.0 112.63 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 29' ' ' TYR . 7.5 m-20 26.0 48.87 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.159 0.504 . . . . 0.0 111.504 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.093 HG23 ' O ' ' A' ' 29' ' ' TYR . 44.6 p -121.92 150.94 41.28 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 109.635 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -139.32 171.46 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.68 158.63 10.67 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.27 -29.59 47.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -1.1 . . . . 0.0 110.095 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.99 32.0 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.812 -1.18 . . . . 0.0 109.77 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' CB ' ' A' ' 24' ' ' CYS . 90.0 m 49.74 27.23 2.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.211 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.472 ' OD1' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -94.82 20.44 8.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.342 -0.848 . . . . 0.0 109.624 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -130.7 -174.6 3.41 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.074 -1.017 . . . . 0.0 109.577 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.433 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 98.8 m -120.15 135.43 54.96 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' CE ' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -55.77 147.14 19.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.552 -1.343 . . . . 0.0 110.09 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.15 123.59 17.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.701 . . . . 0.0 109.69 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.43 -33.38 4.17 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.51 ' CE2' ' CE ' ' A' ' 40' ' ' LYS . 7.9 m-85 -122.47 129.83 52.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.219 1.009 . . . . 0.0 108.726 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.6 m-85 -118.46 178.85 4.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.16 -143.8 14.59 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 80.8 m-20 -115.98 110.11 44.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.482 -1.01 . . . . 0.0 109.061 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.4 Cg_endo -78.42 -9.78 16.16 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.169 1.913 . . . . 0.0 110.586 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.79 37.89 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HE2' ' A' ' 55' ' ' LYS . . . -93.23 153.16 41.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.232 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.01 -29.67 7.97 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.117 1.878 . . . . 0.0 108.949 179.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -101.27 138.56 19.97 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.75 -19.4 16.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.104 1.869 . . . . 0.0 110.142 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.14 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 109.194 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -113.38 17.84 18.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 109.288 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -71.85 -130.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 9.7 m -101.07 102.89 13.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.8 mmtt -109.2 168.28 9.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.387 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.487 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 34.8 Cg_endo -78.23 -90.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.623 2.216 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 5' ' ' CYS . 57.1 m -103.7 151.71 22.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 109.325 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 0.0 OUTLIER -55.97 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -166.29 160.99 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 14.4 m120 -159.83 -160.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER 81.88 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 0.0 110.338 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 4.6 m120 -132.93 73.0 1.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.623 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.8 pp -146.48 150.85 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 108.921 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.779 ' OD2' HG21 ' A' ' 28' ' ' ILE . 3.6 m-20 -109.29 142.28 25.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.208 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.27 -8.94 17.62 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.507 2.138 . . . . 0.0 110.406 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -76.75 -48.66 18.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.466 -0.771 . . . . 0.0 110.804 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.36 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.564 -1.335 . . . . 0.0 108.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.96 83.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.859 -1.15 . . . . 0.0 110.916 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 2' ' ' PRO . . . 105.64 -38.21 3.42 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.51 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 4.7 m-80 52.22 16.43 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -1.225 . . . . 0.0 110.251 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.2 p -129.75 169.72 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.665 -1.272 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.633 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.31 122.47 20.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.768 -1.208 . . . . 0.0 108.247 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -18.12 55.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.028 -1.045 . . . . 0.0 110.422 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -39.25 6.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 111.898 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -90.59 -42.26 10.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.342 -1.474 . . . . 0.0 110.411 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.11 76.07 1.32 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.8 tp10 -176.61 163.1 2.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.941 -1.329 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' SG ' HG21 ' A' ' 9' ' ' ILE . 3.5 m -48.34 114.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.0 109.218 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 18' ' ' ASN . 12.5 tp -122.43 12.69 10.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.223 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HG3' ' C ' ' A' ' 25' ' ' LEU . 10.4 mttm -154.02 67.21 0.73 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 36.9 m -53.09 149.6 6.63 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.806 -1.184 . . . . 0.0 108.559 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.779 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -104.13 -62.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.065 -1.022 . . . . 0.0 112.481 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.933 ' O ' HG23 ' A' ' 31' ' ' THR . 69.5 m-85 -69.7 73.07 0.38 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 29' ' ' TYR . 8.1 m-20 27.48 59.13 0.1 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.0 111.056 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 29' ' ' TYR . 30.8 p -121.74 152.38 39.5 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.43 -168.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.387 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.95 23.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.58 -30.5 63.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.913 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 64.5 m-85 -114.55 31.88 6.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.796 -1.19 . . . . 0.0 109.333 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.8 m 49.64 41.21 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 108.979 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -95.68 8.52 43.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -173.76 3.15 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.003 -1.061 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.64 137.57 53.79 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -55.82 146.73 20.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.65 -1.281 . . . . 0.0 109.791 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.31 129.0 38.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.249 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.85 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.221 -2.752 . . . . 0.0 106.221 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.66 129.96 46.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.102 0.953 . . . . 0.0 108.658 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -113.01 -173.95 2.35 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.65 -142.18 13.47 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.992 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 48.8 m-20 -129.08 103.72 18.42 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.536 -0.979 . . . . 0.0 109.173 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 31' ' ' THR . 33.3 Cg_endo -73.4 -5.95 18.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.806 1.671 . . . . 0.0 110.283 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -109.86 38.65 2.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 108.867 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -93.4 158.11 37.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.828 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 33.7 Cg_endo -75.37 -15.76 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.288 1.992 . . . . 0.0 109.986 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 54' ' ' ASP . 2.6 m-20 -100.45 135.24 20.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 108.958 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.29 -19.22 17.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 0.0 110.782 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.27 -1.0 25.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.884 -1.135 . . . . 0.0 109.623 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 51' ' ' ASN . 1.8 m-20 -107.76 -3.42 19.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 12.8 mttp -59.27 -105.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 110.312 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 73.7 m -75.21 177.39 6.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.709 -1.244 . . . . 0.0 108.592 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER 163.63 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.202 -0.936 . . . . 0.0 109.79 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.492 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.3 Cg_endo -77.23 135.06 14.81 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.452 2.102 . . . . 0.0 110.692 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 17' ' ' CYS . 5.6 m 61.78 -178.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.099 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 7.5 tt0 179.76 127.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.524 -0.735 . . . . 0.0 109.09 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 1.5 t -145.09 174.59 10.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 109.86 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 55.2 m-80 -164.59 -165.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 56.9 m-20 66.4 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 110.608 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.947 ' HA ' HD11 ' A' ' 28' ' ' ILE . 6.2 m-20 -115.73 63.45 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.123 . . . . 0.0 110.959 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.528 ' C ' HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -142.47 173.19 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.074 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.665 ' CG ' HG21 ' A' ' 28' ' ' ILE . 6.9 m-20 -107.8 128.56 25.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.845 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 -1.03 11.16 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.723 2.282 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.64 -68.82 0.59 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.369 -0.832 . . . . 0.0 109.381 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.43 161.7 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.894 -1.129 . . . . 0.0 108.694 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.7 116.51 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 0.0 109.971 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 108.55 -40.35 2.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 5.6 m120 38.85 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.997 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 15' ' ' GLY . 15.5 p -124.98 172.5 9.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.772 -1.205 . . . . 0.0 110.691 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.65 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 126.36 29.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -20.48 54.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.803 -1.186 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -109.08 -42.68 4.36 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.812 -1.18 . . . . 0.0 111.924 -178.769 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -82.81 -32.94 27.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.436 -1.415 . . . . 0.0 110.228 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 76.22 67.31 1.71 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -160.69 158.95 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.243 . . . . 0.0 108.978 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 72.4 m -48.45 111.54 0.47 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.074 -1.016 . . . . 0.0 108.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 18' ' ' ASN . 37.7 tp -126.8 9.47 6.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.248 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -126.1 60.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 111.561 -179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 67.2 m -56.34 146.37 24.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.549 -1.344 . . . . 0.0 107.741 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.947 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -110.02 -62.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.629 -1.294 . . . . 0.0 112.813 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.805 ' H ' HD12 ' A' ' 28' ' ' ILE . 60.2 m-85 -72.59 69.54 0.88 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.27 -0.894 . . . . 0.0 112.69 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 33.63 63.79 0.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.431 177.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' SG ' ' A' ' 56' ' ' CYS . 3.3 p -122.1 158.82 28.44 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.219 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -118.32 -173.4 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.975 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.61 147.9 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.03 -33.93 58.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -1.066 . . . . 0.0 109.816 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' SG ' ' A' ' 24' ' ' CYS . 3.7 m-85 -116.28 36.91 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.91 -1.119 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 5.3 m 52.99 50.54 17.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.991 . . . . 0.0 108.804 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -92.99 -6.32 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.013 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.28 -167.64 1.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 6.2 m -121.6 137.36 54.77 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -55.4 149.28 13.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.556 -1.34 . . . . 0.0 109.661 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 126.67 28.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.647 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.22 4.22 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.553 ' HB3' ' CA ' ' A' ' 57' ' ' LYS . 25.4 m-85 -127.92 129.86 47.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.159 0.98 . . . . 0.0 109.076 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.14 178.62 4.25 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.61 -144.52 14.89 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.336 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.4 m120 -132.66 105.28 12.97 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.897 . . . . 0.0 108.947 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.72 0.78 6.5 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.305 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -116.38 41.51 2.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.03 -1.044 . . . . 0.0 109.18 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.2 157.36 38.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.247 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.93 -13.72 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.335 2.023 . . . . 0.0 110.422 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 57.7 m-20 -100.55 132.5 22.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.7 -20.18 13.83 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.145 1.896 . . . . 0.0 110.638 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.36 -8.43 45.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.998 -1.064 . . . . 0.0 109.623 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 51' ' ' ASN . 46.2 m-20 -105.69 -15.35 14.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.708 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.4 mtmm -59.3 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.094 -1.004 . . . . 0.0 109.933 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 85.6 m -93.93 144.89 25.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 108.79 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 170.36 172.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.34 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 4' ' ' GLN . 36.2 Cg_endo -75.41 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.274 1.983 . . . . 0.0 110.003 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 2' ' ' PRO . 24.5 t 35.46 -91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 0.0 110.536 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' N ' ' O ' ' A' ' 2' ' ' PRO . 5.8 tt0 -40.03 116.35 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.82 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.2 p -110.59 -143.87 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 0.0 108.956 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 m120 -52.09 -176.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.0 70.62 5.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.003 -1.061 . . . . 0.0 110.65 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 77.2 m-20 -144.88 63.66 1.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.887 -1.133 . . . . 0.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pt -149.96 150.32 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.171 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 1.4 m-20 -108.39 120.08 47.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 109.242 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.54 -3.79 14.41 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.551 2.167 . . . . 0.0 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.29 -67.75 0.71 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 109.488 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.76 179.22 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.402 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.09 149.27 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 109.54 -12.8 33.01 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -38.22 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -1.161 . . . . 0.0 110.474 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' GLY . 6.3 t -123.88 156.12 36.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -81.08 119.21 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -18.27 63.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.824 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -105.92 -40.6 5.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.818 -1.176 . . . . 0.0 111.817 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 1.9 p -91.34 -33.54 15.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.424 -1.423 . . . . 0.0 110.667 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 82.69 70.24 1.36 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 4.3 tp10 -163.41 167.98 20.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.27 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 62.2 m -64.44 107.13 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.487 -1.383 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.75 14.8 25.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 70.81 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.703 -1.248 . . . . 0.0 111.422 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 75.2 m -54.78 148.61 12.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.303 -1.498 . . . . 0.0 108.293 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.578 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.47 -63.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.794 -1.191 . . . . 0.0 112.82 -178.628 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.038 ' O ' HG23 ' A' ' 31' ' ' THR . 99.4 m-85 -57.17 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 0.0 112.159 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 29' ' ' TYR . 62.2 m-80 21.2 49.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.356 0.598 . . . . 0.0 111.341 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.038 HG23 ' O ' ' A' ' 29' ' ' TYR . 26.6 p -122.86 155.21 37.09 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.364 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -125.01 -162.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.564 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.19 146.39 6.58 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.99 -30.02 13.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.478 -1.013 . . . . 0.0 109.828 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.98 41.32 3.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.75 -1.219 . . . . 0.0 109.838 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.6 m 50.6 29.74 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.005 . . . . 0.0 109.573 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.625 ' HA ' HD21 ' A' ' 48' ' ' LEU . 9.7 p30 -90.23 10.73 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.48 -167.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.256 -0.903 . . . . 0.0 109.167 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 23.0 m -121.84 128.8 52.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -57.0 143.45 38.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.61 126.26 26.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.88 -31.65 4.68 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.617 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -134.23 128.39 33.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.195 0.998 . . . . 0.0 109.428 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 4.8 m-85 -108.2 -179.38 3.87 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.76 -142.21 13.63 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.373 -1.394 . . . . 0.0 109.997 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 58.8 m-80 -128.56 105.07 19.17 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.933 . . . . 0.0 109.121 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.7 Cg_endo -80.34 -4.81 13.27 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.406 2.071 . . . . 0.0 110.357 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 37' ' ' ASP . 70.2 mt -110.08 38.48 2.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.21 36.3 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.133 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.67 -24.07 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.201 1.934 . . . . 0.0 109.277 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.2 135.56 19.88 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 -18.99 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.193 1.928 . . . . 0.0 110.29 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.93 -17.66 60.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 109.419 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 55' ' ' LYS . 96.9 m-20 -105.03 11.91 32.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -63.41 -139.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.324 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 14.1 m -99.69 104.33 16.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.866 -1.146 . . . . 0.0 108.913 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mtmt -109.1 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.484 179.927 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.37 2.7 7.83 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.655 2.236 . . . . 0.0 110.567 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.9 t -148.86 141.29 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.03 140.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.026 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.7 129.27 22.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.865 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -78.24 81.32 4.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.086 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -152.59 -134.92 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.756 ' OD1' HG21 ' A' ' 31' ' ' THR . 15.6 m120 -89.42 76.14 7.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 110.066 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -141.73 167.01 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 108.877 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.62 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -105.12 135.35 19.32 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.365 -0.834 . . . . 0.0 109.156 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.43 -25.22 9.92 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.362 2.042 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -77.32 -10.58 59.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 111.086 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.422 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . . . -78.83 -165.8 0.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.286 -1.509 . . . . 0.0 109.017 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.3 t -111.63 83.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 110.288 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 81.92 -19.69 9.34 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.798 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 5.9 m120 45.12 25.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.424 . . . . 0.0 109.214 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 34.1 m -123.0 175.94 6.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.91 123.38 31.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -61.84 -10.92 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 110.963 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -110.33 -41.05 4.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.7 -1.25 . . . . 0.0 111.986 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -90.12 -33.01 16.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.292 -1.505 . . . . 0.0 110.132 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.99 1.33 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -166.35 145.87 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.32 . . . . 0.0 109.384 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.25 107.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.868 HD13 ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.36 44.28 2.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.0 110.534 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -148.72 60.07 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 108.895 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 92.1 m -54.15 150.03 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.87 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.82 -62.05 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.279 -0.888 . . . . 0.0 111.92 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.471 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 8.8 m-30 -75.24 65.62 1.61 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.647 -0.658 . . . . 0.0 112.378 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 29' ' ' TYR . 17.3 m120 38.47 62.07 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 110.924 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.756 HG21 ' OD1' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -125.74 156.79 38.85 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.284 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -122.98 -164.99 1.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.38 22.28 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -32.96 43.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -1.069 . . . . 0.0 109.712 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' OH ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 m-85 -121.47 38.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 109.557 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.4 m 55.72 33.3 21.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.547 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.81 13.77 13.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.714 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.9 ttt180 -131.31 -178.08 4.69 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 64.1 m -125.49 129.79 50.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -56.99 143.43 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.696 -1.252 . . . . 0.0 109.729 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.11 136.3 57.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.274 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.27 -39.85 2.2 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 106.25 -2.74 . . . . 0.0 106.25 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 56' ' ' CYS . 8.9 m-85 -120.55 130.98 54.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -109.61 175.57 5.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 130.69 -140.79 12.06 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 6.8 m-80 -134.01 123.23 16.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.672 -0.899 . . . . 0.0 109.091 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.582 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -77.28 -8.31 17.38 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.742 1.628 . . . . 0.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.08 38.59 2.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.41 151.0 37.28 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.48 -25.23 13.2 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.272 1.981 . . . . 0.0 109.56 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.92 134.44 20.44 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.452 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 33.7 Cg_endo -75.75 -17.16 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.996 1.797 . . . . 0.0 110.169 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.51 -13.44 54.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.012 -1.055 . . . . 0.0 109.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.64 11.03 16.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 6.5 ttmm -77.57 -129.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.189 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 3.9 m -91.61 81.81 5.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.663 -1.273 . . . . 0.0 108.308 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -114.74 167.29 10.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.76 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.433 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 176.25 10.11 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.689 2.259 . . . . 0.0 111.034 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.446 ' C ' ' HG3' ' A' ' 4' ' ' GLN . 8.8 p -115.42 90.74 3.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG3' ' C ' ' A' ' 3' ' ' CYS . 86.0 mt-30 -155.08 117.07 4.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.35 -135.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -56.96 -174.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.581 -1.324 . . . . 0.0 108.344 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.68 67.61 9.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.864 -1.148 . . . . 0.0 110.608 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 5.6 m-20 -138.22 57.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.78 -1.2 . . . . 0.0 110.145 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.58 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pp -150.32 154.88 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.162 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.745 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -108.39 129.14 24.42 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.01 -4.48 14.93 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.517 2.144 . . . . 0.0 110.906 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.57 -72.15 0.39 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.813 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -57.08 161.23 3.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 t -106.15 141.75 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 107.56 -11.2 39.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 34.1 m-80 -40.75 -32.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -1.177 . . . . 0.0 110.047 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 15.8 p -122.57 125.87 46.58 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.0 -1.062 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.884 ' ND2' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -100.82 118.75 37.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.438 -0.789 . . . . 0.0 112.101 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.589 ' HG3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -80.9 -24.38 38.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -92.35 -38.37 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.026 . . . . 0.0 110.486 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 18' ' ' ASN . 15.7 p -85.54 7.25 23.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 108.622 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . 123.6 -79.93 0.35 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER 177.62 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.29 -1.712 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.22 119.49 35.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.127 -1.608 . . . . 0.0 107.243 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.884 HD12 ' ND2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -119.57 -13.07 9.22 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.88 -177.064 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 23.2 mtpt -156.82 77.48 0.89 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.491 -1.381 . . . . 0.0 111.03 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.8 m -53.74 145.94 14.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.468 -1.395 . . . . 0.0 108.17 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -96.97 -63.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.882 -1.136 . . . . 0.0 112.397 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.048 ' O ' HG23 ' A' ' 31' ' ' THR . 22.9 m-85 -57.85 81.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.287 0.565 . . . . 0.0 112.386 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' TYR . 11.4 m-20 20.62 50.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.477 0.656 . . . . 0.0 111.796 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.048 HG23 ' O ' ' A' ' 29' ' ' TYR . 34.5 p -120.37 149.64 42.02 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.41 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.48 -175.47 2.95 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.247 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.4 150.43 22.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CZ ' ' O ' ' A' ' 21' ' ' THR . 22.1 t80 -57.0 -28.58 62.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.114 -1.227 . . . . 0.0 110.177 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -116.42 26.83 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.682 -1.261 . . . . 0.0 109.967 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.3 m 52.52 54.27 10.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 108.914 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -8.71 31.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 0.0 110.262 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.51 -172.61 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.919 -1.113 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 22.3 m -117.8 134.99 54.36 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 152.01 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.384 -1.447 . . . . 0.0 109.147 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.58 124.28 19.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.406 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.22 -34.57 3.79 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.12 128.76 47.84 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.197 0.998 . . . . 0.0 108.984 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -123.43 -179.35 4.3 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.37 -142.47 12.47 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.8 m120 -130.85 103.24 15.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.554 -0.968 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -79.18 -1.56 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.278 1.985 . . . . 0.0 110.311 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 37.99 2.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.84 156.38 42.69 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.129 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.06 -20.75 12.71 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.272 1.981 . . . . 0.0 109.522 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.45 131.18 24.26 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.31 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.3 -18.62 15.88 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.268 1.979 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 -21.63 59.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.075 . . . . 0.0 109.498 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.16 13.81 30.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.968 . . . . 0.0 109.401 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -67.58 -137.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 56.8 m -99.36 105.34 17.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.766 -1.209 . . . . 0.0 109.479 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -115.95 -156.46 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.482 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.66 104.69 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.545 2.163 . . . . 0.0 110.296 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.1 100.41 8.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.619 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.12 114.33 1.72 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.8 t -178.07 154.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 9' ' ' ILE . 68.6 m-80 -144.58 -154.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.239 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 3.8 m-20 82.51 -134.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.77 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.901 ' OD1' HG21 ' A' ' 31' ' ' THR . 9.1 m-80 -89.35 72.32 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.98 HG21 ' SG ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -142.89 148.76 19.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.642 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 19.9 m-20 -114.88 154.9 46.95 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 110.575 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.76 -19.67 12.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.5 2.133 . . . . 0.0 110.095 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . 30.1 m120 -77.66 -32.99 53.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 112.021 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.475 ' HB3' ' ND2' ' A' ' 16' ' ' ASN . . . -54.56 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.164 -1.585 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.76 79.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.987 -1.071 . . . . 0.0 110.155 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 88.05 -32.51 4.32 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 10.6 m120 64.4 1.85 1.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -1.086 . . . . 0.0 110.916 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.6 m -123.68 179.48 4.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.541 -1.349 . . . . 0.0 109.862 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -92.34 131.09 37.81 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -68.89 -24.94 64.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.669 -1.269 . . . . 0.0 110.426 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -96.63 -36.53 10.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.921 -1.112 . . . . 0.0 111.23 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -90.48 -39.1 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.748 -1.22 . . . . 0.0 110.098 -179.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.72 70.73 1.34 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 2.5 tp10 -171.54 157.26 4.73 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.305 . . . . 0.0 109.332 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.98 ' SG ' HG21 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -63.04 111.53 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.744 -0.598 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.961 HD22 ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -128.89 39.42 3.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.107 -0.996 . . . . 0.0 110.791 178.971 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -149.8 67.83 1.0 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 75.4 m -53.92 146.93 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.879 -1.138 . . . . 0.0 109.839 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -103.54 -61.82 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.89 . . . . 0.0 111.88 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD2' ' HD3' ' A' ' 55' ' ' LYS . 42.1 m-85 -77.54 63.62 2.7 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 112.292 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 29' ' ' TYR . 69.5 m-80 39.06 60.84 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.839 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.901 HG21 ' OD1' ' A' ' 8' ' ' ASN . 35.8 p -123.17 148.1 46.13 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 108.956 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -112.66 -165.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.92 18.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' PHE . 1.2 t80 -53.55 -29.9 39.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.779 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 85.4 m-85 -120.62 37.53 4.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 46.2 m 49.42 52.94 13.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.161 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.52 0.79 31.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 110.463 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -131.27 -173.7 3.18 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.802 -1.186 . . . . 0.0 109.143 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 64.8 m -111.94 126.62 55.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -57.42 151.89 15.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.807 -1.183 . . . . 0.0 109.763 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.85 125.37 23.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.14 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.8 -32.52 4.4 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -129.51 129.0 43.97 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.325 1.06 . . . . 0.0 109.178 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -114.58 174.34 6.01 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 133.53 -144.05 15.9 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.382 -1.389 . . . . 0.0 109.962 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 45.7 m-20 -130.06 112.47 17.17 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.573 -0.957 . . . . 0.0 109.353 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 35.0 Cg_endo -75.88 -3.07 13.37 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.128 1.885 . . . . 0.0 110.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.49 40.68 2.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.0 153.43 38.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.005 . . . . 0.0 109.197 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.51 -27.66 9.03 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.083 1.855 . . . . 0.0 109.285 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.22 137.6 19.73 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.69 -17.17 18.28 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.142 1.895 . . . . 0.0 110.326 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.9 -24.74 58.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 109.16 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.23 27.28 9.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -83.38 -143.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 95.2 m -91.95 83.33 5.18 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.2 mtpt -115.37 170.56 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.008 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.65 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.473 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.4 Cg_endo -76.29 175.31 11.51 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.496 2.131 . . . . 0.0 110.285 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.6 t -64.01 91.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.69 94.03 3.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -113.02 85.78 2.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.06 -1.025 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 68.7 m-80 -35.88 -97.88 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.585 -0.697 . . . . 0.0 110.704 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' ASN . 12.5 m-20 42.27 -94.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.139 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.757 ' CG ' HG21 ' A' ' 31' ' ' THR . 4.2 m120 -144.23 68.22 1.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.016 -1.052 . . . . 0.0 110.184 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.745 HG21 ' SG ' ' A' ' 24' ' ' CYS . 2.7 pp -142.5 163.93 17.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.756 ' OD1' HG21 ' A' ' 28' ' ' ILE . 90.3 m-20 -105.96 109.83 63.52 Favored Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.4 -5.74 15.83 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.851 2.367 . . . . 0.0 111.18 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.26 -70.77 0.47 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 109.079 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 160.62 13.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.147 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.2 t -104.13 151.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.53 -2.69 32.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 11.2 m-80 -60.34 -5.92 1.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.366 . . . . 0.0 111.189 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 25' ' ' LEU . 79.8 m -121.66 177.39 5.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.584 -1.323 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -93.01 133.17 36.42 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -11.24 60.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.916 -1.115 . . . . 0.0 111.677 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 21' ' ' THR . 1.7 pp -102.09 -47.99 4.37 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.539 -1.351 . . . . 0.0 110.985 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.478 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.0 -23.84 20.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.636 -1.29 . . . . 0.0 109.872 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.54 61.48 3.85 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -147.25 156.52 43.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.108 -1.23 . . . . 0.0 109.273 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.745 ' SG ' HG21 ' A' ' 9' ' ' ILE . 2.1 m -64.43 112.52 3.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.949 HD22 ' O ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.88 41.74 3.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.977 -1.077 . . . . 0.0 110.339 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 68.72 0.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.449 -0.782 . . . . 0.0 108.979 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 79.7 m -53.72 151.4 6.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.92 -1.113 . . . . 0.0 109.953 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -105.35 -58.74 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.49 -0.757 . . . . 0.0 111.327 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 28' ' ' ILE . 54.4 m-85 -77.86 47.59 0.64 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.589 -0.695 . . . . 0.0 111.695 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.07 63.47 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.722 -1.236 . . . . 0.0 110.532 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.757 HG21 ' CG ' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -123.33 158.53 30.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 108.701 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -116.35 -163.8 0.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.38 147.83 12.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 3.8 t80 -53.95 -32.06 52.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -1.092 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -119.82 38.59 3.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.786 -1.196 . . . . 0.0 109.293 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 68.6 m 52.88 53.43 12.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -107.8 7.31 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.845 . . . . 0.0 109.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.79 -167.36 1.82 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.207 -0.933 . . . . 0.0 109.745 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 1.6 m -121.26 135.87 55.06 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -56.5 145.62 27.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.662 -1.274 . . . . 0.0 109.692 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.46 124.77 21.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 109.585 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.99 -31.89 4.58 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.495 ' HB3' ' N ' ' A' ' 57' ' ' LYS . 4.3 m-85 -127.28 129.75 48.27 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.302 1.049 . . . . 0.0 109.114 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.07 175.5 5.44 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.155 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 140.85 -147.21 18.84 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.441 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 53.7 m-20 -135.67 102.11 10.53 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.984 . . . . 0.0 109.844 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HG3' ' C ' ' A' ' 38' ' ' ARG . 34.3 Cg_endo -75.1 1.4 7.82 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.13 1.887 . . . . 0.0 110.448 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.471 HD13 ' HA ' ' A' ' 48' ' ' LEU . 0.4 OUTLIER -109.95 39.29 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 108.915 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.75 156.67 44.61 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.58 -16.34 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.386 2.057 . . . . 0.0 110.121 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.23 128.44 33.42 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.074 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.92 -19.64 15.81 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.192 1.928 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.49 5.78 46.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.412 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -119.68 1.3 11.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 86.8 mttt -69.72 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.987 -1.07 . . . . 0.0 110.358 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 13.8 m -99.14 147.52 25.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 0.0 109.375 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -160.22 167.38 27.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 109.171 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.519 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.423 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 3' ' ' CYS . 36.2 Cg_endo -77.69 -157.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.524 2.149 . . . . 0.0 110.561 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -36.36 148.55 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.599 -0.688 . . . . 0.0 110.409 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' A' ' 9' ' ' ILE . 38.0 tt0 -177.97 118.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.868 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.72 159.5 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -80.06 85.71 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 0.0 109.209 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 41.5 p30 -170.93 -140.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.837 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 1.015 ' ND2' HG21 ' A' ' 31' ' ' THR . 12.9 m-20 -96.69 83.01 3.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.056 -1.028 . . . . 0.0 110.137 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 1.01 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.5 pp -149.26 150.36 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.532 -0.73 . . . . 0.0 109.157 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.619 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 5.4 m-20 -107.94 126.9 28.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.302 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.84 -15.47 18.94 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.365 2.044 . . . . 0.0 110.924 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.84 -71.48 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 109.605 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.09 176.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 15' ' ' GLY . 39.3 t -115.32 163.68 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 107.38 -17.57 36.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.619 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 39.3 m-80 -64.69 -2.56 2.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.275 . . . . 0.0 111.125 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t -136.08 142.3 44.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.629 -1.294 . . . . 0.0 108.923 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.585 ' OD1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.43 125.18 28.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.951 -1.093 . . . . 0.0 108.23 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -20.61 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.967 . . . . 0.0 110.29 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.41 -42.0 5.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.011 -1.056 . . . . 0.0 111.499 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -86.31 -39.3 16.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.609 -1.307 . . . . 0.0 110.274 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 71.11 1.32 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 1.3 tp10 -174.84 161.97 3.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.988 -1.301 . . . . 0.0 108.734 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 1.01 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m -48.76 124.46 8.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.879 -1.138 . . . . 0.0 109.888 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -123.6 -28.43 3.88 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.09 -1.006 . . . . 0.0 111.613 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -114.1 84.31 2.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.52 -1.363 . . . . 0.0 110.952 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 60.9 m -55.37 153.33 7.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.637 -1.29 . . . . 0.0 110.039 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -106.66 -66.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.035 -1.041 . . . . 0.0 112.421 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.06 ' O ' HG23 ' A' ' 31' ' ' THR . 6.3 m-30 -68.87 75.97 0.31 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.55 -0.719 . . . . 0.0 112.895 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' C ' ' O ' ' A' ' 29' ' ' TYR . 4.3 m-20 29.42 52.24 0.09 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.435 0.636 . . . . 0.0 111.224 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 29' ' ' TYR . 70.0 p -120.9 151.8 39.24 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 108.816 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -119.88 -153.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.46 148.45 6.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.09 -24.09 62.64 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.36 -1.082 . . . . 0.0 110.256 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 55.3 m-85 -114.58 20.87 15.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.63 -1.294 . . . . 0.0 110.24 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 82.6 m 62.26 29.5 17.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 109.655 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -103.2 23.95 11.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.181 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.39 -176.67 4.04 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.215 -0.928 . . . . 0.0 109.208 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.66 139.8 53.09 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.03 141.45 34.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.469 -1.394 . . . . 0.0 109.47 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.53 128.58 37.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.642 -0.661 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.24 2.95 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -128.63 129.57 46.06 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.162 0.982 . . . . 0.0 108.756 177.569 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.9 m-85 -111.07 -179.61 3.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.17 -139.35 9.76 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.454 -1.355 . . . . 0.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -124.67 100.43 34.51 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.733 -0.863 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.614 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -79.68 -8.41 14.68 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 37.88 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 109.952 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.47 152.66 42.17 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.118 -0.989 . . . . 0.0 109.136 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.78 -27.44 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -101.12 134.15 20.54 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.33 -1.04 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.105 1.87 . . . . 0.0 110.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.01 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 108.661 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.6 31.74 4.52 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 6.6 ttmt -73.01 -145.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.691 -0.631 . . . . 0.0 109.919 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 6.9 m -100.13 94.07 6.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.083 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.33 -167.03 1.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.483 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.66 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 110.44 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.719 ' HB3' HD13 ' A' ' 9' ' ' ILE . 3.8 t -99.8 154.87 17.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' CYS . 1.8 mt-30 -39.32 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.725 -0.609 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 16.1 p -53.75 125.37 18.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 109.346 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 72.2 m-20 -106.04 -144.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.1 t0 83.21 -72.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 1.052 ' ND2' HG21 ' A' ' 31' ' ' THR . 4.0 m120 -137.69 70.83 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.832 -1.167 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.719 HD13 ' HB3' ' A' ' 3' ' ' CYS . 0.9 OUTLIER -141.92 149.54 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.072 -1.018 . . . . 0.0 109.646 179.172 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.818 ' CG ' HG21 ' A' ' 28' ' ' ILE . 31.5 m-20 -109.39 126.3 29.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.262 -0.899 . . . . 0.0 109.909 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.02 -9.16 16.72 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.376 2.05 . . . . 0.0 110.636 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.0 -74.2 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.0 109.811 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 170.15 3.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.077 -1.015 . . . . 0.0 109.548 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.71 157.41 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 25' ' ' LEU . . . 106.48 -31.87 7.86 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 11.7 m-80 -44.38 -24.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -1.211 . . . . 0.0 109.897 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 3.6 m -127.7 161.77 28.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 109.293 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.569 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -95.86 130.04 42.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.751 -1.218 . . . . 0.0 108.217 179.176 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -62.73 -34.39 77.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 0.0 110.632 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 -37.48 8.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.847 -1.158 . . . . 0.0 111.617 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.77 -13.02 49.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.618 -1.301 . . . . 0.0 110.168 -179.155 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.59 47.82 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -129.9 170.27 14.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -1.139 . . . . 0.0 108.637 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 9' ' ' ILE . 60.1 m -70.06 102.52 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.665 -1.272 . . . . 0.0 109.411 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.11 -11.31 59.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.127 . . . . 0.0 110.118 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -160.16 95.63 1.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.727 -1.233 . . . . 0.0 111.25 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 71.3 m -54.43 153.64 5.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.336 -1.477 . . . . 0.0 108.77 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -102.53 -59.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.723 -1.236 . . . . 0.0 112.871 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -75.12 40.1 0.15 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.742 . . . . 0.0 112.169 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 58.29 68.6 0.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.476 -1.39 . . . . 0.0 110.571 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.052 HG21 ' ND2' ' A' ' 8' ' ' ASN . 36.9 p -133.68 147.48 51.4 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -110.3 -159.02 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.36 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 147.32 10.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 t80 -50.67 -30.35 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -1.002 . . . . 0.0 109.764 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -124.12 43.4 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.892 -1.13 . . . . 0.0 109.375 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HB3' ' OD1' ' A' ' 8' ' ' ASN . 60.1 m 51.88 48.27 23.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 108.633 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.46 3.52 45.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.289 -0.882 . . . . 0.0 110.48 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -131.17 -172.26 2.79 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.918 -1.114 . . . . 0.0 109.659 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 77.6 m -117.32 130.52 56.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -57.14 146.75 26.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.787 -1.196 . . . . 0.0 109.667 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.21 129.04 38.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.483 -0.761 . . . . 0.0 109.697 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.47 -35.85 3.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.398 -2.681 . . . . 0.0 106.398 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 7.9 m-85 -126.11 132.14 51.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.189 0.995 . . . . 0.0 108.661 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' LYS . 4.4 m-85 -111.69 -178.11 3.35 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 127.98 -144.96 15.63 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 87.6 m-20 -129.06 120.22 20.14 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.597 -0.943 . . . . 0.0 109.066 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.6 Cg_endo -77.41 -18.02 14.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.979 1.786 . . . . 0.0 111.204 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD13 ' OD2' ' A' ' 7' ' ' ASP . 12.9 tp -109.55 37.11 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.943 -1.098 . . . . 0.0 110.019 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.16 151.43 41.7 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 108.762 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.44 -29.61 9.09 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.155 1.903 . . . . 0.0 109.022 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -101.26 128.63 28.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.76 -12.02 24.13 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.053 1.835 . . . . 0.0 110.469 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.96 59.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.98 -1.075 . . . . 0.0 108.792 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.63 15.0 22.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -65.96 -146.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 71.0 m -90.95 82.44 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.018 -1.051 . . . . 0.0 108.417 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 43' ' ' PHE . 1.7 mttm -124.83 -174.61 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.576 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.294 179.801 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.44 156.41 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.395 2.063 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 160.62 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 108.832 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.86 116.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 110.072 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 p -157.88 176.43 12.57 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -51.52 159.35 0.75 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 75.34 5.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.502 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.898 ' HA ' HD11 ' A' ' 28' ' ' ILE . 50.2 m-20 -145.02 67.03 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 0.0 110.24 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.53 ' C ' HG12 ' A' ' 28' ' ' ILE . 2.7 pt -149.52 176.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -106.56 147.36 34.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.206 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 -40.24 0.49 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.439 2.093 . . . . 0.0 111.201 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -78.34 -5.17 51.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -178.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.963 -1.71 . . . . 0.0 109.011 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.7 80.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.074 . . . . 0.0 110.329 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 -22.91 6.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 22.9 m-80 54.88 15.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.883 -1.363 . . . . 0.0 110.63 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.21 159.77 32.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.883 -1.136 . . . . 0.0 109.503 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.7 120.18 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -64.62 -19.65 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.869 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -97.77 -41.26 8.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.771 -1.205 . . . . 0.0 110.893 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -91.94 -64.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.698 -1.251 . . . . 0.0 109.922 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 116.92 79.16 0.72 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -178.15 159.3 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.984 -1.303 . . . . 0.0 108.259 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.2 m -47.86 119.23 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.604 -1.31 . . . . 0.0 108.648 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.946 HD13 ' O ' ' A' ' 25' ' ' LEU . 1.1 tm? -125.77 27.86 6.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 110.294 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.4 mttt -160.2 63.1 0.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.965 -1.084 . . . . 0.0 109.927 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 46.6 m -55.39 150.66 11.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.956 -1.09 . . . . 0.0 109.709 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.898 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.8 -64.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.0 111.816 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 1.084 ' O ' HG23 ' A' ' 31' ' ' THR . 24.5 m-85 -59.5 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' C ' ' O ' ' A' ' 29' ' ' TYR . 10.1 m-20 24.32 52.65 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.233 0.539 . . . . 0.0 111.257 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 29' ' ' TYR . 38.2 p -121.45 144.67 48.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.075 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -115.56 -169.82 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.594 -0.691 . . . . 0.0 109.567 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.93 148.1 21.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 3.1 t80 -52.66 -27.31 16.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CZ ' ' HD2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -126.55 37.91 4.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.814 -1.178 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.6 m 52.18 53.5 12.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.931 -1.105 . . . . 0.0 108.605 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -97.75 -7.42 30.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.782 . . . . 0.0 110.376 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -174.74 3.46 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.828 -1.17 . . . . 0.0 109.685 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 47' ' ' PRO . 3.2 m -122.15 136.21 54.88 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -56.21 149.82 15.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.655 -1.278 . . . . 0.0 108.944 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.54 132.6 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -36.5 3.13 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 106.769 -2.533 . . . . 0.0 106.769 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.622 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -124.24 129.58 51.03 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.21 1.005 . . . . 0.0 108.999 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.51 173.35 6.45 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.78 19.24 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.635 -1.269 . . . . 0.0 109.975 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 38.6 m-20 -115.27 107.35 49.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.435 -1.038 . . . . 0.0 109.53 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.521 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 37.7 Cg_endo -79.35 -13.35 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.246 1.964 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.1 39.07 2.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.8 . . . . 0.0 109.828 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.78 148.68 35.63 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.37 -23.32 13.32 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.358 2.039 . . . . 0.0 109.901 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -99.89 135.58 20.42 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.412 -0.805 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.91 -19.89 17.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.152 1.901 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.15 -27.22 59.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.26 38.16 2.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.171 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -89.84 -145.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.681 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 47' ' ' PRO . 74.9 m -101.47 106.16 17.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 109.719 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.11 173.14 8.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -0.968 . . . . 0.0 109.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.507 -179.876 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ARG . . . . . 0.496 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.8 Cg_endo -78.07 -59.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.647 2.231 . . . . 0.0 110.772 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 29.7 m -80.1 174.71 11.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.494 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' O ' ' C ' ' A' ' 5' ' ' CYS . 15.8 tp60 179.85 -115.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' C ' ' O ' ' A' ' 4' ' ' GLN . 27.2 p -0.15 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.391 0.615 . . . . 0.0 112.197 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.513 ' HA ' HG12 ' A' ' 9' ' ' ILE . 78.7 m-20 -78.03 -135.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 38.1 m-20 74.27 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.932 . . . . 0.0 110.693 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.492 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 1.8 m120 -115.62 74.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.799 -1.188 . . . . 0.0 110.492 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.8 pp -154.22 146.85 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 108.818 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.902 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.93 128.53 25.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.407 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.13 -14.38 18.78 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.427 2.084 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -79.32 -72.24 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.37 163.05 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 109.29 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.76 152.13 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.076 -1.015 . . . . 0.0 109.36 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 112.35 -28.48 9.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 13.6 m-80 -42.72 -26.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -1.183 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 3' ' ' CYS . 1.7 p -126.06 149.63 48.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 108.998 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -82.71 126.64 32.59 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -34.0 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.734 -1.229 . . . . 0.0 110.215 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -34.36 10.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.93 -1.106 . . . . 0.0 111.425 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -22.73 23.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.659 -1.276 . . . . 0.0 110.378 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.45 69.56 1.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -163.97 169.5 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 108.861 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 7.0 m -65.58 101.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.241 -1.537 . . . . 0.0 109.301 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.26 -26.04 26.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 79.52 1.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.787 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 76.3 m -53.62 152.85 4.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.432 -1.418 . . . . 0.0 108.518 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.902 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -92.13 -64.85 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.966 -1.084 . . . . 0.0 112.317 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' THR . 57.0 m-85 -73.21 71.54 1.19 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.428 -0.795 . . . . 0.0 112.616 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 31.34 54.22 0.22 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.586 -0.697 . . . . 0.0 111.094 177.812 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 29' ' ' TYR . 11.5 p -122.55 151.74 41.08 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.161 -0.962 . . . . 0.0 109.65 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -123.49 -163.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.04 152.86 27.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 1.1 t80 -51.61 -34.34 36.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 109.832 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -119.67 39.62 3.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.796 -1.19 . . . . 0.0 109.63 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 39.4 m 50.31 32.64 6.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.01 -1.056 . . . . 0.0 109.013 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.31 10.88 20.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.403 -0.811 . . . . 0.0 109.707 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.68 -173.72 3.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.107 -0.996 . . . . 0.0 109.529 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 56.4 m -119.97 131.7 55.26 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.722 -1.236 . . . . 0.0 109.355 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.62 130.27 46.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.561 -0.712 . . . . 0.0 109.614 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.53 -36.52 3.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 43' ' ' PHE . 3.2 m-85 -126.08 129.43 49.1 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.238 1.018 . . . . 0.0 109.001 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -110.58 171.93 7.17 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.9 -145.02 17.16 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.932 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 11.3 m120 -115.27 108.05 48.5 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.969 . . . . 0.0 108.793 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.734 ' HB3' HG22 ' A' ' 31' ' ' THR . 34.8 Cg_endo -75.14 -7.73 19.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.87 1.714 . . . . 0.0 110.749 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.09 42.48 3.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 155.58 43.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 0.0 108.952 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.35 -22.02 14.63 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.203 1.935 . . . . 0.0 109.689 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m-80 -100.82 134.47 20.47 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.528 -0.733 . . . . 0.0 109.157 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.71 -19.19 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.243 1.962 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.35 12.44 29.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.061 -1.024 . . . . 0.0 109.724 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 m-20 -135.62 30.01 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.904 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 39.3 mttm -97.57 -116.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.957 -1.089 . . . . 0.0 110.544 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 2.8 m -100.67 105.69 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.648 -1.283 . . . . 0.0 109.59 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 1.5 mptt -105.54 170.51 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.487 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.488 ' O ' ' NE2' ' A' ' 4' ' ' GLN . 35.3 Cg_endo -78.37 -76.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.564 2.176 . . . . 0.0 110.213 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.4 t -73.71 151.18 40.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -158.13 110.69 2.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 110.42 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 22.7 p -164.95 169.75 16.08 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 35' ' ' TYR . 28.1 m120 -39.92 147.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.486 -0.759 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 8' ' ' ASN . 6.5 t70 -80.81 69.72 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.957 ' HA ' HD11 ' A' ' 28' ' ' ILE . 2.2 m120 -139.26 64.62 1.46 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.116 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -154.4 -177.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 43.5 m-20 -107.35 112.47 62.68 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.773 -1.205 . . . . 0.0 109.304 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.15 -8.47 17.58 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.665 2.244 . . . . 0.0 110.954 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -78.63 -74.1 0.29 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.28 -167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.107 -0.996 . . . . 0.0 109.269 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.16 156.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.968 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.89 36.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 28.8 m-80 -52.41 -16.19 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 110.51 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t -121.95 149.08 43.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 108.902 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.558 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.19 126.62 31.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.877 -1.139 . . . . 0.0 108.302 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -69.16 -39.83 78.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.401 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -24.92 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.549 -1.345 . . . . 0.0 111.242 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -92.55 -32.65 14.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.358 -1.464 . . . . 0.0 109.881 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' CD ' ' A' ' 23' ' ' GLU . . . 71.25 63.24 3.18 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -159.89 159.41 32.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.104 -1.233 . . . . 0.0 109.258 -179.369 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 23.3 m -55.83 114.85 2.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.91 -34.49 10.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.884 -1.135 . . . . 0.0 109.862 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -123.21 83.05 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.197 -0.939 . . . . 0.0 110.376 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 65.1 m -53.91 155.71 3.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.488 -1.383 . . . . 0.0 109.278 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -107.13 -64.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 120.84 -1.163 . . . . 0.0 112.86 -178.89 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.764 ' H ' HD12 ' A' ' 28' ' ' ILE . 55.4 m-85 -59.21 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.294 -0.879 . . . . 0.0 112.091 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' C ' ' O ' ' A' ' 29' ' ' TYR . 76.2 m-20 22.99 50.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.304 0.573 . . . . 0.0 111.254 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 29' ' ' TYR . 1.2 p -121.54 151.28 40.5 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.72 176.47 5.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.9 152.23 24.72 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 5.0 t80 -56.56 -32.0 64.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -1.123 . . . . 0.0 109.714 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 26.2 m-85 -117.33 22.38 12.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.917 -1.114 . . . . 0.0 109.245 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 m 61.17 61.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' N ' ' OD1' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -90.28 -21.59 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.873 . . . . 0.0 111.286 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -131.9 -174.26 3.37 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.584 -1.322 . . . . 0.0 109.596 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 34.1 m -112.62 137.55 50.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -55.43 156.9 4.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.488 -1.382 . . . . 0.0 109.604 -178.32 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 123.94 18.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.24 -30.52 4.97 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 107.111 -2.395 . . . . 0.0 107.111 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 30' ' ' ASN . 6.0 m-85 -127.04 128.46 46.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.272 1.034 . . . . 0.0 109.109 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -108.45 -156.85 0.59 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.53 -151.48 18.32 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.323 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 13.4 m120 -135.06 104.77 10.45 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 36.1 Cg_endo -78.01 1.48 8.88 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.028 1.819 . . . . 0.0 109.857 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 48' ' ' LEU . 2.1 mm? -108.8 38.22 2.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 108.863 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.52 148.5 39.34 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.447 -0.783 . . . . 0.0 109.142 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.92 -28.52 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.23 1.954 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -101.19 140.99 21.73 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.123 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.95 -11.75 21.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.233 1.955 . . . . 0.0 110.39 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.84 60.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.942 -1.098 . . . . 0.0 109.099 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -117.21 30.13 7.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 109.018 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.2 ttmt -87.21 -139.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.795 . . . . 0.0 109.175 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 56.6 m -91.96 162.65 14.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.951 -1.093 . . . . 0.0 109.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 1.3 mmtp 174.39 -167.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.348 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.485 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 4' ' ' GLN . 35.2 Cg_endo -75.6 -94.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.203 1.935 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' O ' ' C ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER 48.47 -87.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -37.81 130.63 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.49 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.4 p -151.02 108.33 3.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.433 -0.792 . . . . 0.0 109.203 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 8.2 m-20 -54.63 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 49.7 m-20 102.89 -102.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.3 m120 -120.97 67.57 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.857 -1.152 . . . . 0.0 109.546 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.569 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.4 pt -139.18 162.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.699 ' CG ' HG21 ' A' ' 28' ' ' ILE . 58.5 m-20 -106.77 119.34 51.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.66 -4.14 14.63 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.684 2.256 . . . . 0.0 111.234 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.69 -68.76 0.62 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.358 -0.839 . . . . 0.0 109.85 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.27 171.04 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.989 -1.069 . . . . 0.0 110.039 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 15' ' ' GLY . 35.9 t -111.44 164.64 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.302 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 98.05 4.61 57.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 8.4 m-80 -63.26 -0.92 0.9 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.837 -1.39 . . . . 0.0 111.669 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 p -128.41 158.23 38.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.334 -1.479 . . . . 0.0 109.747 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.634 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.59 130.14 40.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -58.84 -35.98 73.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.73 -1.231 . . . . 0.0 111.786 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.15 -34.24 10.12 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.545 -1.347 . . . . 0.0 112.158 -177.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 2.6 p -83.86 -34.15 24.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.431 -1.418 . . . . 0.0 110.446 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.77 66.68 1.99 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 8.5 tp10 -162.32 160.9 27.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 108.832 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' CYS . . . . . 0.403 ' SG ' HG21 ' A' ' 9' ' ' ILE . 4.5 m -48.18 120.08 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.975 -1.078 . . . . 0.0 108.348 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 18' ' ' ASN . 8.7 tp -125.65 15.62 8.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.294 -0.878 . . . . 0.0 110.724 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 12.2 mtpt -159.07 77.89 0.74 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.131 -0.98 . . . . 0.0 109.586 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 13.7 m -57.86 155.25 10.73 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.666 -1.271 . . . . 0.0 110.189 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.699 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -111.26 -63.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.833 ' O ' HG23 ' A' ' 31' ' ' THR . 25.5 m-85 -68.15 72.53 0.19 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER 33.09 52.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 111.476 177.621 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 29' ' ' TYR . 20.3 p -122.07 145.15 48.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.955 -1.09 . . . . 0.0 109.091 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -124.56 166.21 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.39 155.38 9.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.04 -30.35 61.79 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -1.121 . . . . 0.0 109.949 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.49 29.41 7.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.164 . . . . 0.0 109.628 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.3 m 49.84 43.25 24.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.705 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.38 21.29 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.33 -179.22 5.13 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.223 -0.923 . . . . 0.0 108.874 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 1.4 m -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 4.9 ttmt -55.77 138.14 48.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.717 -1.24 . . . . 0.0 109.805 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 5.0 pt-20 -61.09 130.54 46.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.597 -0.689 . . . . 0.0 109.815 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.74 -34.96 3.57 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 13.9 m-85 -130.53 131.74 45.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.133 0.968 . . . . 0.0 108.479 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' LYS . 2.3 m-85 -105.53 -179.91 4.08 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.34 -145.22 17.09 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.886 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 30.6 m120 -118.73 111.93 37.27 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.972 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.491 ' CB ' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -78.63 -29.1 3.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 110.731 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.16 44.93 1.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.989 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.67 154.06 50.4 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.002 -1.062 . . . . 0.0 108.859 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.73 -31.13 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.019 1.813 . . . . 0.0 108.83 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.94 139.33 20.22 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 33.5 Cg_endo -75.18 0.77 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.048 1.832 . . . . 0.0 109.869 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.95 -13.6 53.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.701 -1.249 . . . . 0.0 109.248 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 4.0 m-20 -111.03 40.37 2.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.293 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -70.43 -155.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 109.057 -179.233 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 5.9 m -101.37 90.57 4.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -114.84 177.04 4.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.571 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.61 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 18.0 t . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.472 ' ND2' ' OD1' ' A' ' 37' ' ' ASP . 2.8 m120 -54.09 170.41 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.489 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.72 67.36 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.2 -0.937 . . . . 0.0 110.912 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -142.82 62.72 1.4 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.93 -1.106 . . . . 0.0 109.17 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.558 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -154.14 152.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -107.77 129.23 24.47 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.26 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.91 -6.65 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.625 2.217 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.47 -69.33 0.57 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 169.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.596 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.01 152.78 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.256 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.62 65.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -15.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.091 -1.241 . . . . 0.0 111.019 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 150.0 43.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.723 -1.235 . . . . 0.0 109.476 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.593 ' ND2' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -84.29 122.06 28.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -6.91 57.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.844 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.896 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -108.22 -45.08 4.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 111.147 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -91.71 -15.5 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.65 -1.281 . . . . 0.0 110.199 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.96 61.01 5.87 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.593 ' CG ' ' ND2' ' A' ' 18' ' ' ASN . 9.2 pt-20 -156.56 152.46 27.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -1.164 . . . . 0.0 108.404 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 35.6 m -51.94 118.97 3.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.359 -1.463 . . . . 0.0 109.858 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CB ' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -84.61 -31.37 24.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.917 -1.115 . . . . 0.0 109.335 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -143.89 84.66 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' THR . 9.7 m -53.42 155.69 2.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.518 -1.364 . . . . 0.0 108.655 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -86.44 -66.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.04 -1.038 . . . . 0.0 112.452 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.093 ' O ' HG23 ' A' ' 31' ' ' THR . 19.0 m-85 -64.58 77.73 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.558 -0.714 . . . . 0.0 112.63 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m120 26.0 48.87 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.159 0.504 . . . . 0.0 111.504 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.093 HG23 ' O ' ' A' ' 29' ' ' TYR . 44.6 p -121.92 150.94 41.28 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 109.635 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -139.32 171.46 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.68 158.63 10.67 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.27 -29.59 47.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -1.1 . . . . 0.0 110.095 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.99 32.0 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.812 -1.18 . . . . 0.0 109.77 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' CB ' ' A' ' 24' ' ' CYS . 90.0 m 49.74 27.23 2.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.211 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.472 ' OD1' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -94.82 20.44 8.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.342 -0.848 . . . . 0.0 109.624 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -130.7 -174.6 3.41 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.074 -1.017 . . . . 0.0 109.577 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.433 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 98.8 m -120.15 135.43 54.96 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.51 ' CE ' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -55.77 147.14 19.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.552 -1.343 . . . . 0.0 110.09 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.15 123.59 17.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.701 . . . . 0.0 109.69 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.43 -33.38 4.17 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.51 ' CE2' ' CE ' ' A' ' 40' ' ' LYS . 7.9 m-85 -122.47 129.83 52.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.219 1.009 . . . . 0.0 108.726 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.6 m-85 -118.46 178.85 4.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.16 -143.8 14.59 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 80.8 m-20 -115.98 110.11 44.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.482 -1.01 . . . . 0.0 109.061 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.4 Cg_endo -78.42 -9.78 16.16 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.169 1.913 . . . . 0.0 110.586 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.79 37.89 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HE2' ' A' ' 55' ' ' LYS . . . -93.23 153.16 41.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.232 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HG2' ' ND2' ' A' ' 51' ' ' ASN . 33.9 Cg_endo -75.01 -29.67 7.97 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.117 1.878 . . . . 0.0 108.949 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.488 ' ND2' ' HG2' ' A' ' 50' ' ' PRO . 4.4 m-80 -101.27 138.56 19.97 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.75 -19.4 16.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.104 1.869 . . . . 0.0 110.142 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.14 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 109.194 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -113.38 17.84 18.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 109.288 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -71.85 -130.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 9.7 m -101.07 102.89 13.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.8 mmtt -109.2 168.28 9.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.387 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 14.4 m120 -159.83 -160.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER 81.88 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 0.0 110.338 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 4.6 m120 -132.93 73.0 1.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.623 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.8 pp -146.48 150.85 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 108.921 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.779 ' OD2' HG21 ' A' ' 28' ' ' ILE . 3.6 m-20 -109.29 142.28 25.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.208 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.27 -8.94 17.62 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.507 2.138 . . . . 0.0 110.406 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -76.75 -48.66 18.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.466 -0.771 . . . . 0.0 110.804 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.36 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.564 -1.335 . . . . 0.0 108.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.96 83.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.859 -1.15 . . . . 0.0 110.916 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.64 -38.21 3.42 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.51 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 4.7 m-80 52.22 16.43 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -1.225 . . . . 0.0 110.251 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.2 p -129.75 169.72 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.665 -1.272 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.633 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.31 122.47 20.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.768 -1.208 . . . . 0.0 108.247 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -18.12 55.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.028 -1.045 . . . . 0.0 110.422 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -39.25 6.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 111.898 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -90.59 -42.26 10.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.342 -1.474 . . . . 0.0 110.411 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.11 76.07 1.32 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.8 tp10 -176.61 163.1 2.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.941 -1.329 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.623 ' SG ' HG21 ' A' ' 9' ' ' ILE . 3.5 m -48.34 114.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.0 109.218 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 18' ' ' ASN . 12.5 tp -122.43 12.69 10.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.223 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HG3' ' C ' ' A' ' 25' ' ' LEU . 10.4 mttm -154.02 67.21 0.73 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 36.9 m -53.09 149.6 6.63 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.806 -1.184 . . . . 0.0 108.559 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.779 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -104.13 -62.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.065 -1.022 . . . . 0.0 112.481 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.933 ' O ' HG23 ' A' ' 31' ' ' THR . 69.5 m-85 -69.7 73.07 0.38 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 29' ' ' TYR . 8.1 m-20 27.48 59.13 0.1 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.0 111.056 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 29' ' ' TYR . 30.8 p -121.74 152.38 39.5 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.43 -168.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.387 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.95 23.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.58 -30.5 63.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.913 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 64.5 m-85 -114.55 31.88 6.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.796 -1.19 . . . . 0.0 109.333 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.8 m 49.64 41.21 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 108.979 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -95.68 8.52 43.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -173.76 3.15 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.003 -1.061 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.64 137.57 53.79 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -55.82 146.73 20.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.65 -1.281 . . . . 0.0 109.791 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.31 129.0 38.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.249 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.85 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.221 -2.752 . . . . 0.0 106.221 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.66 129.96 46.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.102 0.953 . . . . 0.0 108.658 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -113.01 -173.95 2.35 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.65 -142.18 13.47 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.992 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 48.8 m-20 -129.08 103.72 18.42 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.536 -0.979 . . . . 0.0 109.173 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 31' ' ' THR . 33.3 Cg_endo -73.4 -5.95 18.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.806 1.671 . . . . 0.0 110.283 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -109.86 38.65 2.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 108.867 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -93.4 158.11 37.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.828 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 33.7 Cg_endo -75.37 -15.76 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.288 1.992 . . . . 0.0 109.986 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 54' ' ' ASP . 2.6 m-20 -100.45 135.24 20.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 108.958 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.29 -19.22 17.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 0.0 110.782 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.27 -1.0 25.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.884 -1.135 . . . . 0.0 109.623 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 51' ' ' ASN . 1.8 m-20 -107.76 -3.42 19.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 12.8 mttp -59.27 -105.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 110.312 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 73.7 m -75.21 177.39 6.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.709 -1.244 . . . . 0.0 108.592 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER 163.63 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.202 -0.936 . . . . 0.0 109.79 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 1.5 t . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.356 0.598 . . . . 0.0 109.86 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 55.2 m-80 -164.59 -165.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 56.9 m-20 66.4 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 110.608 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.947 ' HA ' HD11 ' A' ' 28' ' ' ILE . 2.3 m120 -115.73 63.45 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.123 . . . . 0.0 110.959 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.528 ' C ' HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -142.47 173.19 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.074 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.665 ' CG ' HG21 ' A' ' 28' ' ' ILE . 6.9 m-20 -107.8 128.56 25.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.845 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 -1.03 11.16 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.723 2.282 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.64 -68.82 0.59 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.369 -0.832 . . . . 0.0 109.381 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.43 161.7 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.894 -1.129 . . . . 0.0 108.694 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.7 116.51 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 0.0 109.971 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 108.55 -40.35 2.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 15' ' ' GLY . 2.7 m-80 38.85 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.997 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 15' ' ' GLY . 15.5 p -124.98 172.5 9.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.772 -1.205 . . . . 0.0 110.691 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.65 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 126.36 29.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -20.48 54.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.803 -1.186 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -109.08 -42.68 4.36 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.812 -1.18 . . . . 0.0 111.924 -178.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -82.81 -32.94 27.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.436 -1.415 . . . . 0.0 110.228 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 76.22 67.31 1.71 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -160.69 158.95 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.243 . . . . 0.0 108.978 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 72.4 m -48.45 111.54 0.47 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.074 -1.016 . . . . 0.0 108.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 18' ' ' ASN . 37.7 tp -126.8 9.47 6.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.248 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -126.1 60.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 111.561 -179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 67.2 m -56.34 146.37 24.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.549 -1.344 . . . . 0.0 107.741 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.947 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -110.02 -62.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.629 -1.294 . . . . 0.0 112.813 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.805 ' H ' HD12 ' A' ' 28' ' ' ILE . 60.2 m-85 -72.59 69.54 0.88 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.27 -0.894 . . . . 0.0 112.69 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 33.63 63.79 0.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.431 177.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' SG ' ' A' ' 56' ' ' CYS . 3.3 p -122.1 158.82 28.44 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.219 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -118.32 -173.4 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.975 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.61 147.9 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.03 -33.93 58.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -1.066 . . . . 0.0 109.816 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' SG ' ' A' ' 24' ' ' CYS . 3.7 m-85 -116.28 36.91 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.91 -1.119 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 5.3 m 52.99 50.54 17.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.991 . . . . 0.0 108.804 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -92.99 -6.32 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.013 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.28 -167.64 1.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 6.2 m -121.6 137.36 54.77 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -55.4 149.28 13.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.556 -1.34 . . . . 0.0 109.661 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 126.67 28.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.647 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.22 4.22 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.553 ' HB3' ' CA ' ' A' ' 57' ' ' LYS . 25.4 m-85 -127.92 129.86 47.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.159 0.98 . . . . 0.0 109.076 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.14 178.62 4.25 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.61 -144.52 14.89 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.336 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.4 m120 -132.66 105.28 12.97 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.897 . . . . 0.0 108.947 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.72 0.78 6.5 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.305 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -116.38 41.51 2.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.03 -1.044 . . . . 0.0 109.18 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.2 157.36 38.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.247 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.93 -13.72 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.335 2.023 . . . . 0.0 110.422 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 3.3 m120 -100.55 132.5 22.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.7 -20.18 13.83 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.145 1.896 . . . . 0.0 110.638 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.36 -8.43 45.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.998 -1.064 . . . . 0.0 109.623 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 51' ' ' ASN . 46.2 m-20 -105.69 -15.35 14.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.708 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.4 mtmm -59.3 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.094 -1.004 . . . . 0.0 109.933 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 85.6 m -93.93 144.89 25.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 108.79 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 170.36 172.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.34 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.2 p . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 m120 -52.09 -176.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.0 70.62 5.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.003 -1.061 . . . . 0.0 110.65 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 77.2 m-20 -144.88 63.66 1.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.887 -1.133 . . . . 0.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pt -149.96 150.32 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.171 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 1.4 m-20 -108.39 120.08 47.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 109.242 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.54 -3.79 14.41 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.551 2.167 . . . . 0.0 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.29 -67.75 0.71 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 109.488 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.76 179.22 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.402 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.09 149.27 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 109.54 -12.8 33.01 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -38.22 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -1.161 . . . . 0.0 110.474 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' GLY . 6.3 t -123.88 156.12 36.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -81.08 119.21 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -18.27 63.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.824 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -105.92 -40.6 5.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.818 -1.176 . . . . 0.0 111.817 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 1.9 p -91.34 -33.54 15.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.424 -1.423 . . . . 0.0 110.667 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 82.69 70.24 1.36 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 4.3 tp10 -163.41 167.98 20.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.27 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 62.2 m -64.44 107.13 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.487 -1.383 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.75 14.8 25.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 70.81 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.703 -1.248 . . . . 0.0 111.422 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 75.2 m -54.78 148.61 12.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.303 -1.498 . . . . 0.0 108.293 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.578 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.47 -63.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.794 -1.191 . . . . 0.0 112.82 -178.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.038 ' O ' HG23 ' A' ' 31' ' ' THR . 99.4 m-85 -57.17 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 0.0 112.159 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 29' ' ' TYR . 62.2 m-80 21.2 49.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.356 0.598 . . . . 0.0 111.341 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.038 HG23 ' O ' ' A' ' 29' ' ' TYR . 26.6 p -122.86 155.21 37.09 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.364 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -125.01 -162.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.564 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.19 146.39 6.58 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.99 -30.02 13.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.478 -1.013 . . . . 0.0 109.828 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.98 41.32 3.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.75 -1.219 . . . . 0.0 109.838 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.6 m 50.6 29.74 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.005 . . . . 0.0 109.573 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.625 ' HA ' HD21 ' A' ' 48' ' ' LEU . 9.7 p30 -90.23 10.73 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.48 -167.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.256 -0.903 . . . . 0.0 109.167 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.473 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 23.0 m -121.84 128.8 52.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -57.0 143.45 38.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.61 126.26 26.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.88 -31.65 4.68 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -134.23 128.39 33.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.195 0.998 . . . . 0.0 109.428 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 4.8 m-85 -108.2 -179.38 3.87 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.76 -142.21 13.63 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.373 -1.394 . . . . 0.0 109.997 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 58.8 m-80 -128.56 105.07 19.17 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.933 . . . . 0.0 109.121 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.7 Cg_endo -80.34 -4.81 13.27 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.406 2.071 . . . . 0.0 110.357 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 37' ' ' ASP . 70.2 mt -110.08 38.48 2.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.21 36.3 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.133 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.67 -24.07 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.201 1.934 . . . . 0.0 109.277 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.2 135.56 19.88 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 -18.99 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.193 1.928 . . . . 0.0 110.29 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.93 -17.66 60.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 109.419 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 55' ' ' LYS . 96.9 m-20 -105.03 11.91 32.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -63.41 -139.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.324 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 14.1 m -99.69 104.33 16.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.866 -1.146 . . . . 0.0 108.913 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mtmt -109.1 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.484 179.927 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.275 0.559 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -78.24 81.32 4.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.086 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -152.59 -134.92 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.756 ' OD1' HG21 ' A' ' 31' ' ' THR . 15.6 m120 -89.42 76.14 7.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 110.066 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -141.73 167.01 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 108.877 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -105.12 135.35 19.32 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.365 -0.834 . . . . 0.0 109.156 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.43 -25.22 9.92 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.362 2.042 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -77.32 -10.58 59.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 111.086 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.83 -165.8 0.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.286 -1.509 . . . . 0.0 109.017 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.3 t -111.63 83.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 110.288 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 81.92 -19.69 9.34 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.798 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-80 45.12 25.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.424 . . . . 0.0 109.214 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 34.1 m -123.0 175.94 6.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.91 123.38 31.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -61.84 -10.92 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 110.963 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -110.33 -41.05 4.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.7 -1.25 . . . . 0.0 111.986 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -90.12 -33.01 16.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.292 -1.505 . . . . 0.0 110.132 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.99 1.33 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -166.35 145.87 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.32 . . . . 0.0 109.384 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.25 107.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.36 44.28 2.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.0 110.534 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -148.72 60.07 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 108.895 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 92.1 m -54.15 150.03 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.87 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.82 -62.05 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.279 -0.888 . . . . 0.0 111.92 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 8.8 m-30 -75.24 65.62 1.61 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.647 -0.658 . . . . 0.0 112.378 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 29' ' ' TYR . 17.3 m120 38.47 62.07 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 110.924 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.756 HG21 ' OD1' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -125.74 156.79 38.85 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.284 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -122.98 -164.99 1.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.38 22.28 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -32.96 43.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -1.069 . . . . 0.0 109.712 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.497 ' OH ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 m-85 -121.47 38.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 109.557 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.4 m 55.72 33.3 21.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.547 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.81 13.77 13.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.714 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.9 ttt180 -131.31 -178.08 4.69 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 64.1 m -125.49 129.79 50.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -56.99 143.43 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.696 -1.252 . . . . 0.0 109.729 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.11 136.3 57.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.274 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.27 -39.85 2.2 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 106.25 -2.74 . . . . 0.0 106.25 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 56' ' ' CYS . 8.9 m-85 -120.55 130.98 54.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -109.61 175.57 5.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 130.69 -140.79 12.06 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 6.8 m-80 -134.01 123.23 16.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.672 -0.899 . . . . 0.0 109.091 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.582 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -77.28 -8.31 17.38 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.742 1.628 . . . . 0.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.08 38.59 2.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.41 151.0 37.28 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.48 -25.23 13.2 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.272 1.981 . . . . 0.0 109.56 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.92 134.44 20.44 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.452 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 33.7 Cg_endo -75.75 -17.16 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.996 1.797 . . . . 0.0 110.169 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.51 -13.44 54.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.012 -1.055 . . . . 0.0 109.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.64 11.03 16.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 6.5 ttmm -77.57 -129.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.189 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 3.9 m -91.61 81.81 5.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.663 -1.273 . . . . 0.0 108.308 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -114.74 167.29 10.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.76 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.433 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -56.96 -174.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.581 -1.324 . . . . 0.0 108.344 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.68 67.61 9.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.864 -1.148 . . . . 0.0 110.608 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.432 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 5.6 m-20 -138.22 57.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.78 -1.2 . . . . 0.0 110.145 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.58 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pp -150.32 154.88 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.162 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.745 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -108.39 129.14 24.42 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.01 -4.48 14.93 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.517 2.144 . . . . 0.0 110.906 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.57 -72.15 0.39 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.813 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -57.08 161.23 3.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 t -106.15 141.75 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 107.56 -11.2 39.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 34.1 m-80 -40.75 -32.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -1.177 . . . . 0.0 110.047 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 15.8 p -122.57 125.87 46.58 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.0 -1.062 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.884 ' ND2' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -100.82 118.75 37.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.438 -0.789 . . . . 0.0 112.101 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.589 ' HG3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -80.9 -24.38 38.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -92.35 -38.37 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.026 . . . . 0.0 110.486 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 18' ' ' ASN . 15.7 p -85.54 7.25 23.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 108.622 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . 123.6 -79.93 0.35 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER 177.62 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.29 -1.712 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.22 119.49 35.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.127 -1.608 . . . . 0.0 107.243 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.884 HD12 ' ND2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -119.57 -13.07 9.22 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.88 -177.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 23.2 mtpt -156.82 77.48 0.89 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.491 -1.381 . . . . 0.0 111.03 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.8 m -53.74 145.94 14.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.468 -1.395 . . . . 0.0 108.17 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -96.97 -63.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.882 -1.136 . . . . 0.0 112.397 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.048 ' O ' HG23 ' A' ' 31' ' ' THR . 22.9 m-85 -57.85 81.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.287 0.565 . . . . 0.0 112.386 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' TYR . 11.4 m-20 20.62 50.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.477 0.656 . . . . 0.0 111.796 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.048 HG23 ' O ' ' A' ' 29' ' ' TYR . 34.5 p -120.37 149.64 42.02 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.41 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.48 -175.47 2.95 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.247 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.4 150.43 22.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CZ ' ' O ' ' A' ' 21' ' ' THR . 22.1 t80 -57.0 -28.58 62.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.114 -1.227 . . . . 0.0 110.177 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -116.42 26.83 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.682 -1.261 . . . . 0.0 109.967 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.3 m 52.52 54.27 10.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 108.914 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -8.71 31.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 0.0 110.262 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.51 -172.61 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.919 -1.113 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 22.3 m -117.8 134.99 54.36 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 152.01 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.384 -1.447 . . . . 0.0 109.147 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.58 124.28 19.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.406 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.22 -34.57 3.79 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.12 128.76 47.84 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.197 0.998 . . . . 0.0 108.984 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -123.43 -179.35 4.3 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.37 -142.47 12.47 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.8 m120 -130.85 103.24 15.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.554 -0.968 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -79.18 -1.56 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.278 1.985 . . . . 0.0 110.311 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 37.99 2.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.84 156.38 42.69 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.129 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.06 -20.75 12.71 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.272 1.981 . . . . 0.0 109.522 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.45 131.18 24.26 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.31 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.3 -18.62 15.88 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.268 1.979 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 -21.63 59.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.075 . . . . 0.0 109.498 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.16 13.81 30.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.968 . . . . 0.0 109.401 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -67.58 -137.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 56.8 m -99.36 105.34 17.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.766 -1.209 . . . . 0.0 109.479 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -115.95 -156.46 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.482 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 9' ' ' ILE . 68.6 m-80 -144.58 -154.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.239 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 3.8 m-20 82.51 -134.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.77 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.901 ' OD1' HG21 ' A' ' 31' ' ' THR . 9.1 m-80 -89.35 72.32 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.98 HG21 ' SG ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -142.89 148.76 19.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.547 ' OD2' HG21 ' A' ' 28' ' ' ILE . 19.9 m-20 -114.88 154.9 46.95 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 110.575 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.76 -19.67 12.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.5 2.133 . . . . 0.0 110.095 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . 30.1 m120 -77.66 -32.99 53.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 112.021 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.56 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.164 -1.585 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.76 79.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.987 -1.071 . . . . 0.0 110.155 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 88.05 -32.51 4.32 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 7.4 m-80 64.4 1.85 1.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -1.086 . . . . 0.0 110.916 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.6 m -123.68 179.48 4.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.541 -1.349 . . . . 0.0 109.862 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.538 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -92.34 131.09 37.81 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -68.89 -24.94 64.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.669 -1.269 . . . . 0.0 110.426 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -96.63 -36.53 10.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.921 -1.112 . . . . 0.0 111.23 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -90.48 -39.1 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.748 -1.22 . . . . 0.0 110.098 -179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.72 70.73 1.34 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 2.5 tp10 -171.54 157.26 4.73 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.305 . . . . 0.0 109.332 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.98 ' SG ' HG21 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -63.04 111.53 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.744 -0.598 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.961 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -128.89 39.42 3.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.107 -0.996 . . . . 0.0 110.791 178.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -149.8 67.83 1.0 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 75.4 m -53.92 146.93 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.879 -1.138 . . . . 0.0 109.839 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -103.54 -61.82 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.89 . . . . 0.0 111.88 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD2' ' HD3' ' A' ' 55' ' ' LYS . 42.1 m-85 -77.54 63.62 2.7 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 112.292 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 29' ' ' TYR . 69.5 m-80 39.06 60.84 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.839 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.901 HG21 ' OD1' ' A' ' 8' ' ' ASN . 35.8 p -123.17 148.1 46.13 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 108.956 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -112.66 -165.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.92 18.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' PHE . 1.2 t80 -53.55 -29.9 39.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.779 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 85.4 m-85 -120.62 37.53 4.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 46.2 m 49.42 52.94 13.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.161 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.52 0.79 31.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 110.463 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -131.27 -173.7 3.18 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.802 -1.186 . . . . 0.0 109.143 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 64.8 m -111.94 126.62 55.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -57.42 151.89 15.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.807 -1.183 . . . . 0.0 109.763 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.85 125.37 23.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.14 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.8 -32.52 4.4 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -129.51 129.0 43.97 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.325 1.06 . . . . 0.0 109.178 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -114.58 174.34 6.01 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 133.53 -144.05 15.9 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.382 -1.389 . . . . 0.0 109.962 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 45.7 m-20 -130.06 112.47 17.17 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.573 -0.957 . . . . 0.0 109.353 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 35.0 Cg_endo -75.88 -3.07 13.37 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.128 1.885 . . . . 0.0 110.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.49 40.68 2.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.0 153.43 38.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.005 . . . . 0.0 109.197 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.51 -27.66 9.03 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.083 1.855 . . . . 0.0 109.285 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.22 137.6 19.73 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.69 -17.17 18.28 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.142 1.895 . . . . 0.0 110.326 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.9 -24.74 58.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 109.16 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.23 27.28 9.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -83.38 -143.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 95.2 m -91.95 83.33 5.18 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.2 mtpt -115.37 170.56 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.008 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.65 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.778 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 68.7 m-80 -35.88 -97.88 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.585 -0.697 . . . . 0.0 110.704 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' ASN . 12.5 m-20 42.27 -94.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.139 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.757 ' CG ' HG21 ' A' ' 31' ' ' THR . 4.2 m120 -144.23 68.22 1.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.016 -1.052 . . . . 0.0 110.184 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.745 HG21 ' SG ' ' A' ' 24' ' ' CYS . 2.7 pp -142.5 163.93 17.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.756 ' OD1' HG21 ' A' ' 28' ' ' ILE . 90.3 m-20 -105.96 109.83 63.52 Favored Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.4 -5.74 15.83 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.851 2.367 . . . . 0.0 111.18 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.26 -70.77 0.47 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 109.079 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 160.62 13.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.147 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.2 t -104.13 151.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.53 -2.69 32.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 11.2 m-80 -60.34 -5.92 1.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.366 . . . . 0.0 111.189 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 25' ' ' LEU . 79.8 m -121.66 177.39 5.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.584 -1.323 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -93.01 133.17 36.42 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -11.24 60.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.916 -1.115 . . . . 0.0 111.677 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 21' ' ' THR . 1.7 pp -102.09 -47.99 4.37 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.539 -1.351 . . . . 0.0 110.985 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.478 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.0 -23.84 20.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.636 -1.29 . . . . 0.0 109.872 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.54 61.48 3.85 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -147.25 156.52 43.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.108 -1.23 . . . . 0.0 109.273 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.745 ' SG ' HG21 ' A' ' 9' ' ' ILE . 2.1 m -64.43 112.52 3.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.949 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.88 41.74 3.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.977 -1.077 . . . . 0.0 110.339 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 68.72 0.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.449 -0.782 . . . . 0.0 108.979 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 79.7 m -53.72 151.4 6.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.92 -1.113 . . . . 0.0 109.953 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -105.35 -58.74 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.49 -0.757 . . . . 0.0 111.327 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 28' ' ' ILE . 54.4 m-85 -77.86 47.59 0.64 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.589 -0.695 . . . . 0.0 111.695 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.07 63.47 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.722 -1.236 . . . . 0.0 110.532 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.757 HG21 ' CG ' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -123.33 158.53 30.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 108.701 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -116.35 -163.8 0.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.38 147.83 12.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.414 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 3.8 t80 -53.95 -32.06 52.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -1.092 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -119.82 38.59 3.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.786 -1.196 . . . . 0.0 109.293 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 68.6 m 52.88 53.43 12.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -107.8 7.31 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.845 . . . . 0.0 109.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.79 -167.36 1.82 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.207 -0.933 . . . . 0.0 109.745 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 1.6 m -121.26 135.87 55.06 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -56.5 145.62 27.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.662 -1.274 . . . . 0.0 109.692 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.46 124.77 21.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 109.585 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.99 -31.89 4.58 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.495 ' HB3' ' N ' ' A' ' 57' ' ' LYS . 4.3 m-85 -127.28 129.75 48.27 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.302 1.049 . . . . 0.0 109.114 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.07 175.5 5.44 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.155 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 140.85 -147.21 18.84 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.441 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 53.7 m-20 -135.67 102.11 10.53 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.984 . . . . 0.0 109.844 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HG3' ' C ' ' A' ' 38' ' ' ARG . 34.3 Cg_endo -75.1 1.4 7.82 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.13 1.887 . . . . 0.0 110.448 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -109.95 39.29 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 108.915 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.75 156.67 44.61 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.58 -16.34 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.386 2.057 . . . . 0.0 110.121 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.23 128.44 33.42 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.074 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.92 -19.64 15.81 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.192 1.928 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.49 5.78 46.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.412 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -119.68 1.3 11.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 86.8 mttt -69.72 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.987 -1.07 . . . . 0.0 110.358 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 13.8 m -99.14 147.52 25.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 0.0 109.375 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -160.22 167.38 27.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 109.171 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.519 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -80.06 85.71 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 0.0 109.209 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 7' ' ' ASP . 41.5 p30 -170.93 -140.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.837 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 1.015 ' ND2' HG21 ' A' ' 31' ' ' THR . 12.9 m-20 -96.69 83.01 3.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.056 -1.028 . . . . 0.0 110.137 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 1.01 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.5 pp -149.26 150.36 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.532 -0.73 . . . . 0.0 109.157 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.4 m-20 -107.94 126.9 28.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.302 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.84 -15.47 18.94 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.365 2.044 . . . . 0.0 110.924 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.84 -71.48 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 109.605 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.09 176.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 15' ' ' GLY . 39.3 t -115.32 163.68 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 107.38 -17.57 36.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.7 m120 -64.69 -2.56 2.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.275 . . . . 0.0 111.125 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.7 t -136.08 142.3 44.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.629 -1.294 . . . . 0.0 108.923 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.585 ' OD1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.43 125.18 28.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.951 -1.093 . . . . 0.0 108.23 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -20.61 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.967 . . . . 0.0 110.29 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.41 -42.0 5.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.011 -1.056 . . . . 0.0 111.499 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -86.31 -39.3 16.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.609 -1.307 . . . . 0.0 110.274 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 71.11 1.32 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.562 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 1.3 tp10 -174.84 161.97 3.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.988 -1.301 . . . . 0.0 108.734 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 1.01 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m -48.76 124.46 8.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.879 -1.138 . . . . 0.0 109.888 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -123.6 -28.43 3.88 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.09 -1.006 . . . . 0.0 111.613 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -114.1 84.31 2.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.52 -1.363 . . . . 0.0 110.952 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 60.9 m -55.37 153.33 7.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.637 -1.29 . . . . 0.0 110.039 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -106.66 -66.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.035 -1.041 . . . . 0.0 112.421 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.06 ' O ' HG23 ' A' ' 31' ' ' THR . 6.3 m-30 -68.87 75.97 0.31 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.55 -0.719 . . . . 0.0 112.895 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.49 ' C ' ' O ' ' A' ' 29' ' ' TYR . 4.3 m-20 29.42 52.24 0.09 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.435 0.636 . . . . 0.0 111.224 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 29' ' ' TYR . 70.0 p -120.9 151.8 39.24 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 108.816 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -119.88 -153.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.46 148.45 6.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.09 -24.09 62.64 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.36 -1.082 . . . . 0.0 110.256 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 55.3 m-85 -114.58 20.87 15.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.63 -1.294 . . . . 0.0 110.24 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 82.6 m 62.26 29.5 17.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 109.655 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -103.2 23.95 11.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.181 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.39 -176.67 4.04 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.215 -0.928 . . . . 0.0 109.208 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.66 139.8 53.09 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.03 141.45 34.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.469 -1.394 . . . . 0.0 109.47 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.53 128.58 37.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.642 -0.661 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.24 2.95 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -128.63 129.57 46.06 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.162 0.982 . . . . 0.0 108.756 177.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.9 m-85 -111.07 -179.61 3.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.17 -139.35 9.76 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.454 -1.355 . . . . 0.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -124.67 100.43 34.51 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.733 -0.863 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.614 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -79.68 -8.41 14.68 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 37.88 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 109.952 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.47 152.66 42.17 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.118 -0.989 . . . . 0.0 109.136 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.78 -27.44 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -101.12 134.15 20.54 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.33 -1.04 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.105 1.87 . . . . 0.0 110.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.01 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 108.661 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.6 31.74 4.52 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 6.6 ttmt -73.01 -145.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.691 -0.631 . . . . 0.0 109.919 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 6.9 m -100.13 94.07 6.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.083 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.33 -167.03 1.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.483 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 16.1 p . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 72.2 m-20 -106.04 -144.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.1 t0 83.21 -72.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 1.052 ' ND2' HG21 ' A' ' 31' ' ' THR . 4.0 m120 -137.69 70.83 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.832 -1.167 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.553 ' CA ' HG12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -141.92 149.54 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.072 -1.018 . . . . 0.0 109.646 179.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.818 ' CG ' HG21 ' A' ' 28' ' ' ILE . 31.5 m-20 -109.39 126.3 29.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.262 -0.899 . . . . 0.0 109.909 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.02 -9.16 16.72 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.376 2.05 . . . . 0.0 110.636 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.0 -74.2 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.0 109.811 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 170.15 3.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.077 -1.015 . . . . 0.0 109.548 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.71 157.41 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 25' ' ' LEU . . . 106.48 -31.87 7.86 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 11.7 m-80 -44.38 -24.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -1.211 . . . . 0.0 109.897 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 3.6 m -127.7 161.77 28.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 109.293 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.569 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -95.86 130.04 42.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.751 -1.218 . . . . 0.0 108.217 179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -62.73 -34.39 77.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 0.0 110.632 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 -37.48 8.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.847 -1.158 . . . . 0.0 111.617 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.77 -13.02 49.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.618 -1.301 . . . . 0.0 110.168 -179.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.59 47.82 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -129.9 170.27 14.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -1.139 . . . . 0.0 108.637 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 9' ' ' ILE . 60.1 m -70.06 102.52 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.665 -1.272 . . . . 0.0 109.411 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.11 -11.31 59.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.127 . . . . 0.0 110.118 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -160.16 95.63 1.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.727 -1.233 . . . . 0.0 111.25 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 71.3 m -54.43 153.64 5.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.336 -1.477 . . . . 0.0 108.77 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -102.53 -59.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.723 -1.236 . . . . 0.0 112.871 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -75.12 40.1 0.15 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.742 . . . . 0.0 112.169 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 58.29 68.6 0.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.476 -1.39 . . . . 0.0 110.571 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.052 HG21 ' ND2' ' A' ' 8' ' ' ASN . 36.9 p -133.68 147.48 51.4 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -110.3 -159.02 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.36 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 147.32 10.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 t80 -50.67 -30.35 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -1.002 . . . . 0.0 109.764 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -124.12 43.4 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.892 -1.13 . . . . 0.0 109.375 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HB3' ' OD1' ' A' ' 8' ' ' ASN . 60.1 m 51.88 48.27 23.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 108.633 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.46 3.52 45.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.289 -0.882 . . . . 0.0 110.48 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -131.17 -172.26 2.79 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.918 -1.114 . . . . 0.0 109.659 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.46 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 77.6 m -117.32 130.52 56.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -57.14 146.75 26.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.787 -1.196 . . . . 0.0 109.667 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.21 129.04 38.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.483 -0.761 . . . . 0.0 109.697 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.47 -35.85 3.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.398 -2.681 . . . . 0.0 106.398 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 7.9 m-85 -126.11 132.14 51.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.189 0.995 . . . . 0.0 108.661 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' LYS . 4.4 m-85 -111.69 -178.11 3.35 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 127.98 -144.96 15.63 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 22.8 m120 -129.06 120.22 20.14 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.597 -0.943 . . . . 0.0 109.066 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.6 Cg_endo -77.41 -18.02 14.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.979 1.786 . . . . 0.0 111.204 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.418 HD13 ' OD2' ' A' ' 7' ' ' ASP . 12.9 tp -109.55 37.11 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.943 -1.098 . . . . 0.0 110.019 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.16 151.43 41.7 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 108.762 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.44 -29.61 9.09 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.155 1.903 . . . . 0.0 109.022 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -101.26 128.63 28.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.76 -12.02 24.13 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.053 1.835 . . . . 0.0 110.469 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.96 59.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.98 -1.075 . . . . 0.0 108.792 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.63 15.0 22.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -65.96 -146.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 71.0 m -90.95 82.44 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.018 -1.051 . . . . 0.0 108.417 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 43' ' ' PHE . 1.7 mttm -124.83 -174.61 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.576 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.294 179.801 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 p . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -51.52 159.35 0.75 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 75.34 5.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.502 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.898 ' HA ' HD11 ' A' ' 28' ' ' ILE . 50.2 m-20 -145.02 67.03 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 0.0 110.24 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.53 ' C ' HG12 ' A' ' 28' ' ' ILE . 2.7 pt -149.52 176.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -106.56 147.36 34.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.206 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 -40.24 0.49 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.439 2.093 . . . . 0.0 111.201 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.511 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -78.34 -5.17 51.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -178.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.963 -1.71 . . . . 0.0 109.011 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.7 80.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.074 . . . . 0.0 110.329 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 -22.91 6.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 22.9 m-80 54.88 15.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.883 -1.363 . . . . 0.0 110.63 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.21 159.77 32.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.883 -1.136 . . . . 0.0 109.503 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.7 120.18 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -64.62 -19.65 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.869 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -97.77 -41.26 8.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.771 -1.205 . . . . 0.0 110.893 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -91.94 -64.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.698 -1.251 . . . . 0.0 109.922 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 116.92 79.16 0.72 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -178.15 159.3 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.984 -1.303 . . . . 0.0 108.259 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.2 m -47.86 119.23 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.604 -1.31 . . . . 0.0 108.648 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.946 ' O ' HD13 ' A' ' 25' ' ' LEU . 1.1 tm? -125.77 27.86 6.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 110.294 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.4 mttt -160.2 63.1 0.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.965 -1.084 . . . . 0.0 109.927 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 46.6 m -55.39 150.66 11.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.956 -1.09 . . . . 0.0 109.709 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.898 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.8 -64.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.0 111.816 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 1.084 ' O ' HG23 ' A' ' 31' ' ' THR . 24.5 m-85 -59.5 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.528 ' C ' ' O ' ' A' ' 29' ' ' TYR . 10.1 m-20 24.32 52.65 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.233 0.539 . . . . 0.0 111.257 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 29' ' ' TYR . 38.2 p -121.45 144.67 48.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.075 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -115.56 -169.82 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.594 -0.691 . . . . 0.0 109.567 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.93 148.1 21.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 3.1 t80 -52.66 -27.31 16.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CZ ' ' HD2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -126.55 37.91 4.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.814 -1.178 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.6 m 52.18 53.5 12.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.931 -1.105 . . . . 0.0 108.605 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -97.75 -7.42 30.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.782 . . . . 0.0 110.376 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -174.74 3.46 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.828 -1.17 . . . . 0.0 109.685 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 47' ' ' PRO . 3.2 m -122.15 136.21 54.88 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -56.21 149.82 15.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.655 -1.278 . . . . 0.0 108.944 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.54 132.6 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -36.5 3.13 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 106.769 -2.533 . . . . 0.0 106.769 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -124.24 129.58 51.03 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.21 1.005 . . . . 0.0 108.999 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.51 173.35 6.45 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.78 19.24 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.635 -1.269 . . . . 0.0 109.975 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 38.6 m-20 -115.27 107.35 49.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.435 -1.038 . . . . 0.0 109.53 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.521 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 37.7 Cg_endo -79.35 -13.35 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.246 1.964 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.1 39.07 2.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.8 . . . . 0.0 109.828 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.78 148.68 35.63 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.37 -23.32 13.32 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.358 2.039 . . . . 0.0 109.901 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -99.89 135.58 20.42 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.412 -0.805 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.91 -19.89 17.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.152 1.901 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.15 -27.22 59.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.26 38.16 2.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.171 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -89.84 -145.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.681 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 47' ' ' PRO . 74.9 m -101.47 106.16 17.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 109.719 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.11 173.14 8.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -0.968 . . . . 0.0 109.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.507 -179.876 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 5' ' ' CYS . 27.2 p . . . . . 0 N--CA 1.506 2.338 0 CA-C-O 121.391 0.615 . . . . 0.0 112.197 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.513 ' HA ' HG12 ' A' ' 9' ' ' ILE . 78.7 m-20 -78.03 -135.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 38.1 m-20 74.27 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.932 . . . . 0.0 110.693 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.492 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 1.8 m120 -115.62 74.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.799 -1.188 . . . . 0.0 110.492 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.568 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.8 pp -154.22 146.85 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 108.818 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.902 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.93 128.53 25.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.407 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.13 -14.38 18.78 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.427 2.084 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.32 -72.24 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.37 163.05 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 109.29 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.76 152.13 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.076 -1.015 . . . . 0.0 109.36 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 112.35 -28.48 9.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 13.6 m-80 -42.72 -26.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -1.183 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 15' ' ' GLY . 1.7 p -126.06 149.63 48.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 108.998 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -82.71 126.64 32.59 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -34.0 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.734 -1.229 . . . . 0.0 110.215 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -34.36 10.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.93 -1.106 . . . . 0.0 111.425 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -22.73 23.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.659 -1.276 . . . . 0.0 110.378 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.45 69.56 1.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -163.97 169.5 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 108.861 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 7.0 m -65.58 101.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.241 -1.537 . . . . 0.0 109.301 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.26 -26.04 26.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 79.52 1.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.787 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 76.3 m -53.62 152.85 4.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.432 -1.418 . . . . 0.0 108.518 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.902 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -92.13 -64.85 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.966 -1.084 . . . . 0.0 112.317 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' THR . 57.0 m-85 -73.21 71.54 1.19 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.428 -0.795 . . . . 0.0 112.616 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 31.34 54.22 0.22 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.586 -0.697 . . . . 0.0 111.094 177.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 29' ' ' TYR . 11.5 p -122.55 151.74 41.08 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.161 -0.962 . . . . 0.0 109.65 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -123.49 -163.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.04 152.86 27.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 1.1 t80 -51.61 -34.34 36.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 109.832 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -119.67 39.62 3.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.796 -1.19 . . . . 0.0 109.63 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 39.4 m 50.31 32.64 6.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.01 -1.056 . . . . 0.0 109.013 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.31 10.88 20.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.403 -0.811 . . . . 0.0 109.707 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.68 -173.72 3.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.107 -0.996 . . . . 0.0 109.529 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 56.4 m -119.97 131.7 55.26 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.722 -1.236 . . . . 0.0 109.355 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.62 130.27 46.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.561 -0.712 . . . . 0.0 109.614 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.53 -36.52 3.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -126.08 129.43 49.1 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.238 1.018 . . . . 0.0 109.001 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -110.58 171.93 7.17 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.9 -145.02 17.16 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.932 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 11.3 m120 -115.27 108.05 48.5 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.969 . . . . 0.0 108.793 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.734 ' HB3' HG22 ' A' ' 31' ' ' THR . 34.8 Cg_endo -75.14 -7.73 19.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.87 1.714 . . . . 0.0 110.749 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.09 42.48 3.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 155.58 43.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 0.0 108.952 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.35 -22.02 14.63 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.203 1.935 . . . . 0.0 109.689 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m-80 -100.82 134.47 20.47 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.528 -0.733 . . . . 0.0 109.157 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.71 -19.19 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.243 1.962 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.35 12.44 29.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.061 -1.024 . . . . 0.0 109.724 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.469 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 m-20 -135.62 30.01 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.904 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 39.3 mttm -97.57 -116.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.957 -1.089 . . . . 0.0 110.544 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 2.8 m -100.67 105.69 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.648 -1.283 . . . . 0.0 109.59 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 1.5 mptt -105.54 170.51 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.487 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 22.7 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 35' ' ' TYR . 28.1 m120 -39.92 147.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.486 -0.759 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 8' ' ' ASN . 6.5 t70 -80.81 69.72 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.957 ' HA ' HD11 ' A' ' 28' ' ' ILE . 2.2 m120 -139.26 64.62 1.46 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.116 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -154.4 -177.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 43.5 m-20 -107.35 112.47 62.68 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.773 -1.205 . . . . 0.0 109.304 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.15 -8.47 17.58 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.665 2.244 . . . . 0.0 110.954 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -78.63 -74.1 0.29 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.28 -167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.107 -0.996 . . . . 0.0 109.269 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.16 156.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.968 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.89 36.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 28.8 m-80 -52.41 -16.19 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 110.51 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t -121.95 149.08 43.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 108.902 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.558 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.19 126.62 31.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.877 -1.139 . . . . 0.0 108.302 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -69.16 -39.83 78.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.401 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -24.92 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.549 -1.345 . . . . 0.0 111.242 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -92.55 -32.65 14.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.358 -1.464 . . . . 0.0 109.881 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' CD ' ' A' ' 23' ' ' GLU . . . 71.25 63.24 3.18 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -159.89 159.41 32.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.104 -1.233 . . . . 0.0 109.258 -179.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 23.3 m -55.83 114.85 2.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.558 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.91 -34.49 10.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.884 -1.135 . . . . 0.0 109.862 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -123.21 83.05 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.197 -0.939 . . . . 0.0 110.376 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 65.1 m -53.91 155.71 3.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.488 -1.383 . . . . 0.0 109.278 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -107.13 -64.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 120.84 -1.163 . . . . 0.0 112.86 -178.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.764 ' H ' HD12 ' A' ' 28' ' ' ILE . 55.4 m-85 -59.21 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.294 -0.879 . . . . 0.0 112.091 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.531 ' C ' ' O ' ' A' ' 29' ' ' TYR . 76.2 m-20 22.99 50.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.304 0.573 . . . . 0.0 111.254 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 29' ' ' TYR . 1.2 p -121.54 151.28 40.5 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.72 176.47 5.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.9 152.23 24.72 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 5.0 t80 -56.56 -32.0 64.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -1.123 . . . . 0.0 109.714 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 26.2 m-85 -117.33 22.38 12.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.917 -1.114 . . . . 0.0 109.245 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 m 61.17 61.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -90.28 -21.59 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.873 . . . . 0.0 111.286 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -131.9 -174.26 3.37 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.584 -1.322 . . . . 0.0 109.596 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 34.1 m -112.62 137.55 50.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -55.43 156.9 4.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.488 -1.382 . . . . 0.0 109.604 -178.32 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 123.94 18.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.24 -30.52 4.97 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 107.111 -2.395 . . . . 0.0 107.111 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 30' ' ' ASN . 6.0 m-85 -127.04 128.46 46.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.272 1.034 . . . . 0.0 109.109 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -108.45 -156.85 0.59 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.53 -151.48 18.32 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.323 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 13.4 m120 -135.06 104.77 10.45 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 36.1 Cg_endo -78.01 1.48 8.88 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.028 1.819 . . . . 0.0 109.857 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 48' ' ' LEU . 2.1 mm? -108.8 38.22 2.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 108.863 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.52 148.5 39.34 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.447 -0.783 . . . . 0.0 109.142 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.92 -28.52 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.23 1.954 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -101.19 140.99 21.73 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.123 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.95 -11.75 21.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.233 1.955 . . . . 0.0 110.39 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.84 60.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.942 -1.098 . . . . 0.0 109.099 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -117.21 30.13 7.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 109.018 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.2 ttmt -87.21 -139.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.795 . . . . 0.0 109.175 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 56.6 m -91.96 162.65 14.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.951 -1.093 . . . . 0.0 109.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 1.3 mmtp 174.39 -167.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.348 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.485 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.4 p . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 8.2 m-20 -54.63 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 49.7 m-20 102.89 -102.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.3 m120 -120.97 67.57 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.857 -1.152 . . . . 0.0 109.546 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.569 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.4 pt -139.18 162.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.699 ' CG ' HG21 ' A' ' 28' ' ' ILE . 58.5 m-20 -106.77 119.34 51.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.66 -4.14 14.63 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.684 2.256 . . . . 0.0 111.234 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.69 -68.76 0.62 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.358 -0.839 . . . . 0.0 109.85 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.27 171.04 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.989 -1.069 . . . . 0.0 110.039 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 15' ' ' GLY . 35.9 t -111.44 164.64 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.302 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 98.05 4.61 57.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 8.4 m-80 -63.26 -0.92 0.9 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.837 -1.39 . . . . 0.0 111.669 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 p -128.41 158.23 38.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.334 -1.479 . . . . 0.0 109.747 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.634 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.59 130.14 40.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -58.84 -35.98 73.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.73 -1.231 . . . . 0.0 111.786 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.15 -34.24 10.12 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.545 -1.347 . . . . 0.0 112.158 -177.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 2.6 p -83.86 -34.15 24.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.431 -1.418 . . . . 0.0 110.446 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.77 66.68 1.99 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 8.5 tp10 -162.32 160.9 27.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 108.832 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' CYS . . . . . 0.403 ' SG ' HG21 ' A' ' 9' ' ' ILE . 4.5 m -48.18 120.08 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.975 -1.078 . . . . 0.0 108.348 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 18' ' ' ASN . 8.7 tp -125.65 15.62 8.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.294 -0.878 . . . . 0.0 110.724 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 12.2 mtpt -159.07 77.89 0.74 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.131 -0.98 . . . . 0.0 109.586 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 13.7 m -57.86 155.25 10.73 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.666 -1.271 . . . . 0.0 110.189 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.699 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -111.26 -63.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.833 ' O ' HG23 ' A' ' 31' ' ' THR . 25.5 m-85 -68.15 72.53 0.19 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER 33.09 52.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 111.476 177.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 29' ' ' TYR . 20.3 p -122.07 145.15 48.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.955 -1.09 . . . . 0.0 109.091 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -124.56 166.21 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.39 155.38 9.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.04 -30.35 61.79 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -1.121 . . . . 0.0 109.949 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.49 29.41 7.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.164 . . . . 0.0 109.628 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.3 m 49.84 43.25 24.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.705 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.38 21.29 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.33 -179.22 5.13 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.223 -0.923 . . . . 0.0 108.874 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 1.4 m -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 4.9 ttmt -55.77 138.14 48.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.717 -1.24 . . . . 0.0 109.805 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 5.0 pt-20 -61.09 130.54 46.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.597 -0.689 . . . . 0.0 109.815 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.74 -34.96 3.57 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 13.9 m-85 -130.53 131.74 45.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.133 0.968 . . . . 0.0 108.479 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' LYS . 2.3 m-85 -105.53 -179.91 4.08 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.34 -145.22 17.09 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.886 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 30.6 m120 -118.73 111.93 37.27 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.972 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PRO . . . . . 0.491 ' CB ' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -78.63 -29.1 3.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 110.731 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.16 44.93 1.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.989 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.67 154.06 50.4 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.002 -1.062 . . . . 0.0 108.859 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.73 -31.13 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.019 1.813 . . . . 0.0 108.83 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.94 139.33 20.22 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 33.5 Cg_endo -75.18 0.77 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.048 1.832 . . . . 0.0 109.869 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.95 -13.6 53.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.701 -1.249 . . . . 0.0 109.248 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 4.0 m-20 -111.03 40.37 2.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.293 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -70.43 -155.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 109.057 -179.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 5.9 m -101.37 90.57 4.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -114.84 177.04 4.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.571 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.61 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.1 -41.54 0.29 Allowed 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.45 2.1 . . . . 0.0 110.364 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 2.3 p -106.11 133.91 50.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.268 -0.895 . . . . 0.0 109.391 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.464 ' O ' ' HB2' ' A' ' 5' ' ' CYS . 19.6 mm-40 -64.97 136.02 56.33 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.299 -0.876 . . . . 0.0 109.742 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 4' ' ' GLN . 18.0 t 178.9 157.19 0.5 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.285 -0.884 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.472 ' ND2' ' OD1' ' A' ' 37' ' ' ASP . 2.8 m120 -54.09 170.41 0.14 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.176 -0.952 . . . . 0.0 109.489 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -82.72 67.36 8.75 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.2 -0.937 . . . . 0.0 110.912 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.468 ' OD1' ' HB3' ' A' ' 6' ' ' ASN . 0.3 OUTLIER -142.82 62.72 1.4 Allowed 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.93 -1.106 . . . . 0.0 109.17 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.558 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -154.14 152.36 9.84 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 O-C-N 121.281 -0.887 . . . . 0.0 109.148 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -107.77 129.23 24.47 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.357 -0.839 . . . . 0.0 109.26 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.91 -6.65 17.66 Favored 'Trans proline' 0 C--N 1.314 -1.242 0 C-N-CA 122.625 2.217 . . . . 0.0 111.11 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -78.47 -69.33 0.57 Allowed 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.302 -0.874 . . . . 0.0 109.773 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.72 169.23 1.43 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.596 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.6 t -119.01 152.78 21.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.305 -0.872 . . . . 0.0 109.256 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.44 -11.62 65.06 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -52.55 -15.33 0.65 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.091 -1.241 . . . . 0.0 111.019 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.36 150.0 43.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.723 -1.235 . . . . 0.0 109.476 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.593 ' ND2' ' CG ' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -84.29 122.06 28.38 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.28 -6.91 57.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.129 -0.982 . . . . 0.0 110.844 -178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.896 HD23 ' H ' ' A' ' 20' ' ' LEU . 2.5 pt? -108.22 -45.08 4.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.797 -1.189 . . . . 0.0 111.147 -179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.604 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.6 OUTLIER -91.71 -15.5 28.31 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.65 -1.281 . . . . 0.0 110.199 -179.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.96 61.01 5.87 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 108.943 -1.663 . . . . 0.0 108.943 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.593 ' CG ' ' ND2' ' A' ' 18' ' ' ASN . 9.2 pt-20 -156.56 152.46 27.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.222 -1.164 . . . . 0.0 108.404 -179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.453 ' CB ' ' SG ' ' A' ' 36' ' ' CYS . 35.6 m -51.94 118.97 3.81 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.359 -1.463 . . . . 0.0 109.858 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.593 ' CB ' ' OD1' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -84.61 -31.37 24.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.917 -1.115 . . . . 0.0 109.335 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mttm -143.89 84.66 1.79 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.109 -0.994 . . . . 0.0 109.949 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 31' ' ' THR . 9.7 m -53.42 155.69 2.78 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.518 -1.364 . . . . 0.0 108.655 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -86.44 -66.64 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.04 -1.038 . . . . 0.0 112.452 -178.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.093 ' O ' HG23 ' A' ' 31' ' ' THR . 19.0 m-85 -64.58 77.73 0.04 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.558 -0.714 . . . . 0.0 112.63 -177.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.498 ' C ' ' O ' ' A' ' 29' ' ' TYR . 3.1 m120 26.0 48.87 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.159 0.504 . . . . 0.0 111.504 177.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.093 HG23 ' O ' ' A' ' 29' ' ' TYR . 44.6 p -121.92 150.94 41.28 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.088 -1.008 . . . . 0.0 109.635 179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.531 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -139.32 171.46 14.24 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.832 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.68 158.63 10.67 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -54.27 -29.59 47.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -1.1 . . . . 0.0 110.095 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 35.8 m-85 -121.99 32.0 6.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.812 -1.18 . . . . 0.0 109.77 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.453 ' SG ' ' CB ' ' A' ' 24' ' ' CYS . 90.0 m 49.74 27.23 2.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.118 -0.989 . . . . 0.0 109.211 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.472 ' OD1' ' ND2' ' A' ' 6' ' ' ASN . 0.2 OUTLIER -94.82 20.44 8.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.342 -0.848 . . . . 0.0 109.624 -179.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -130.7 -174.6 3.41 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.074 -1.017 . . . . 0.0 109.577 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.433 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 98.8 m -120.15 135.43 54.96 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.51 ' CE ' ' CE2' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -55.77 147.14 19.53 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.552 -1.343 . . . . 0.0 110.09 -178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -60.15 123.59 17.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.578 -0.701 . . . . 0.0 109.69 -179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.43 -33.38 4.17 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.51 ' CE2' ' CE ' ' A' ' 40' ' ' LYS . 7.9 m-85 -122.47 129.83 52.43 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.219 1.009 . . . . 0.0 108.726 177.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.6 m-85 -118.46 178.85 4.3 Favored 'General case' 0 C--N 1.282 -2.353 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 127.16 -143.8 14.59 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 80.8 m-20 -115.98 110.11 44.22 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.482 -1.01 . . . . 0.0 109.061 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.485 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.4 Cg_endo -78.42 -9.78 16.16 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.169 1.913 . . . . 0.0 110.586 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -109.79 37.89 2.53 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.926 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HE2' ' A' ' 55' ' ' LYS . . . -93.23 153.16 41.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.153 -0.967 . . . . 0.0 109.232 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HG2' ' ND2' ' A' ' 51' ' ' ASN . 33.9 Cg_endo -75.01 -29.67 7.97 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.117 1.878 . . . . 0.0 108.949 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.488 ' ND2' ' HG2' ' A' ' 50' ' ' PRO . 4.4 m-80 -101.27 138.56 19.97 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -75.75 -19.4 16.36 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.104 1.869 . . . . 0.0 110.142 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.14 60.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.071 -1.018 . . . . 0.0 109.194 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -113.38 17.84 18.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.865 . . . . 0.0 109.288 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.8 OUTLIER -71.85 -130.69 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.255 -0.903 . . . . 0.0 109.257 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 9.7 m -101.07 102.89 13.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.684 -1.26 . . . . 0.0 109.228 179.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.8 mmtt -109.2 168.28 9.49 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.033 -1.042 . . . . 0.0 109.85 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.387 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.487 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 34.8 Cg_endo -78.23 -90.87 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.623 2.216 . . . . 0.0 110.235 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.466 ' O ' ' N ' ' A' ' 5' ' ' CYS . 57.1 m -103.7 151.71 22.67 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.154 -0.966 . . . . 0.0 109.325 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -55.97 89.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.277 -0.889 . . . . 0.0 109.373 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' CYS . 0.5 OUTLIER -166.29 160.99 16.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.229 -0.919 . . . . 0.0 109.501 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 14.4 m120 -159.83 -160.71 0.83 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -0.836 . . . . 0.0 109.567 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 0.6 OUTLIER 81.88 -74.72 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.591 -0.693 . . . . 0.0 110.338 179.559 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 4.6 m120 -132.93 73.0 1.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.97 -1.081 . . . . 0.0 110.319 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.623 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.8 pp -146.48 150.85 14.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.293 -0.879 . . . . 0.0 108.921 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.779 ' OD2' HG21 ' A' ' 28' ' ' ILE . 3.6 m-20 -109.29 142.28 25.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.172 -0.955 . . . . 0.0 110.208 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.27 -8.94 17.62 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.507 2.138 . . . . 0.0 110.406 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' ALA . 0.1 OUTLIER -76.75 -48.66 18.06 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.466 -0.771 . . . . 0.0 110.804 -178.751 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.36 -171.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.564 -1.335 . . . . 0.0 108.938 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -111.96 83.2 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.859 -1.15 . . . . 0.0 110.916 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA2' ' HB2' ' A' ' 2' ' ' PRO . . . 105.64 -38.21 3.42 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 119.878 -1.153 . . . . 0.0 110.51 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 4.7 m-80 52.22 16.43 0.57 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.118 -1.225 . . . . 0.0 110.251 -179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 30.2 p -129.75 169.72 14.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.665 -1.272 . . . . 0.0 109.72 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.633 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.31 122.47 20.34 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.768 -1.208 . . . . 0.0 108.247 179.011 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -18.12 55.86 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.028 -1.045 . . . . 0.0 110.422 -179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.06 -39.25 6.04 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.866 -1.146 . . . . 0.0 111.898 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.499 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -90.59 -42.26 10.89 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.342 -1.474 . . . . 0.0 110.411 -179.091 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.11 76.07 1.32 Allowed Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.55 ' CG ' ' CE2' ' A' ' 35' ' ' TYR . 2.8 tp10 -176.61 163.1 2.33 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.941 -1.329 . . . . 0.0 108.844 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.623 ' SG ' HG21 ' A' ' 9' ' ' ILE . 3.5 m -48.34 114.28 0.92 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.033 -1.042 . . . . 0.0 109.218 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.633 HD23 ' HA ' ' A' ' 18' ' ' ASN . 12.5 tp -122.43 12.69 10.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.405 -0.809 . . . . 0.0 109.223 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.438 ' HG3' ' C ' ' A' ' 25' ' ' LEU . 10.4 mttm -154.02 67.21 0.73 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.178 -0.951 . . . . 0.0 109.325 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 36.9 m -53.09 149.6 6.63 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 120.806 -1.184 . . . . 0.0 108.559 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.779 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -104.13 -62.87 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.065 -1.022 . . . . 0.0 112.481 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.933 ' O ' HG23 ' A' ' 31' ' ' THR . 69.5 m-85 -69.7 73.07 0.38 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.506 ' C ' ' O ' ' A' ' 29' ' ' TYR . 8.1 m-20 27.48 59.13 0.1 Allowed 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.615 -0.678 . . . . 0.0 111.056 177.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.933 HG23 ' O ' ' A' ' 29' ' ' TYR . 30.8 p -121.74 152.38 39.5 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.43 -168.7 1.63 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.049 -1.032 . . . . 0.0 110.387 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.95 23.38 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -56.58 -30.5 63.24 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -1.112 . . . . 0.0 109.913 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.55 ' CE2' ' CG ' ' A' ' 23' ' ' GLU . 64.5 m-85 -114.55 31.88 6.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.796 -1.19 . . . . 0.0 109.333 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.8 m 49.64 41.21 21.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 108.979 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -95.68 8.52 43.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.386 -0.821 . . . . 0.0 109.931 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.36 -173.76 3.15 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.003 -1.061 . . . . 0.0 109.672 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 m -119.64 137.57 53.79 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tttp -55.82 146.73 20.84 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.65 -1.281 . . . . 0.0 109.791 -178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -62.31 129.0 38.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.583 -0.698 . . . . 0.0 109.249 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.85 2.76 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 106.221 -2.752 . . . . 0.0 106.221 -178.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.66 129.96 46.56 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 122.102 0.953 . . . . 0.0 108.658 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -113.01 -173.95 2.35 Favored 'General case' 0 C--N 1.282 -2.335 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 135.65 -142.18 13.47 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.497 -1.335 . . . . 0.0 109.992 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.6 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 48.8 m-20 -129.08 103.72 18.42 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.536 -0.979 . . . . 0.0 109.173 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 31' ' ' THR . 33.3 Cg_endo -73.4 -5.95 18.0 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 121.806 1.671 . . . . 0.0 110.283 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.5 OUTLIER -109.86 38.65 2.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.341 -0.849 . . . . 0.0 108.867 178.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.411 ' HB1' ' HD2' ' A' ' 50' ' ' PRO . . . -93.4 158.11 37.53 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.376 -0.828 . . . . 0.0 109.111 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.411 ' HD2' ' HB1' ' A' ' 49' ' ' ALA . 33.7 Cg_endo -75.37 -15.76 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.288 1.992 . . . . 0.0 109.986 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.455 ' CB ' ' HB2' ' A' ' 54' ' ' ASP . 2.6 m-20 -100.45 135.24 20.26 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.384 -0.822 . . . . 0.0 108.958 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.29 -19.22 17.47 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.244 1.962 . . . . 0.0 110.782 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.27 -1.0 25.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.884 -1.135 . . . . 0.0 109.623 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 51' ' ' ASN . 1.8 m-20 -107.76 -3.42 19.11 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.16 -0.962 . . . . 0.0 109.741 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 12.8 mttp -59.27 -105.97 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.218 -0.926 . . . . 0.0 110.312 -178.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.553 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 73.7 m -75.21 177.39 6.52 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.709 -1.244 . . . . 0.0 108.592 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 0.3 OUTLIER 163.63 153.19 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.202 -0.936 . . . . 0.0 109.79 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.022 -0.99 . . . . 0.0 109.454 179.889 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.492 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.3 Cg_endo -77.23 135.06 14.81 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.452 2.102 . . . . 0.0 110.692 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 17' ' ' CYS . 5.6 m 61.78 -178.06 0.12 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.37 -0.831 . . . . 0.0 110.099 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 3' ' ' CYS . 7.5 tt0 179.76 127.92 0.08 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.524 -0.735 . . . . 0.0 109.09 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.436 ' O ' ' CG ' ' A' ' 6' ' ' ASN . 1.5 t -145.09 174.59 10.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.084 -1.01 . . . . 0.0 109.86 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 55.2 m-80 -164.59 -165.35 0.92 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.434 -0.791 . . . . 0.0 109.195 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 56.9 m-20 66.4 -84.07 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.53 -0.731 . . . . 0.0 110.608 179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.947 ' HA ' HD11 ' A' ' 28' ' ' ILE . 2.3 m120 -115.73 63.45 0.69 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.904 -1.123 . . . . 0.0 110.959 -178.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.528 ' C ' HG12 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -142.47 173.19 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.46 -0.775 . . . . 0.0 109.074 178.091 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.665 ' CG ' HG21 ' A' ' 28' ' ' ILE . 6.9 m-20 -107.8 128.56 25.6 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 120.973 -1.079 . . . . 0.0 109.845 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.94 -1.03 11.16 Favored 'Trans proline' 0 C--N 1.316 -1.166 0 C-N-CA 122.723 2.282 . . . . 0.0 110.972 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -77.64 -68.82 0.59 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.369 -0.832 . . . . 0.0 109.381 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -54.43 161.7 1.33 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.894 -1.129 . . . . 0.0 108.694 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.7 116.51 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.055 -1.028 . . . . 0.0 109.971 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 108.55 -40.35 2.57 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.446 ' C ' ' O ' ' A' ' 15' ' ' GLY . 2.7 m-80 38.85 28.43 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.506 -0.997 . . . . 0.0 110.152 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 15' ' ' GLY . 15.5 p -124.98 172.5 9.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.772 -1.205 . . . . 0.0 110.691 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.65 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -68.61 126.36 29.44 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -20.48 54.23 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.803 -1.186 . . . . 0.0 110.71 -179.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -109.08 -42.68 4.36 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.812 -1.18 . . . . 0.0 111.924 -178.769 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.469 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -82.81 -32.94 27.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.436 -1.415 . . . . 0.0 110.228 -178.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.469 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 76.22 67.31 1.71 Allowed Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.106 -1.598 . . . . 0.0 109.106 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.604 ' HB3' ' CE1' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -160.69 158.95 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.088 -1.243 . . . . 0.0 108.978 -179.28 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.571 ' SG ' ' CE2' ' A' ' 35' ' ' TYR . 72.4 m -48.45 111.54 0.47 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.074 -1.016 . . . . 0.0 108.88 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD23 ' HA ' ' A' ' 18' ' ' ASN . 37.7 tp -126.8 9.47 6.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.315 -0.866 . . . . 0.0 110.248 -178.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.43 ' HD2' ' C ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -126.1 60.76 1.29 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.614 -1.304 . . . . 0.0 111.561 -179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.478 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 67.2 m -56.34 146.37 24.26 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.549 -1.344 . . . . 0.0 107.741 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.947 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -110.02 -62.13 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.629 -1.294 . . . . 0.0 112.813 -178.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.805 ' H ' HD12 ' A' ' 28' ' ' ILE . 60.2 m-85 -72.59 69.54 0.88 Allowed 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.27 -0.894 . . . . 0.0 112.69 -177.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.48 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.2 OUTLIER 33.63 63.79 0.36 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.348 -0.845 . . . . 0.0 110.431 177.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.535 HG22 ' SG ' ' A' ' 56' ' ' CYS . 3.3 p -122.1 158.82 28.44 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 119.773 -0.771 . . . . 0.0 109.219 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -118.32 -173.4 2.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.975 -179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.61 147.9 11.68 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.604 ' CE1' ' HB3' ' A' ' 23' ' ' GLU . 0.3 OUTLIER -54.03 -33.93 58.63 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.387 -1.066 . . . . 0.0 109.816 -179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.571 ' CE2' ' SG ' ' A' ' 24' ' ' CYS . 3.7 m-85 -116.28 36.91 3.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.91 -1.119 . . . . 0.0 109.454 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 5.3 m 52.99 50.54 17.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.114 -0.991 . . . . 0.0 108.804 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 36.6 m-20 -92.99 -6.32 48.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.46 -0.775 . . . . 0.0 110.013 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.471 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.28 -167.64 1.85 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.053 -1.03 . . . . 0.0 110.09 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.476 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 6.2 m -121.6 137.36 54.77 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -55.4 149.28 13.5 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.556 -1.34 . . . . 0.0 109.661 -178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.55 126.67 28.56 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.623 -0.673 . . . . 0.0 109.647 -179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.45 -33.22 4.22 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 106.88 -2.488 . . . . 0.0 106.88 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.553 ' HB3' ' CA ' ' A' ' 57' ' ' LYS . 25.4 m-85 -127.92 129.86 47.53 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-O 122.159 0.98 . . . . 0.0 109.076 177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -112.14 178.62 4.25 Favored 'General case' 0 C--N 1.284 -2.265 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.61 -144.52 14.89 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.561 -1.304 . . . . 0.0 110.336 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.622 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 2.4 m120 -132.66 105.28 12.97 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.675 -0.897 . . . . 0.0 108.947 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -71.72 0.78 6.5 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 121.985 1.79 . . . . 0.0 111.305 -178.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.47 ' HA ' HD22 ' A' ' 48' ' ' LEU . 0.2 OUTLIER -116.38 41.51 2.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.03 -1.044 . . . . 0.0 109.18 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -110.2 157.36 38.22 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.173 -0.955 . . . . 0.0 109.247 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.93 -13.72 17.39 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.335 2.023 . . . . 0.0 110.422 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.46 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 3.3 m120 -100.55 132.5 22.27 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.275 -0.89 . . . . 0.0 109.528 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.7 -20.18 13.83 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.145 1.896 . . . . 0.0 110.638 179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.36 -8.43 45.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.998 -1.064 . . . . 0.0 109.623 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.46 ' HB2' ' HB2' ' A' ' 51' ' ' ASN . 46.2 m-20 -105.69 -15.35 14.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.708 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 7.4 mtmm -59.3 -105.61 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.094 -1.004 . . . . 0.0 109.933 -179.36 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.536 ' O ' ' CG ' ' A' ' 57' ' ' LYS . 85.6 m -93.93 144.89 25.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.815 -1.178 . . . . 0.0 108.79 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER 170.36 172.19 0.06 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.303 -0.873 . . . . 0.0 109.298 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.504 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.34 -179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 4' ' ' GLN . 36.2 Cg_endo -75.41 -94.79 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.274 1.983 . . . . 0.0 110.003 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.467 ' C ' ' O ' ' A' ' 2' ' ' PRO . 24.5 t 35.46 -91.89 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.589 -0.694 . . . . 0.0 110.536 179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' N ' ' O ' ' A' ' 2' ' ' PRO . 5.8 tt0 -40.03 116.35 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.389 -0.82 . . . . 0.0 110.068 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' O ' ' A' ' 6' ' ' ASN . 21.2 p -110.59 -143.87 0.39 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.455 -0.778 . . . . 0.0 108.956 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.471 ' O ' ' O ' ' A' ' 5' ' ' CYS . 2.6 m120 -52.09 -176.22 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.1 -1.0 . . . . 0.0 109.083 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.0 70.62 5.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.003 -1.061 . . . . 0.0 110.65 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 77.2 m-20 -144.88 63.66 1.3 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.887 -1.133 . . . . 0.0 109.804 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.578 ' HA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pt -149.96 150.32 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.171 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.531 ' N ' ' OD1' ' A' ' 16' ' ' ASN . 1.4 m-20 -108.39 120.08 47.63 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.25 -0.906 . . . . 0.0 109.242 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -74.54 -3.79 14.41 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 C-N-CA 122.551 2.167 . . . . 0.0 111.046 -179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -78.29 -67.75 0.71 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 121.462 -0.774 . . . . 0.0 109.488 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.76 179.22 0.27 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.93 -1.106 . . . . 0.0 109.402 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 29.7 t -116.09 149.27 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.19 -0.944 . . . . 0.0 109.465 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.488 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 109.54 -12.8 33.01 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 10' ' ' ASP . 0.9 OUTLIER -38.22 -29.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.227 -1.161 . . . . 0.0 110.474 -179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.488 ' N ' ' O ' ' A' ' 15' ' ' GLY . 6.3 t -123.88 156.12 36.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.228 -0.92 . . . . 0.0 108.937 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.3 OUTLIER -81.08 119.21 23.26 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.161 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -18.27 63.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.186 -0.946 . . . . 0.0 110.824 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.503 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -105.92 -40.6 5.65 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.818 -1.176 . . . . 0.0 111.817 -178.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.476 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 1.9 p -91.34 -33.54 15.26 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.424 -1.423 . . . . 0.0 110.667 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 82.69 70.24 1.36 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 4.3 tp10 -163.41 167.98 20.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.042 -1.27 . . . . 0.0 108.682 -179.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 62.2 m -64.44 107.13 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.487 -1.383 . . . . 0.0 109.425 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.522 ' HG ' ' CG ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.75 14.8 25.67 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.233 -0.917 . . . . 0.0 109.646 -179.543 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -165.04 70.81 0.16 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.703 -1.248 . . . . 0.0 111.422 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 75.2 m -54.78 148.61 12.65 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.303 -1.498 . . . . 0.0 108.293 178.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.578 HG12 ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -105.47 -63.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.794 -1.191 . . . . 0.0 112.82 -178.628 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.038 ' O ' HG23 ' A' ' 31' ' ' THR . 99.4 m-85 -57.17 82.86 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 0.0 112.159 -176.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.509 ' C ' ' O ' ' A' ' 29' ' ' TYR . 62.2 m-80 21.2 49.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.948 0 CA-C-O 121.356 0.598 . . . . 0.0 111.341 178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.038 HG23 ' O ' ' A' ' 29' ' ' TYR . 26.6 p -122.86 155.21 37.09 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.364 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.686 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -125.01 -162.47 1.1 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.321 -0.862 . . . . 0.0 109.564 -179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 83.19 146.39 6.58 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.734 -1.346 . . . . 0.0 109.734 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -50.99 -30.02 13.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.478 -1.013 . . . . 0.0 109.828 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -121.98 41.32 3.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.75 -1.219 . . . . 0.0 109.838 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.478 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 3.6 m 50.6 29.74 4.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.091 -1.005 . . . . 0.0 109.573 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.625 ' HA ' HD21 ' A' ' 48' ' ' LEU . 9.7 p30 -90.23 10.73 23.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.686 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.48 -167.44 1.83 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.256 -0.903 . . . . 0.0 109.167 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.473 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 23.0 m -121.84 128.8 52.05 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 46.7 tttm -57.0 143.45 38.05 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.889 -1.132 . . . . 0.0 109.234 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -59.61 126.26 26.91 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.0 109.462 -179.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.88 -31.65 4.68 Favored Glycine 0 N--CA 1.485 1.941 0 N-CA-C 107.26 -2.336 . . . . 0.0 107.26 -178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.617 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -134.23 128.39 33.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 122.195 0.998 . . . . 0.0 109.428 177.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.489 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 4.8 m-85 -108.2 -179.38 3.87 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.76 -142.21 13.63 Favored Glycine 0 N--CA 1.491 2.306 0 C-N-CA 119.373 -1.394 . . . . 0.0 109.997 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 58.8 m-80 -128.56 105.07 19.17 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.614 -0.933 . . . . 0.0 109.121 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.709 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.7 Cg_endo -80.34 -4.81 13.27 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.406 2.071 . . . . 0.0 110.357 -179.118 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 37' ' ' ASP . 70.2 mt -110.08 38.48 2.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.319 -0.863 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.74 156.21 36.3 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.925 . . . . 0.0 109.133 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.67 -24.07 13.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.201 1.934 . . . . 0.0 109.277 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.2 135.56 19.88 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.81 -18.99 16.62 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.193 1.928 . . . . 0.0 110.29 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.93 -17.66 60.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.084 -1.01 . . . . 0.0 109.419 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 55' ' ' LYS . 96.9 m-20 -105.03 11.91 32.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.0 109.198 179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.532 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.5 OUTLIER -63.41 -139.7 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.397 -0.814 . . . . 0.0 109.324 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 14.1 m -99.69 104.33 16.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.866 -1.146 . . . . 0.0 108.913 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 9.7 mtmt -109.1 -172.88 2.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.014 -0.993 . . . . 0.0 109.484 179.927 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 31.7 mtt-85 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.37 2.7 7.83 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.655 2.236 . . . . 0.0 110.567 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 36.9 t -148.86 141.29 24.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.149 -0.97 . . . . 0.0 109.562 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.03 140.12 1.18 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.38 -0.825 . . . . 0.0 109.026 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.7 129.27 22.75 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.138 -0.976 . . . . 0.0 109.865 -179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -78.24 81.32 4.61 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.277 -0.889 . . . . 0.0 109.086 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -152.59 -134.92 0.06 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.499 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.756 ' OD1' HG21 ' A' ' 31' ' ' THR . 15.6 m120 -89.42 76.14 7.54 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.964 -1.085 . . . . 0.0 110.066 -179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.3 pp -141.73 167.01 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.319 -0.863 . . . . 0.0 108.877 178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.561 ' OD1' HG23 ' A' ' 28' ' ' ILE . 0.0 OUTLIER -105.12 135.35 19.32 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.365 -0.834 . . . . 0.0 109.156 179.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.43 -25.22 9.92 Favored 'Trans proline' 0 C--N 1.313 -1.334 0 C-N-CA 122.362 2.042 . . . . 0.0 110.498 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -77.32 -10.58 59.53 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.164 -0.96 . . . . 0.0 111.086 -179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -78.83 -165.8 0.79 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.286 -1.509 . . . . 0.0 109.017 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 97.3 t -111.63 83.09 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 110.288 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 81.92 -19.69 9.34 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.999 -1.096 . . . . 0.0 110.798 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 1.3 m-80 45.12 25.51 0.18 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.779 -1.424 . . . . 0.0 109.214 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 34.1 m -123.0 175.94 6.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.079 -1.013 . . . . 0.0 109.158 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.544 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.91 123.38 31.19 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -61.84 -10.92 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.159 -0.963 . . . . 0.0 110.963 -178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.9 pt? -110.33 -41.05 4.48 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.7 -1.25 . . . . 0.0 111.986 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.584 ' N ' ' HG ' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -90.12 -33.01 16.42 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.292 -1.505 . . . . 0.0 110.132 -179.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.3 70.99 1.33 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.5 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER -166.35 145.87 5.91 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.957 -1.32 . . . . 0.0 109.384 -179.784 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . . . . . . . . . 1.3 m -58.25 107.77 0.53 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.519 -0.738 . . . . 0.0 109.54 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.36 44.28 2.95 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.291 -0.881 . . . . 0.0 110.534 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.3 tptp -148.72 60.07 1.07 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.43 -0.794 . . . . 0.0 108.895 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 92.1 m -54.15 150.03 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.18 -0.95 . . . . 0.0 109.87 -179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.602 HG12 ' CA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -108.82 -62.05 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.279 -0.888 . . . . 0.0 111.92 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.471 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 8.8 m-30 -75.24 65.62 1.61 Allowed 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.647 -0.658 . . . . 0.0 112.378 -177.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.43 ' C ' ' O ' ' A' ' 29' ' ' TYR . 17.3 m120 38.47 62.07 1.06 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.048 -1.033 . . . . 0.0 110.924 178.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.756 HG21 ' OD1' ' A' ' 8' ' ' ASN . 0.8 OUTLIER -125.74 156.79 38.85 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.284 179.034 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.714 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -122.98 -164.99 1.25 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.21 -0.931 . . . . 0.0 109.954 -179.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.12 150.38 22.28 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -52.58 -32.96 43.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.383 -1.069 . . . . 0.0 109.712 -179.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.497 ' OH ' ' HG2' ' A' ' 23' ' ' GLU . 27.5 m-85 -121.47 38.58 4.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.777 -1.202 . . . . 0.0 109.557 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 60.4 m 55.72 33.3 21.11 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.123 -0.986 . . . . 0.0 109.547 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.81 13.77 13.6 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.297 -0.877 . . . . 0.0 109.443 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.714 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 2.9 ttt180 -131.31 -178.08 4.69 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.285 -0.884 . . . . 0.0 109.159 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 64.1 m -125.49 129.79 50.49 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -56.99 143.43 38.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.696 -1.252 . . . . 0.0 109.729 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.11 136.3 57.88 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.452 -0.78 . . . . 0.0 109.274 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.27 -39.85 2.2 Favored Glycine 0 N--CA 1.486 2.001 0 N-CA-C 106.25 -2.74 . . . . 0.0 106.25 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.454 ' HB3' ' O ' ' A' ' 56' ' ' CYS . 8.9 m-85 -120.55 130.98 54.46 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' CD1' ' N ' ' A' ' 44' ' ' PHE . 0.1 OUTLIER -109.61 175.57 5.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 130.69 -140.79 12.06 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.51 -1.329 . . . . 0.0 110.266 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.621 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 6.8 m-80 -134.01 123.23 16.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.672 -0.899 . . . . 0.0 109.091 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.582 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -77.28 -8.31 17.38 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 121.742 1.628 . . . . 0.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.9 tp -111.08 38.59 2.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.085 -1.009 . . . . 0.0 109.886 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -98.41 151.0 37.28 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.48 -25.23 13.2 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.272 1.981 . . . . 0.0 109.56 179.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -100.92 134.44 20.44 Favored Pre-proline 0 N--CA 1.488 1.464 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.452 ' O ' ' HE3' ' A' ' 57' ' ' LYS . 33.7 Cg_endo -75.75 -17.16 18.17 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 121.996 1.797 . . . . 0.0 110.169 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.51 -13.44 54.59 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.012 -1.055 . . . . 0.0 109.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -114.64 11.03 16.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.373 -0.829 . . . . 0.0 109.434 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 6.5 ttmm -77.57 -129.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.143 -0.973 . . . . 0.0 109.189 -179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 3.9 m -91.61 81.81 5.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.663 -1.273 . . . . 0.0 108.308 179.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.495 ' HE3' ' HB3' ' A' ' 55' ' ' LYS . 0.0 OUTLIER -114.74 167.29 10.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.04 -1.038 . . . . 0.0 109.76 -179.343 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.955 -1.021 . . . . 0.0 109.433 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.59 176.25 10.11 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.689 2.259 . . . . 0.0 111.034 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.446 ' C ' ' HG3' ' A' ' 4' ' ' GLN . 8.8 p -115.42 90.74 3.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.348 -0.845 . . . . 0.0 109.204 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.446 ' HG3' ' C ' ' A' ' 3' ' ' CYS . 86.0 mt-30 -155.08 117.07 4.15 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.176 -0.953 . . . . 0.0 109.915 -179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.2 m -69.35 -135.47 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -56.96 -174.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.581 -1.324 . . . . 0.0 108.344 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -83.68 67.61 9.54 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.864 -1.148 . . . . 0.0 110.608 -179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.432 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 5.6 m-20 -138.22 57.97 1.69 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.78 -1.2 . . . . 0.0 110.145 179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.58 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.1 pp -150.32 154.88 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.214 -0.929 . . . . 0.0 109.162 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.745 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.8 OUTLIER -108.39 129.14 24.42 Favored Pre-proline 0 C--N 1.3 -1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.01 -4.48 14.93 Favored 'Trans proline' 0 C--N 1.314 -1.283 0 C-N-CA 122.517 2.144 . . . . 0.0 110.906 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -78.57 -72.15 0.39 Allowed 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.315 -0.865 . . . . 0.0 109.813 -179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . -57.08 161.23 3.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.073 -1.017 . . . . 0.0 109.539 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.3 t -106.15 141.75 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.286 -0.884 . . . . 0.0 109.475 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' O ' ' C ' ' A' ' 16' ' ' ASN . . . 107.56 -11.2 39.04 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.484 ' ND2' ' O ' ' A' ' 13' ' ' ALA . 34.1 m-80 -40.75 -32.4 0.22 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -1.177 . . . . 0.0 110.047 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 15.8 p -122.57 125.87 46.58 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.0 -1.062 . . . . 0.0 110.217 -179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.884 ' ND2' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -100.82 118.75 37.52 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.438 -0.789 . . . . 0.0 112.101 -179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.589 ' HG3' HD23 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -80.9 -24.38 38.31 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.38 -0.825 . . . . 0.0 109.525 178.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.589 HD23 ' HG3' ' A' ' 19' ' ' ARG . 0.2 OUTLIER -92.35 -38.37 12.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.059 -1.026 . . . . 0.0 110.486 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.54 ' OG1' ' HB3' ' A' ' 18' ' ' ASN . 15.7 p -85.54 7.25 23.72 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.838 -1.164 . . . . 0.0 108.622 179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . 123.6 -79.93 0.35 Allowed Glycine 0 N--CA 1.487 2.049 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.3 OUTLIER 177.62 -40.9 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.29 -1.712 . . . . 0.0 111.27 -179.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -97.22 119.49 35.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.127 -1.608 . . . . 0.0 107.243 178.879 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.884 HD12 ' ND2' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -119.57 -13.07 9.22 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.637 -1.225 . . . . 0.0 111.88 -177.064 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 23.2 mtpt -156.82 77.48 0.89 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.491 -1.381 . . . . 0.0 111.03 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.473 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 62.8 m -53.74 145.94 14.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.468 -1.395 . . . . 0.0 108.17 178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.745 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -96.97 -63.84 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 120.882 -1.136 . . . . 0.0 112.397 -178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.048 ' O ' HG23 ' A' ' 31' ' ' THR . 22.9 m-85 -57.85 81.52 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 121.287 0.565 . . . . 0.0 112.386 -176.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.504 ' C ' ' O ' ' A' ' 29' ' ' TYR . 11.4 m-20 20.62 50.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.477 0.656 . . . . 0.0 111.796 178.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.048 HG23 ' O ' ' A' ' 29' ' ' TYR . 34.5 p -120.37 149.64 42.02 Favored 'General case' 0 C--N 1.293 -1.875 0 C-N-CA 119.314 -0.954 . . . . 0.0 109.41 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -119.48 -175.47 2.95 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.247 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 89.4 150.43 22.77 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.791 -1.724 . . . . 0.0 108.791 -179.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.506 ' CZ ' ' O ' ' A' ' 21' ' ' THR . 22.1 t80 -57.0 -28.58 62.58 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.114 -1.227 . . . . 0.0 110.177 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -116.42 26.83 9.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.682 -1.261 . . . . 0.0 109.967 -179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.3 m 52.52 54.27 10.91 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.129 -0.982 . . . . 0.0 108.914 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.45 -8.71 31.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 0.0 110.262 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.51 -172.61 2.85 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 120.919 -1.113 . . . . 0.0 109.356 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 56' ' ' CYS . 22.3 m -117.8 134.99 54.36 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.77 152.01 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.384 -1.447 . . . . 0.0 109.147 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.58 124.28 19.58 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.385 -0.822 . . . . 0.0 109.406 -179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.22 -34.57 3.79 Favored Glycine 0 N--CA 1.483 1.833 0 N-CA-C 106.688 -2.565 . . . . 0.0 106.688 -178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -126.12 128.76 47.84 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 122.197 0.998 . . . . 0.0 108.984 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.467 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.6 OUTLIER -123.43 -179.35 4.3 Favored 'General case' 0 C--N 1.282 -2.355 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.555 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.37 -142.47 12.47 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.87 -1.292 . . . . 0.0 109.87 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 5.8 m120 -130.85 103.24 15.87 Favored Pre-proline 0 N--CA 1.495 1.782 0 O-C-N 121.554 -0.968 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.521 ' HA ' ' HD2' ' A' ' 55' ' ' LYS . 36.6 Cg_endo -79.18 -1.56 11.66 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.278 1.985 . . . . 0.0 110.311 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.35 37.99 2.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.228 -0.92 . . . . 0.0 109.326 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.84 156.38 42.69 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.843 . . . . 0.0 109.129 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.06 -20.75 12.71 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.272 1.981 . . . . 0.0 109.522 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.1 m120 -100.45 131.18 24.26 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.31 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.3 -18.62 15.88 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.268 1.979 . . . . 0.0 110.452 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.66 -21.63 59.33 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.979 -1.075 . . . . 0.0 109.498 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -105.16 13.81 30.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.152 -0.968 . . . . 0.0 109.401 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' HD2' ' HA ' ' A' ' 47' ' ' PRO . 0.1 OUTLIER -67.58 -137.34 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.321 -0.862 . . . . 0.0 109.462 -179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 56.8 m -99.36 105.34 17.3 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.766 -1.209 . . . . 0.0 109.479 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 6.4 mttp -115.95 -156.46 0.61 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.094 -1.004 . . . . 0.0 109.482 -179.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.66 104.69 1.85 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.545 2.163 . . . . 0.0 110.296 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 10.8 t -80.1 100.41 8.2 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.264 -0.897 . . . . 0.0 109.619 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -55.12 114.33 1.72 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.866 . . . . 0.0 109.479 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 49.8 t -178.07 154.45 0.87 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.236 -0.915 . . . . 0.0 109.425 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.563 ' HA ' HD11 ' A' ' 9' ' ' ILE . 68.6 m-80 -144.58 -154.78 0.55 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.941 . . . . 0.0 109.239 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 3.8 m-20 82.51 -134.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.467 -0.77 . . . . 0.0 109.575 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.901 ' OD1' HG21 ' A' ' 31' ' ' THR . 9.1 m-80 -89.35 72.32 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.913 -1.117 . . . . 0.0 110.257 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.98 HG21 ' SG ' ' A' ' 24' ' ' CYS . 0.9 OUTLIER -142.89 148.76 19.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 178.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.547 ' OD2' HG21 ' A' ' 28' ' ' ILE . 19.9 m-20 -114.88 154.9 46.95 Favored Pre-proline 0 N--CA 1.494 1.746 0 O-C-N 120.977 -1.077 . . . . 0.0 110.575 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -77.76 -19.67 12.51 Favored 'Trans proline' 0 C--N 1.312 -1.386 0 C-N-CA 122.5 2.133 . . . . 0.0 110.095 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . 30.1 m120 -77.66 -32.99 53.58 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.374 -0.829 . . . . 0.0 112.021 -178.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' O ' ' A' ' 12' ' ' ASN . . . -54.56 -169.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.164 -1.585 . . . . 0.0 109.375 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 85.3 t -103.76 79.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.987 -1.071 . . . . 0.0 110.155 -179.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . 88.05 -32.51 4.32 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.489 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 7.4 m-80 64.4 1.85 1.4 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.354 -1.086 . . . . 0.0 110.916 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.552 ' HA ' HD12 ' A' ' 25' ' ' LEU . 5.6 m -123.68 179.48 4.77 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.541 -1.349 . . . . 0.0 109.862 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.538 ' ND2' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -92.34 131.09 37.81 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 179.208 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 2.5 ttt180 -68.89 -24.94 64.38 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.669 -1.269 . . . . 0.0 110.426 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.402 ' H ' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -96.63 -36.53 10.68 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.921 -1.112 . . . . 0.0 111.23 -178.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.414 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -90.48 -39.1 12.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.748 -1.22 . . . . 0.0 110.098 -179.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.72 70.73 1.34 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 2.5 tp10 -171.54 157.26 4.73 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.981 -1.305 . . . . 0.0 109.332 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.98 ' SG ' HG21 ' A' ' 9' ' ' ILE . 0.9 OUTLIER -63.04 111.53 2.22 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.744 -0.598 . . . . 0.0 110.202 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.961 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -128.89 39.42 3.79 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.107 -0.996 . . . . 0.0 110.791 178.971 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.5 tttm -149.8 67.83 1.0 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.204 -0.935 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.497 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 75.4 m -53.92 146.93 13.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.879 -1.138 . . . . 0.0 109.839 -179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.547 HG21 ' OD2' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -103.54 -61.82 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.277 -0.89 . . . . 0.0 111.88 -179.524 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.582 ' CD2' ' HD3' ' A' ' 55' ' ' LYS . 42.1 m-85 -77.54 63.62 2.7 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.52 -0.737 . . . . 0.0 112.292 -177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 29' ' ' TYR . 69.5 m-80 39.06 60.84 1.38 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.12 -0.987 . . . . 0.0 110.839 178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.901 HG21 ' OD1' ' A' ' 8' ' ' ASN . 35.8 p -123.17 148.1 46.13 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.221 -0.924 . . . . 0.0 108.956 178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -112.66 -165.79 1.02 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 110.154 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.24 147.92 18.9 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.4 ' CD1' ' O ' ' A' ' 34' ' ' PHE . 1.2 t80 -53.55 -29.9 39.21 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.356 -1.085 . . . . 0.0 109.779 -179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.555 ' CE2' ' HG3' ' A' ' 23' ' ' GLU . 85.4 m-85 -120.62 37.53 4.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.972 -1.08 . . . . 0.0 109.538 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.549 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 46.2 m 49.42 52.94 13.55 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.16 -0.962 . . . . 0.0 109.161 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -103.52 0.79 31.45 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.238 -0.913 . . . . 0.0 110.463 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -131.27 -173.7 3.18 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 120.802 -1.186 . . . . 0.0 109.143 -179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 64.8 m -111.94 126.62 55.32 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.6 ttmt -57.42 151.89 15.53 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.807 -1.183 . . . . 0.0 109.763 -179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -59.85 125.37 23.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -0.843 . . . . 0.0 109.14 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.8 -32.52 4.4 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 106.909 -2.476 . . . . 0.0 106.909 -178.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.485 ' O ' ' HB3' ' A' ' 39' ' ' CYS . 0.5 OUTLIER -129.51 129.0 43.97 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 122.325 1.06 . . . . 0.0 109.178 177.601 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 57' ' ' LYS . 0.1 OUTLIER -114.58 174.34 6.01 Favored 'General case' 0 C--N 1.283 -2.306 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 133.53 -144.05 15.9 Favored Glycine 0 N--CA 1.489 2.221 0 C-N-CA 119.382 -1.389 . . . . 0.0 109.962 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.559 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 45.7 m-20 -130.06 112.47 17.17 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.573 -0.957 . . . . 0.0 109.353 -179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 35.0 Cg_endo -75.88 -3.07 13.37 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.128 1.885 . . . . 0.0 110.786 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mt -115.49 40.68 2.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.477 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -104.0 153.43 38.85 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.091 -1.005 . . . . 0.0 109.197 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.51 -27.66 9.03 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.083 1.855 . . . . 0.0 109.285 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -101.22 137.6 19.73 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.497 -0.752 . . . . 0.0 109.0 179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.69 -17.17 18.28 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.142 1.895 . . . . 0.0 110.326 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.9 -24.74 58.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.021 -1.049 . . . . 0.0 109.16 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.23 27.28 9.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.307 -0.87 . . . . 0.0 109.181 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HD3' ' CD2' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -83.38 -143.49 0.07 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.231 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 95.2 m -91.95 83.33 5.18 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.455 ' N ' ' O ' ' A' ' 44' ' ' PHE . 17.2 mtpt -115.37 170.56 8.31 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.173 -0.954 . . . . 0.0 110.008 -179.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.65 -179.859 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.473 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.4 Cg_endo -76.29 175.31 11.51 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.496 2.131 . . . . 0.0 110.285 179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 33.6 t -64.01 91.94 0.07 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.69 94.03 3.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' O ' HG12 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -113.02 85.78 2.24 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.06 -1.025 . . . . 0.0 109.494 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.516 ' O ' ' N ' ' A' ' 8' ' ' ASN . 68.7 m-80 -35.88 -97.88 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.585 -0.697 . . . . 0.0 110.704 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' ASN . 12.5 m-20 42.27 -94.45 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.947 -1.095 . . . . 0.0 110.139 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.757 ' CG ' HG21 ' A' ' 31' ' ' THR . 4.2 m120 -144.23 68.22 1.26 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.016 -1.052 . . . . 0.0 110.184 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.745 HG21 ' SG ' ' A' ' 24' ' ' CYS . 2.7 pp -142.5 163.93 17.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 178.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.756 ' OD1' HG21 ' A' ' 28' ' ' ILE . 90.3 m-20 -105.96 109.83 63.52 Favored Pre-proline 0 C--N 1.297 -1.703 0 O-C-N 121.258 -0.901 . . . . 0.0 108.981 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.4 -5.74 15.83 Favored 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 122.851 2.367 . . . . 0.0 111.18 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -78.26 -70.77 0.47 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.257 -0.902 . . . . 0.0 109.079 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.74 160.62 13.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 109.147 179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.2 t -104.13 151.69 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.058 -1.026 . . . . 0.0 109.35 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.53 -2.69 32.52 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.44 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 11.2 m-80 -60.34 -5.92 1.33 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.877 -1.366 . . . . 0.0 111.189 -179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.522 ' HA ' HD12 ' A' ' 25' ' ' LEU . 79.8 m -121.66 177.39 5.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.584 -1.323 . . . . 0.0 109.203 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.615 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -93.01 133.17 36.42 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.41 -11.24 60.78 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.916 -1.115 . . . . 0.0 111.677 -178.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 21' ' ' THR . 1.7 pp -102.09 -47.99 4.37 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.539 -1.351 . . . . 0.0 110.985 -179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.478 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -91.0 -23.84 20.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.636 -1.29 . . . . 0.0 109.872 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 71.54 61.48 3.85 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 17' ' ' CYS . 0.7 OUTLIER -147.25 156.52 43.01 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.108 -1.23 . . . . 0.0 109.273 -179.842 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.745 ' SG ' HG21 ' A' ' 9' ' ' ILE . 2.1 m -64.43 112.52 3.15 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.321 -0.862 . . . . 0.0 109.59 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.949 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -127.88 41.74 3.45 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.977 -1.077 . . . . 0.0 110.339 179.304 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.89 68.72 0.77 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.449 -0.782 . . . . 0.0 108.979 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 79.7 m -53.72 151.4 6.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.92 -1.113 . . . . 0.0 109.953 -179.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.756 HG21 ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -105.35 -58.74 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.49 -0.757 . . . . 0.0 111.327 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.606 ' CE2' HD12 ' A' ' 28' ' ' ILE . 54.4 m-85 -77.86 47.59 0.64 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.589 -0.695 . . . . 0.0 111.695 -178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 49.07 63.47 2.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.722 -1.236 . . . . 0.0 110.532 178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.757 HG21 ' CG ' ' A' ' 8' ' ' ASN . 0.7 OUTLIER -123.33 158.53 30.84 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.17 -0.956 . . . . 0.0 108.701 179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.749 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -116.35 -163.8 0.93 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.108 -0.995 . . . . 0.0 109.927 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 87.38 147.83 12.92 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.414 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 3.8 t80 -53.95 -32.06 52.57 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.343 -1.092 . . . . 0.0 109.918 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.414 ' CE1' ' HD2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -119.82 38.59 3.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.786 -1.196 . . . . 0.0 109.293 179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 68.6 m 52.88 53.43 12.11 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 109.329 -179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -107.8 7.31 28.18 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.347 -0.845 . . . . 0.0 109.501 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.749 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.79 -167.36 1.82 Allowed 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.207 -0.933 . . . . 0.0 109.745 -179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.474 ' HB3' ' O ' ' A' ' 43' ' ' PHE . 1.6 m -121.26 135.87 55.06 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 11.5 tttm -56.5 145.62 27.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.662 -1.274 . . . . 0.0 109.692 -179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -59.46 124.77 21.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.349 -0.844 . . . . 0.0 109.585 -179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.99 -31.89 4.58 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 107.114 -2.394 . . . . 0.0 107.114 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.495 ' HB3' ' N ' ' A' ' 57' ' ' LYS . 4.3 m-85 -127.28 129.75 48.27 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.302 1.049 . . . . 0.0 109.114 177.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -109.07 175.5 5.44 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.155 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 140.85 -147.21 18.84 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.441 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.582 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 53.7 m-20 -135.67 102.11 10.53 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.527 -0.984 . . . . 0.0 109.844 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.446 ' HG3' ' C ' ' A' ' 38' ' ' ARG . 34.3 Cg_endo -75.1 1.4 7.82 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.13 1.887 . . . . 0.0 110.448 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.471 ' HA ' HD13 ' A' ' 48' ' ' LEU . 0.4 OUTLIER -109.95 39.29 2.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 108.915 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -114.75 156.67 44.61 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.458 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -75.58 -16.34 19.02 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 122.386 2.057 . . . . 0.0 110.121 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -98.23 128.44 33.42 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.815 . . . . 0.0 109.074 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.92 -19.64 15.81 Favored 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 122.192 1.928 . . . . 0.0 110.466 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -90.49 5.78 46.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.061 -1.024 . . . . 0.0 109.412 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -119.68 1.3 11.07 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.271 -0.893 . . . . 0.0 110.095 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 86.8 mttt -69.72 -110.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.987 -1.07 . . . . 0.0 110.358 -179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' O ' ' HG2' ' A' ' 57' ' ' LYS . 13.8 m -99.14 147.52 25.01 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 0.0 109.375 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 56' ' ' CYS . 0.2 OUTLIER -160.22 167.38 27.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.56 -0.712 . . . . 0.0 109.171 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.519 -179.875 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.423 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.469 ' O ' ' C ' ' A' ' 3' ' ' CYS . 36.2 Cg_endo -77.69 -157.23 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.524 2.149 . . . . 0.0 110.561 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.469 ' C ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -36.36 148.55 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.599 -0.688 . . . . 0.0 110.409 -179.846 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.463 ' HG3' HD11 ' A' ' 9' ' ' ILE . 38.0 tt0 -177.97 118.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.868 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -110.72 159.5 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -80.06 85.71 5.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.087 -1.008 . . . . 0.0 109.209 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 7' ' ' ASP . 41.5 p30 -170.93 -140.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.089 -1.007 . . . . 0.0 109.837 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 1.015 ' ND2' HG21 ' A' ' 31' ' ' THR . 12.9 m-20 -96.69 83.01 3.38 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.056 -1.028 . . . . 0.0 110.137 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 1.01 HG21 ' SG ' ' A' ' 24' ' ' CYS . 1.5 pp -149.26 150.36 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.532 -0.73 . . . . 0.0 109.157 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.457 ' O ' ' OD1' ' A' ' 16' ' ' ASN . 5.4 m-20 -107.94 126.9 28.72 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.202 -0.936 . . . . 0.0 109.302 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -75.84 -15.47 18.94 Favored 'Trans proline' 0 C--N 1.314 -1.249 0 C-N-CA 122.365 2.044 . . . . 0.0 110.924 -179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -79.84 -71.48 0.45 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.156 -0.965 . . . . 0.0 109.605 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.09 176.55 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.259 -0.901 . . . . 0.0 109.742 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.534 HG12 ' N ' ' A' ' 15' ' ' GLY . 39.3 t -115.32 163.68 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.307 -0.87 . . . . 0.0 109.351 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.534 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 107.38 -17.57 36.81 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' A' ' 24' ' ' CYS . 11.7 m120 -64.69 -2.56 2.53 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.033 -1.275 . . . . 0.0 111.125 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 3' ' ' CYS . 1.7 t -136.08 142.3 44.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.629 -1.294 . . . . 0.0 108.923 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.585 ' OD1' ' HG ' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -77.43 125.18 28.93 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.951 -1.093 . . . . 0.0 108.23 -179.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.17 -20.61 66.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.152 -0.967 . . . . 0.0 110.29 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -104.41 -42.0 5.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.011 -1.056 . . . . 0.0 111.499 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.463 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -86.31 -39.3 16.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.609 -1.307 . . . . 0.0 110.274 -179.121 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.86 71.11 1.32 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.562 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 1.3 tp10 -174.84 161.97 3.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.988 -1.301 . . . . 0.0 108.734 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 1.01 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.3 m -48.76 124.46 8.5 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.879 -1.138 . . . . 0.0 109.888 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.585 ' HG ' ' OD1' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -123.6 -28.43 3.88 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.09 -1.006 . . . . 0.0 111.613 -178.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -114.1 84.31 2.02 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.52 -1.363 . . . . 0.0 110.952 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 60.9 m -55.37 153.33 7.4 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.637 -1.29 . . . . 0.0 110.039 179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.574 HD12 ' CE1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER -106.66 -66.84 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.035 -1.041 . . . . 0.0 112.421 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.06 ' O ' HG23 ' A' ' 31' ' ' THR . 6.3 m-30 -68.87 75.97 0.31 Allowed 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.55 -0.719 . . . . 0.0 112.895 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.49 ' C ' ' O ' ' A' ' 29' ' ' TYR . 4.3 m-20 29.42 52.24 0.09 Allowed 'General case' 0 N--CA 1.5 2.054 0 CA-C-O 121.435 0.636 . . . . 0.0 111.224 177.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.06 HG23 ' O ' ' A' ' 29' ' ' TYR . 70.0 p -120.9 151.8 39.24 Favored 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.3 -0.875 . . . . 0.0 108.816 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.49 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . . . -119.88 -153.84 0.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.296 -0.877 . . . . 0.0 110.085 -178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 81.46 148.45 6.33 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -59.09 -24.09 62.64 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.36 -1.082 . . . . 0.0 110.256 -179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' O ' ' HB2' ' A' ' 36' ' ' CYS . 55.3 m-85 -114.58 20.87 15.0 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.63 -1.294 . . . . 0.0 110.24 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 8' ' ' ASN . 82.6 m 62.26 29.5 17.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.076 -1.015 . . . . 0.0 109.655 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -103.2 23.95 11.63 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.368 -0.832 . . . . 0.0 109.181 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.49 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.39 -176.67 4.04 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 121.215 -0.928 . . . . 0.0 109.208 179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.66 139.8 53.09 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -55.03 141.45 34.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.469 -1.394 . . . . 0.0 109.47 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -60.53 128.58 37.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.642 -0.661 . . . . 0.0 109.522 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.08 -37.24 2.95 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 106.515 -2.634 . . . . 0.0 106.515 -178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.629 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.0 OUTLIER -128.63 129.57 46.06 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 122.162 0.982 . . . . 0.0 108.756 177.569 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.453 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.9 m-85 -111.07 -179.61 3.78 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 140.17 -139.35 9.76 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.454 -1.355 . . . . 0.0 109.789 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 -124.67 100.43 34.51 Favored Pre-proline 0 C--N 1.297 -1.715 0 O-C-N 121.733 -0.863 . . . . 0.0 109.594 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.614 ' HB3' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -79.68 -8.41 14.68 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.622 2.215 . . . . 0.0 110.65 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 37.88 2.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 109.952 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -108.47 152.66 42.17 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.118 -0.989 . . . . 0.0 109.136 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -74.78 -27.44 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.282 1.988 . . . . 0.0 108.959 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -101.12 134.15 20.54 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.33 -1.04 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.105 1.87 . . . . 0.0 110.451 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.52 -28.01 61.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.738 -1.226 . . . . 0.0 108.661 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.6 31.74 4.52 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.449 ' HB2' ' HE3' ' A' ' 55' ' ' LYS . 6.6 ttmt -73.01 -145.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.691 -0.631 . . . . 0.0 109.919 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.481 ' O ' ' HB3' ' A' ' 43' ' ' PHE . 6.9 m -100.13 94.07 6.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.299 -0.876 . . . . 0.0 109.083 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.8 mtmt -101.33 -167.03 1.37 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.111 -0.993 . . . . 0.0 109.483 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 117.984 -1.007 . . . . 0.0 109.483 -179.887 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.66 -168.06 0.58 Allowed 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.598 2.199 . . . . 0.0 110.44 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.719 ' HB3' HD13 ' A' ' 9' ' ' ILE . 3.8 t -99.8 154.87 17.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.262 -0.899 . . . . 0.0 109.466 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 3' ' ' CYS . 1.8 mt-30 -39.32 -96.74 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.725 -0.609 . . . . 0.0 110.242 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 16.1 p -53.75 125.37 18.18 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.772 -1.205 . . . . 0.0 109.346 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 72.2 m-20 -106.04 -144.2 0.38 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.284 -0.885 . . . . 0.0 109.458 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 21.1 t0 83.21 -72.37 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.423 -0.798 . . . . 0.0 110.545 179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 1.052 ' ND2' HG21 ' A' ' 31' ' ' THR . 4.0 m120 -137.69 70.83 1.39 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.832 -1.167 . . . . 0.0 110.886 -178.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.719 HD13 ' HB3' ' A' ' 3' ' ' CYS . 0.9 OUTLIER -141.92 149.54 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.072 -1.018 . . . . 0.0 109.646 179.172 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.818 ' CG ' HG21 ' A' ' 28' ' ' ILE . 31.5 m-20 -109.39 126.3 29.51 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.262 -0.899 . . . . 0.0 109.909 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.02 -9.16 16.72 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 122.376 2.05 . . . . 0.0 110.636 179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -79.0 -74.2 0.3 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.0 109.811 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 170.15 3.94 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.077 -1.015 . . . . 0.0 109.548 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.7 t -106.71 157.41 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.235 -0.915 . . . . 0.0 109.506 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 25' ' ' LEU . . . 106.48 -31.87 7.86 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.428 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 11.7 m-80 -44.38 -24.74 0.19 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.141 -1.211 . . . . 0.0 109.897 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 3.6 m -127.7 161.77 28.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.116 -0.99 . . . . 0.0 109.293 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.569 ' N ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -95.86 130.04 42.93 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.751 -1.218 . . . . 0.0 108.217 179.176 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -62.73 -34.39 77.07 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 0.0 110.632 -179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.39 -37.48 8.44 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.847 -1.158 . . . . 0.0 111.617 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -85.77 -13.02 49.52 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.618 -1.301 . . . . 0.0 110.168 -179.155 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 50.67 45.59 47.82 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.21 -1.556 . . . . 0.0 109.21 -179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.567 ' O ' ' ND2' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -129.9 170.27 14.14 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.264 -1.139 . . . . 0.0 108.637 -179.71 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.552 ' SG ' HG21 ' A' ' 9' ' ' ILE . 60.1 m -70.06 102.52 2.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.665 -1.272 . . . . 0.0 109.411 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.531 HD23 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -79.11 -11.31 59.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.896 -1.127 . . . . 0.0 110.118 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 2.0 tttt -160.16 95.63 1.16 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.727 -1.233 . . . . 0.0 111.25 -178.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 71.3 m -54.43 153.64 5.36 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.336 -1.477 . . . . 0.0 108.77 178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.818 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -102.53 -59.78 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 O-C-N 120.723 -1.236 . . . . 0.0 112.871 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -75.12 40.1 0.15 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.514 -0.742 . . . . 0.0 112.169 -177.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 36.2 m-20 58.29 68.6 0.81 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.476 -1.39 . . . . 0.0 110.571 178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.052 HG21 ' ND2' ' A' ' 8' ' ' ASN . 36.9 p -133.68 147.48 51.4 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -110.3 -159.02 0.67 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.078 -1.014 . . . . 0.0 110.36 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.16 147.32 10.32 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.478 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 8.8 t80 -50.67 -30.35 13.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.497 -1.002 . . . . 0.0 109.764 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.7 m-85 -124.12 43.4 3.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.892 -1.13 . . . . 0.0 109.375 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' HB3' ' OD1' ' A' ' 8' ' ' ASN . 60.1 m 51.88 48.27 23.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 108.633 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.46 3.52 45.72 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.289 -0.882 . . . . 0.0 110.48 -179.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.406 ' HB3' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -131.17 -172.26 2.79 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.918 -1.114 . . . . 0.0 109.659 -179.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.46 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 77.6 m -117.32 130.52 56.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ttmm -57.14 146.75 26.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.787 -1.196 . . . . 0.0 109.667 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 7.0 tm-20 -62.21 129.04 38.94 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.483 -0.761 . . . . 0.0 109.697 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.47 -35.85 3.33 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.398 -2.681 . . . . 0.0 106.398 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.511 ' HB3' ' HA ' ' A' ' 57' ' ' LYS . 7.9 m-85 -126.11 132.14 51.94 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 122.189 0.995 . . . . 0.0 108.661 177.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 57' ' ' LYS . 4.4 m-85 -111.69 -178.11 3.35 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 55' ' ' LYS . . . 127.98 -144.96 15.63 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.421 -1.371 . . . . 0.0 110.083 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.588 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 22.8 m120 -129.06 120.22 20.14 Favored Pre-proline 0 N--CA 1.496 1.825 0 O-C-N 121.597 -0.943 . . . . 0.0 109.066 -179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.46 ' HD3' ' SG ' ' A' ' 39' ' ' CYS . 36.6 Cg_endo -77.41 -18.02 14.22 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 121.979 1.786 . . . . 0.0 111.204 -179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.418 HD13 ' OD2' ' A' ' 7' ' ' ASP . 12.9 tp -109.55 37.11 2.72 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.943 -1.098 . . . . 0.0 110.019 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -92.16 151.43 41.7 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 108.762 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.44 -29.61 9.09 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.155 1.903 . . . . 0.0 109.022 179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -101.26 128.63 28.86 Favored Pre-proline 0 C--N 1.302 -1.474 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -73.76 -12.02 24.13 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.053 1.835 . . . . 0.0 110.469 180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.31 -22.96 59.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.98 -1.075 . . . . 0.0 108.792 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -110.63 15.0 22.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.458 -0.776 . . . . 0.0 108.939 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 0.3 OUTLIER -65.96 -146.89 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.379 -0.826 . . . . 0.0 109.701 -179.508 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 39' ' ' CYS . 71.0 m -90.95 82.44 5.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.018 -1.051 . . . . 0.0 108.417 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 43' ' ' PHE . 1.7 mttm -124.83 -174.61 3.07 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.175 -0.953 . . . . 0.0 109.576 -179.317 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.294 179.801 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 28.0 mtt180 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.44 156.41 36.67 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.395 2.063 . . . . 0.0 110.759 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.74 160.62 9.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.306 -0.871 . . . . 0.0 108.832 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.86 116.08 1.64 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.073 -1.017 . . . . 0.0 110.072 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.9 p -157.88 176.43 12.57 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -51.52 159.35 0.75 Allowed 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 179.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.34 75.34 5.93 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.97 -1.081 . . . . 0.0 109.502 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.898 ' HA ' HD11 ' A' ' 28' ' ' ILE . 50.2 m-20 -145.02 67.03 1.24 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.057 -1.027 . . . . 0.0 110.24 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.53 ' C ' HG12 ' A' ' 28' ' ' ILE . 2.7 pt -149.52 176.95 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.585 ' OD1' HG23 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -106.56 147.36 34.82 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 120.843 -1.161 . . . . 0.0 109.206 -179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.14 -40.24 0.49 Allowed 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.439 2.093 . . . . 0.0 111.201 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.511 ' ND2' ' N ' ' A' ' 12' ' ' ASN . 0.9 OUTLIER -78.34 -5.17 51.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -178.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.32 -168.55 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 119.963 -1.71 . . . . 0.0 109.011 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.9 t -105.7 80.89 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.982 -1.074 . . . . 0.0 110.329 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.93 -22.91 6.28 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 110.247 -1.141 . . . . 0.0 110.247 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 10' ' ' ASP . 22.9 m-80 54.88 15.51 1.16 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.883 -1.363 . . . . 0.0 110.63 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -126.21 159.77 32.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.883 -1.136 . . . . 0.0 109.503 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.507 ' ND2' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -72.7 120.18 17.95 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.723 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 5.4 mtp180 -64.62 -19.65 65.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.869 -178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -97.77 -41.26 8.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.771 -1.205 . . . . 0.0 110.893 -179.155 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.487 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 0.2 OUTLIER -91.94 -64.16 1.15 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.698 -1.251 . . . . 0.0 109.922 -179.935 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' O ' ' OE1' ' A' ' 23' ' ' GLU . . . 116.92 79.16 0.72 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.451 ' OE1' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -178.15 159.3 1.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.984 -1.303 . . . . 0.0 108.259 -179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.448 ' SG ' HG21 ' A' ' 9' ' ' ILE . 1.2 m -47.86 119.23 2.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.604 -1.31 . . . . 0.0 108.648 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.946 ' O ' HD13 ' A' ' 25' ' ' LEU . 1.1 tm? -125.77 27.86 6.32 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.4 -0.812 . . . . 0.0 110.294 -178.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 22.4 mttt -160.2 63.1 0.34 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.965 -1.084 . . . . 0.0 109.927 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.51 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 46.6 m -55.39 150.66 11.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.956 -1.09 . . . . 0.0 109.709 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.898 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -111.8 -64.04 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.122 -0.986 . . . . 0.0 111.816 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 1.084 ' O ' HG23 ' A' ' 31' ' ' THR . 24.5 m-85 -59.5 80.27 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.242 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -177.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.528 ' C ' ' O ' ' A' ' 29' ' ' TYR . 10.1 m-20 24.32 52.65 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-O 121.233 0.539 . . . . 0.0 111.257 177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 1.084 HG23 ' O ' ' A' ' 29' ' ' TYR . 38.2 p -121.45 144.67 48.56 Favored 'General case' 0 C--N 1.294 -1.833 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.075 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.437 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -115.56 -169.82 1.66 Allowed 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.594 -0.691 . . . . 0.0 109.567 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.93 148.1 21.71 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.419 ' HD2' ' CZ ' ' A' ' 35' ' ' TYR . 3.1 t80 -52.66 -27.31 16.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.391 -1.064 . . . . 0.0 109.817 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.419 ' CZ ' ' HD2' ' A' ' 34' ' ' PHE . 0.8 OUTLIER -126.55 37.91 4.22 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.814 -1.178 . . . . 0.0 109.817 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.437 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 1.6 m 52.18 53.5 12.34 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.931 -1.105 . . . . 0.0 108.605 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -97.75 -7.42 30.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.448 -0.782 . . . . 0.0 110.376 -179.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 -174.74 3.46 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.828 -1.17 . . . . 0.0 109.685 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.463 ' SG ' ' HG3' ' A' ' 47' ' ' PRO . 3.2 m -122.15 136.21 54.88 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 179.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tttm -56.21 149.82 15.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.655 -1.278 . . . . 0.0 108.944 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -59.54 132.6 54.49 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.423 -0.798 . . . . 0.0 109.58 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.48 -36.5 3.13 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 106.769 -2.533 . . . . 0.0 106.769 -179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.622 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -124.24 129.58 51.03 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 122.21 1.005 . . . . 0.0 108.999 177.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -113.51 173.35 6.45 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.38 -147.78 19.24 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.635 -1.269 . . . . 0.0 109.975 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 38.6 m-20 -115.27 107.35 49.65 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.435 -1.038 . . . . 0.0 109.53 -179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.521 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 37.7 Cg_endo -79.35 -13.35 13.7 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.246 1.964 . . . . 0.0 110.013 -179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.1 39.07 2.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.419 -0.8 . . . . 0.0 109.828 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -101.78 148.68 35.63 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.111 -0.993 . . . . 0.0 109.407 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.37 -23.32 13.32 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.358 2.039 . . . . 0.0 109.901 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -99.89 135.58 20.42 Favored Pre-proline 0 C--N 1.304 -1.381 0 O-C-N 121.412 -0.805 . . . . 0.0 108.901 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -74.91 -19.89 17.63 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.152 1.901 . . . . 0.0 110.381 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.15 -27.22 59.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 0.0 109.133 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -106.26 38.16 2.11 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.366 -0.834 . . . . 0.0 109.171 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.521 ' NZ ' ' O ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -89.84 -145.07 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.928 . . . . 0.0 109.681 -179.645 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 47' ' ' PRO . 74.9 m -101.47 106.16 17.24 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.155 -0.966 . . . . 0.0 109.719 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.11 173.14 8.93 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.151 -0.968 . . . . 0.0 109.144 179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.507 -179.876 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . 0.496 ' HB2' ' HD2' ' A' ' 2' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD2' ' HB2' ' A' ' 1' ' ' ARG . 35.8 Cg_endo -78.07 -59.47 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.647 2.231 . . . . 0.0 110.772 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 4' ' ' GLN . 29.7 m -80.1 174.71 11.32 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.151 -0.968 . . . . 0.0 109.494 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.577 ' O ' ' C ' ' A' ' 5' ' ' CYS . 15.8 tp60 179.85 -115.73 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.281 -0.887 . . . . 0.0 109.589 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.577 ' C ' ' O ' ' A' ' 4' ' ' GLN . 27.2 p -0.15 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 CA-C-O 121.391 0.615 . . . . 0.0 112.197 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.513 ' HA ' HG12 ' A' ' 9' ' ' ILE . 78.7 m-20 -78.03 -135.84 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.14 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 6' ' ' ASN . 38.1 m-20 74.27 -79.71 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.208 -0.932 . . . . 0.0 110.693 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.492 ' C ' ' CG1' ' A' ' 28' ' ' ILE . 1.8 m120 -115.62 74.07 0.87 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.799 -1.188 . . . . 0.0 110.492 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.568 ' CA ' HG12 ' A' ' 28' ' ' ILE . 2.8 pp -154.22 146.85 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.362 -0.836 . . . . 0.0 108.818 178.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.902 ' OD1' HD13 ' A' ' 28' ' ' ILE . 0.7 OUTLIER -108.93 128.53 25.29 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.185 -0.947 . . . . 0.0 109.407 -179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.13 -14.38 18.78 Favored 'Trans proline' 0 C--N 1.313 -1.331 0 C-N-CA 122.427 2.084 . . . . 0.0 110.602 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -79.32 -72.24 0.4 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.239 -0.913 . . . . 0.0 109.566 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.37 163.05 1.83 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.108 -0.995 . . . . 0.0 109.29 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 13.5 t -108.76 152.13 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.076 -1.015 . . . . 0.0 109.36 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 17' ' ' CYS . . . 112.35 -28.48 9.09 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.497 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 13.6 m-80 -42.72 -26.7 0.14 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.189 -1.183 . . . . 0.0 109.633 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.431 ' HB2' ' HA ' ' A' ' 3' ' ' CYS . 1.7 p -126.06 149.63 48.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 108.998 179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.553 ' OD1' ' N ' ' A' ' 18' ' ' ASN . 0.1 OUTLIER -82.71 126.64 32.59 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.45 -34.0 76.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.734 -1.229 . . . . 0.0 110.215 -179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.07 -34.36 10.43 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.93 -1.106 . . . . 0.0 111.425 -178.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.36 -22.73 23.64 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.659 -1.276 . . . . 0.0 110.378 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.45 69.56 1.25 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.577 ' HB2' ' CE2' ' A' ' 34' ' ' PHE . 0.3 OUTLIER -163.97 169.5 17.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.104 -1.233 . . . . 0.0 108.861 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.438 ' SG ' ' SG ' ' A' ' 36' ' ' CYS . 7.0 m -65.58 101.31 0.59 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.241 -1.537 . . . . 0.0 109.301 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.534 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -85.26 -26.04 26.89 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.18 -0.95 . . . . 0.0 109.804 -179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.89 79.52 1.65 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.061 -1.024 . . . . 0.0 110.787 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.491 ' HB3' ' OG1' ' A' ' 31' ' ' THR . 76.3 m -53.62 152.85 4.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.432 -1.418 . . . . 0.0 108.518 179.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.902 HD13 ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -92.13 -64.85 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.966 -1.084 . . . . 0.0 112.317 -178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 31' ' ' THR . 57.0 m-85 -73.21 71.54 1.19 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.428 -0.795 . . . . 0.0 112.616 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.484 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 31.34 54.22 0.22 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.586 -0.697 . . . . 0.0 111.094 177.812 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 29' ' ' TYR . 11.5 p -122.55 151.74 41.08 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.161 -0.962 . . . . 0.0 109.65 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' CYS . . . -123.49 -163.1 1.09 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 109.82 -179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 90.04 152.86 27.61 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 23' ' ' GLU . 1.1 t80 -51.61 -34.34 36.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -1.105 . . . . 0.0 109.832 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 0.5 OUTLIER -119.67 39.62 3.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.796 -1.19 . . . . 0.0 109.63 -179.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.496 ' HA ' ' O ' ' A' ' 32' ' ' ALA . 39.4 m 50.31 32.64 6.46 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.01 -1.056 . . . . 0.0 109.013 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.31 10.88 20.67 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.403 -0.811 . . . . 0.0 109.707 -179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.52 ' O ' ' CB ' ' A' ' 47' ' ' PRO . 0.0 OUTLIER -131.68 -173.72 3.21 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.107 -0.996 . . . . 0.0 109.529 179.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.431 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 56.4 m -119.97 131.7 55.26 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.22 146.2 24.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.722 -1.236 . . . . 0.0 109.355 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.62 130.27 46.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.561 -0.712 . . . . 0.0 109.614 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.53 -36.52 3.12 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 106.806 -2.517 . . . . 0.0 106.806 -178.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -126.08 129.43 49.1 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.238 1.018 . . . . 0.0 109.001 177.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.462 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 0.1 OUTLIER -110.58 171.93 7.17 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 134.9 -145.02 17.16 Favored Glycine 0 N--CA 1.489 2.21 0 C-N-CA 119.631 -1.271 . . . . 0.0 109.932 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.625 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 11.3 m120 -115.27 108.05 48.5 Favored Pre-proline 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.969 . . . . 0.0 108.793 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.734 ' HB3' HG22 ' A' ' 31' ' ' THR . 34.8 Cg_endo -75.14 -7.73 19.3 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 C-N-CA 121.87 1.714 . . . . 0.0 110.749 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.455 ' HA ' HD13 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -122.09 42.48 3.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.612 179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -91.68 155.58 43.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 120.951 -1.093 . . . . 0.0 108.952 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -75.35 -22.02 14.63 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 122.203 1.935 . . . . 0.0 109.689 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 54' ' ' ASP . 20.1 m-80 -100.82 134.47 20.47 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.528 -0.733 . . . . 0.0 109.157 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.71 -19.19 18.85 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.243 1.962 . . . . 0.0 110.603 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -95.35 12.44 29.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.061 -1.024 . . . . 0.0 109.724 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.469 ' HA ' ' HE3' ' A' ' 57' ' ' LYS . 8.3 m-20 -135.62 30.01 3.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.125 -0.985 . . . . 0.0 109.904 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 39.3 mttm -97.57 -116.8 0.13 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.957 -1.089 . . . . 0.0 110.544 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 2.8 m -100.67 105.69 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.648 -1.283 . . . . 0.0 109.59 -179.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HE3' ' HA ' ' A' ' 54' ' ' ASP . 1.5 mptt -105.54 170.51 7.85 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.259 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.487 -179.941 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 10.5 mtt180 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.37 -76.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.564 2.176 . . . . 0.0 110.213 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . . . . . . . . . 42.4 t -73.71 151.18 40.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -158.13 110.69 2.35 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.083 -1.011 . . . . 0.0 110.42 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' SG ' ' N ' ' A' ' 24' ' ' CYS . 22.7 p -164.95 169.75 16.08 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 178.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 35' ' ' TYR . 28.1 m120 -39.92 147.7 0.09 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.486 -0.759 . . . . 0.0 109.3 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' C ' ' OD1' ' A' ' 8' ' ' ASN . 6.5 t70 -80.81 69.72 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.201 -0.937 . . . . 0.0 110.269 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.957 ' HA ' HD11 ' A' ' 28' ' ' ILE . 2.2 m120 -139.26 64.62 1.46 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.991 -1.068 . . . . 0.0 109.116 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' HA ' HG13 ' A' ' 28' ' ' ILE . 0.1 OUTLIER -154.4 -177.98 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.509 ' O ' ' ND2' ' A' ' 16' ' ' ASN . 43.5 m-20 -107.35 112.47 62.68 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 120.773 -1.205 . . . . 0.0 109.304 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.15 -8.47 17.58 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 122.665 2.244 . . . . 0.0 110.954 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -78.63 -74.1 0.29 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.299 -0.876 . . . . 0.0 109.237 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.28 -167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.107 -0.996 . . . . 0.0 109.269 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 11.3 t -127.16 156.99 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.968 . . . . 0.0 109.451 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.89 -21.89 36.92 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.509 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 28.8 m-80 -52.41 -16.19 0.82 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.245 . . . . 0.0 110.51 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 49.5 t -121.95 149.08 43.95 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.839 -1.163 . . . . 0.0 108.902 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.558 ' OD1' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -76.19 126.62 31.33 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.877 -1.139 . . . . 0.0 108.302 179.744 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -69.16 -39.83 78.55 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.012 -1.055 . . . . 0.0 111.401 -178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.31 -24.92 16.53 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.549 -1.345 . . . . 0.0 111.242 -178.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.535 ' OG1' ' CB ' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -92.55 -32.65 14.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.358 -1.464 . . . . 0.0 109.881 179.792 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' CD ' ' A' ' 23' ' ' GLU . . . 71.25 63.24 3.18 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.595 ' HG2' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -159.89 159.41 32.39 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.104 -1.233 . . . . 0.0 109.258 -179.369 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.498 ' N ' ' SG ' ' A' ' 5' ' ' CYS . 23.3 m -55.83 114.85 2.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.606 -1.309 . . . . 0.0 109.132 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.558 ' HB2' ' OD1' ' A' ' 18' ' ' ASN . 0.0 OUTLIER -97.91 -34.49 10.82 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.884 -1.135 . . . . 0.0 109.862 -179.538 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.1 tttm -123.21 83.05 2.07 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.197 -0.939 . . . . 0.0 110.376 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.559 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 65.1 m -53.91 155.71 3.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.488 -1.383 . . . . 0.0 109.278 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.957 HD11 ' HA ' ' A' ' 8' ' ' ASN . 0.5 OUTLIER -107.13 -64.02 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 O-C-N 120.84 -1.163 . . . . 0.0 112.86 -178.89 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.764 ' H ' HD12 ' A' ' 28' ' ' ILE . 55.4 m-85 -59.21 81.28 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.294 -0.879 . . . . 0.0 112.091 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.531 ' C ' ' O ' ' A' ' 29' ' ' TYR . 76.2 m-20 22.99 50.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.304 0.573 . . . . 0.0 111.254 178.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.554 HG23 ' O ' ' A' ' 29' ' ' TYR . 1.2 p -121.54 151.28 40.5 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 119.202 -0.999 . . . . 0.0 110.057 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -121.72 176.47 5.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.386 -0.821 . . . . 0.0 110.146 -179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.9 152.23 24.72 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.425 ' HD2' ' CE1' ' A' ' 35' ' ' TYR . 5.0 t80 -56.56 -32.0 64.75 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.29 -1.123 . . . . 0.0 109.714 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.595 ' CE2' ' HG2' ' A' ' 23' ' ' GLU . 26.2 m-85 -117.33 22.38 12.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.917 -1.114 . . . . 0.0 109.245 179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.8 m 61.17 61.26 1.61 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.475 ' OD1' ' N ' ' A' ' 37' ' ' ASP . 0.6 OUTLIER -90.28 -21.59 22.0 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.304 -0.873 . . . . 0.0 111.286 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 41.3 mtm-85 -131.9 -174.26 3.37 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.584 -1.322 . . . . 0.0 109.596 -179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 43' ' ' PHE . 34.1 m -112.62 137.55 50.72 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -55.43 156.9 4.12 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.488 -1.382 . . . . 0.0 109.604 -178.32 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -59.32 123.94 18.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.55 -0.719 . . . . 0.0 109.168 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 123.24 -30.52 4.97 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 107.111 -2.395 . . . . 0.0 107.111 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' CD2' ' HB3' ' A' ' 30' ' ' ASN . 6.0 m-85 -127.04 128.46 46.35 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-O 122.272 1.034 . . . . 0.0 109.109 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 56' ' ' CYS . 1.0 OUTLIER -108.45 -156.85 0.59 Allowed 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 113.53 -151.48 18.32 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.349 -1.405 . . . . 0.0 110.323 179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 55' ' ' LYS . 13.4 m120 -135.06 104.77 10.45 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.446 -1.032 . . . . 0.0 109.966 -179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' A' ' 31' ' ' THR . 36.1 Cg_endo -78.01 1.48 8.88 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.028 1.819 . . . . 0.0 109.857 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.415 ' HA ' HD22 ' A' ' 48' ' ' LEU . 2.1 mm? -108.8 38.22 2.32 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.812 . . . . 0.0 108.863 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -112.52 148.5 39.34 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.447 -0.783 . . . . 0.0 109.142 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -73.92 -28.52 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.23 1.954 . . . . 0.0 109.894 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -101.19 140.99 21.73 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.414 -0.804 . . . . 0.0 109.123 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.95 -11.75 21.59 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.233 1.955 . . . . 0.0 110.39 179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.34 -18.84 60.63 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.942 -1.098 . . . . 0.0 109.099 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -117.21 30.13 7.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.347 -0.846 . . . . 0.0 109.018 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 46' ' ' ASN . 1.2 ttmt -87.21 -139.66 0.1 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -0.795 . . . . 0.0 109.175 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 44' ' ' PHE . 56.6 m -91.96 162.65 14.31 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 120.951 -1.093 . . . . 0.0 109.242 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.498 ' CG ' ' O ' ' A' ' 56' ' ' CYS . 1.3 mmtp 174.39 -167.89 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 0.0 109.348 -179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 118.067 -0.968 . . . . 0.0 109.485 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ARG . . . . . . . . . . . . . 4.6 mmt180 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.539 ' O ' ' N ' ' A' ' 4' ' ' GLN . 35.2 Cg_endo -75.6 -94.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.313 -1.32 0 C-N-CA 122.203 1.935 . . . . 0.0 110.124 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' CYS . . . . . 0.455 ' O ' ' C ' ' A' ' 4' ' ' GLN . 0.1 OUTLIER 48.47 -87.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 0.0 110.518 179.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.539 ' N ' ' O ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER -37.81 130.63 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.394 -0.816 . . . . 0.0 110.49 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.48 ' O ' HG12 ' A' ' 9' ' ' ILE . 6.4 p -151.02 108.33 3.61 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.433 -0.792 . . . . 0.0 109.203 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.595 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 8.2 m-20 -54.63 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.287 -0.883 . . . . 0.0 110.18 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.595 ' CB ' ' O ' ' A' ' 6' ' ' ASN . 49.7 m-20 102.89 -102.35 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 27' ' ' CYS . 5.3 m120 -120.97 67.57 0.87 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.857 -1.152 . . . . 0.0 109.546 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.569 ' CA ' HG12 ' A' ' 28' ' ' ILE . 1.4 pt -139.18 162.13 27.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.109 -0.995 . . . . 0.0 109.598 179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.699 ' CG ' HG21 ' A' ' 28' ' ' ILE . 58.5 m-20 -106.77 119.34 51.78 Favored Pre-proline 0 N--CA 1.491 1.615 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.66 -4.14 14.63 Favored 'Trans proline' 0 C--N 1.315 -1.208 0 C-N-CA 122.684 2.256 . . . . 0.0 111.234 -179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -78.69 -68.76 0.62 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.358 -0.839 . . . . 0.0 109.85 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.27 171.04 10.52 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.989 -1.069 . . . . 0.0 110.039 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 15' ' ' GLY . 35.9 t -111.44 164.64 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.457 -0.777 . . . . 0.0 109.302 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.51 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 98.05 4.61 57.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.432 ' ND2' ' O ' ' A' ' 10' ' ' ASP . 8.4 m-80 -63.26 -0.92 0.9 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.837 -1.39 . . . . 0.0 111.669 -178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 13.9 p -128.41 158.23 38.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.334 -1.479 . . . . 0.0 109.747 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.634 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -71.59 130.14 40.47 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 8.8 mtm-85 -58.84 -35.98 73.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.73 -1.231 . . . . 0.0 111.786 -178.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.15 -34.24 10.12 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.545 -1.347 . . . . 0.0 112.158 -177.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.457 ' OG1' ' HB2' ' A' ' 18' ' ' ASN . 2.6 p -83.86 -34.15 24.67 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.431 -1.418 . . . . 0.0 110.446 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.77 66.68 1.99 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 -179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.464 ' O ' ' OD1' ' A' ' 18' ' ' ASN . 8.5 tp10 -162.32 160.9 27.23 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 108.832 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' CYS . . . . . 0.403 ' SG ' HG21 ' A' ' 9' ' ' ILE . 4.5 m -48.18 120.08 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.975 -1.078 . . . . 0.0 108.348 179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.634 HD23 ' HA ' ' A' ' 18' ' ' ASN . 8.7 tp -125.65 15.62 8.14 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.294 -0.878 . . . . 0.0 110.724 -177.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 25' ' ' LEU . 12.2 mtpt -159.07 77.89 0.74 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.131 -0.98 . . . . 0.0 109.586 179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 8' ' ' ASN . 13.7 m -57.86 155.25 10.73 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.666 -1.271 . . . . 0.0 110.189 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.699 HG21 ' CG ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -111.26 -63.77 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 O-C-N 121.111 -0.993 . . . . 0.0 112.244 -179.632 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.833 ' O ' HG23 ' A' ' 31' ' ' THR . 25.5 m-85 -68.15 72.53 0.19 Allowed 'General case' 0 N--CA 1.506 2.34 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -176.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' C ' ' O ' ' A' ' 29' ' ' TYR . 0.3 OUTLIER 33.09 52.67 0.35 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 111.476 177.621 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 29' ' ' TYR . 20.3 p -122.07 145.15 48.43 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.955 -1.09 . . . . 0.0 109.091 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.497 ' O ' ' CB ' ' A' ' 38' ' ' ARG . . . -124.56 166.21 16.48 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 120.39 155.38 9.61 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -56.04 -30.35 61.79 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.295 -1.121 . . . . 0.0 109.949 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.49 29.41 7.88 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.837 -1.164 . . . . 0.0 109.628 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 56.3 m 49.84 43.25 24.89 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.193 -0.942 . . . . 0.0 109.705 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -108.38 21.29 17.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.264 -0.897 . . . . 0.0 109.6 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.497 ' CB ' ' O ' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -130.33 -179.22 5.13 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.223 -0.923 . . . . 0.0 108.874 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . 0.423 ' SG ' ' HD3' ' A' ' 47' ' ' PRO . 1.4 m -121.4 136.96 54.9 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 -179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.413 ' HB3' ' OD1' ' A' ' 30' ' ' ASN . 4.9 ttmt -55.77 138.14 48.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.717 -1.24 . . . . 0.0 109.805 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 41' ' ' GLU . 5.0 pt-20 -61.09 130.54 46.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.597 -0.689 . . . . 0.0 109.815 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 122.74 -34.96 3.57 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 106.894 -2.482 . . . . 0.0 106.894 -179.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.545 ' CB ' ' O ' ' A' ' 56' ' ' CYS . 13.9 m-85 -130.53 131.74 45.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-O 122.133 0.968 . . . . 0.0 108.479 177.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . 0.45 ' O ' ' N ' ' A' ' 57' ' ' LYS . 2.3 m-85 -105.53 -179.91 4.08 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 132.34 -145.22 17.09 Favored Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.886 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 54' ' ' ASP . 30.6 m120 -118.73 111.93 37.27 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.547 -0.972 . . . . 0.0 109.349 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.491 ' CB ' HG22 ' A' ' 31' ' ' THR . 36.3 Cg_endo -78.63 -29.1 3.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 122.353 2.035 . . . . 0.0 110.731 -179.45 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.16 44.93 1.34 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.929 . . . . 0.0 109.989 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -88.67 154.06 50.4 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.002 -1.062 . . . . 0.0 108.859 179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -72.73 -31.13 10.87 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.019 1.813 . . . . 0.0 108.83 179.675 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -101.94 139.33 20.22 Favored Pre-proline 0 C--N 1.3 -1.547 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' O ' ' CG ' ' A' ' 55' ' ' LYS . 33.5 Cg_endo -75.18 0.77 8.58 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.048 1.832 . . . . 0.0 109.869 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -83.95 -13.6 53.0 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.701 -1.249 . . . . 0.0 109.248 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 46' ' ' ASN . 4.0 m-20 -111.03 40.37 2.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 0.0 109.293 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.562 ' CG ' ' O ' ' A' ' 52' ' ' PRO . 0.0 OUTLIER -70.43 -155.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.168 -0.957 . . . . 0.0 109.057 -179.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.545 ' O ' ' CB ' ' A' ' 43' ' ' PHE . 5.9 m -101.37 90.57 4.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 178.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' CA ' ' HB3' ' A' ' 43' ' ' PHE . 0.0 OUTLIER -114.84 177.04 4.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.958 -1.089 . . . . 0.0 109.571 -179.56 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 117.959 -1.019 . . . . 0.0 109.61 -179.917 . . . . . . . . 0 0 . 1 stop_ save_